NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN PESTS

Abstract

This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby.

Description

PRIORITY CLAIM

[0001] This application is a divisional of U.S. patent application Ser. No. 14/577,854 filed on Dec. 19, 2014, which claims the benefit of the filing date of U.S. Provisional Patent Application Ser. No. 61/919,239, filed Dec. 20, 2014, the disclosures of which are hereby incorporated herein in their entirety by this reference.

TECHNICAL FIELD OF THE DISCLOSURE

[0002] The present disclosure relates generally to control of plant damage caused by coleopteran pests. In particular embodiments, the present disclosure relates to identification of target coding and non-coding sequences, and the use of nucleic acid technologies for post-transcriptionally repressing or inhibiting expression of target coding and non-coding sequences in the cells of a coleopteran pest to provide a plant protective effect.

BACKGROUND

[0003] The western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte, is one of the most devastating corn rootworm species in North America and is a particular concern in corn-growing areas of the Midwestern United States. The northern corn rootworm (NCR), Diabrotica barberi Smith and Lawrence, is a closely-related species that co-inhabits much of the same range as WCR. There are several other related subspecies of Diabrotica that are significant pests in North America: the Mexican corn rootworm (MCR), D. virgifera zeae Krysan and Smith; the southern corn rootworm (SCR), D. undecimpunctata howardi Barber; D. balteata LeConte; D. undecimpunctata tenella; and D. u. undecimpunctata Mannerheim. The United States Department of Agriculture currently estimates that corn rootworms cause $1 billion in lost revenue each year, including $800 million in yield loss and $200 million in treatment costs.

[0004] Both WCR and NCR eggs are deposited in the soil during the summer. The insects remain in the egg stage throughout the winter. The eggs are oblong, white, and less than 0.004 inches (0.010 cm) in length. The larvae hatch in late May or early June, with the precise timing of egg hatching varying from year to year due to temperature differences and location. The newly hatched larvae are white worms that are less than 0.125 inches (0.3175 cm) in length. Once hatched, the larvae begin to feed on corn roots. Corn rootworms go through three larval instars. After feeding for several weeks, the larvae molt into the pupal stage. They pupate in the soil, and then they emerge from the soil as adults in July and August. Adult rootworms are about 0.25 inches (0.635 cm) in length.

[0005] Corn rootworm larvae complete development on corn and several other species of grasses. Larvae reared on yellow foxtail emerge later and have a smaller head capsule size as adults than larvae reared on corn. Ellsbury et al. (2005) Environ. Entomol. 34:627-634. WCR adults feed on corn silk, pollen, and kernels on exposed ear tips. If WCR adults emerge before corn reproductive tissues are present, they may feed on leaf tissue, thereby slowing plant growth and occasionally killing the host plant. However, the adults will quickly shift to preferred silks and pollen when they become available. NCR adults also feed on reproductive tissues of the corn plant, but in contrast rarely feed on corn leaves.

[0006] Most of the rootworm damage in corn is caused by larval feeding. Newly hatched rootworms initially feed on fine corn root hairs and burrow into root tips. As the larvae grow larger, they feed on and burrow into primary roots. When corn rootworms are abundant, larval feeding often results in the pruning of roots all the way to the base of the corn stalk. Severe root injury interferes with the roots' ability to transport water and nutrients into the plant, reduces plant growth, and results in reduced grain production, thereby often drastically reducing overall yield. Severe root injury also often results in lodging of corn plants, which makes harvest more difficult and further decreases yield. Furthermore, feeding by adults on the corn reproductive tissues can result in pruning of silks at the ear tip. If this "silk clipping" is severe enough during pollen shed, pollination may be disrupted.

[0007] Control of corn rootworms may be attempted by crop rotation, chemical insecticides, biopesticides (e.g., the spore-forming gram-positive bacterium, Bacillus thuringiensis), or a combination thereof. Crop rotation suffers from the significant disadvantage of placing unwanted restrictions upon the use of farmland. Moreover, oviposition of some rootworm species may occur in soybean fields, thereby mitigating the effectiveness of crop rotation practiced with corn and soybean.

[0008] European pollen beetles (EPB) are serious pests in oilseed rape, both the larvae and adults feed on flowers and pollen. Pollen beetle damage to the crop can cause 20-40% yield loss. The primary pest species is Meligethes aeneus. Currently, pollen beetle control in oilseed rape relies mainly on pyrethroids which are expected to be phased out soon because of their environmental and regulatory profile. Moreover, pollen beetle resistance to existing chemical insecticides has been reported. Therefore, urgently needed are environmentally friendly pollen beetle control solutions with novel modes of action.

[0009] In nature, pollen beetles overwinter as adults in the soil or under leaf litter. In spring the adults emerge from hibernation and start feeding on flowers of weeds, and migrate onto flowering oilseed rape plants. The eggs are laid in oilseed rape flower buds. The larvae feed and develop in the buds and on the flowers. Late stage larvae find a pupation site in the soil. The second generation of adults emerge in July and August and feed on various flowering plants before finding sites for overwintering.

[0010] Chemical insecticides are the most heavily relied upon strategy for achieving corn rootworm control. Chemical insecticide use, though, is an imperfect corn rootworm control strategy; over $1 billion may be lost in the United States each year due to corn rootworm when the costs of the chemical insecticides are added to the costs of the rootworm damage that may occur despite the use of the insecticides. High populations of larvae, heavy rains, and improper application of the insecticide(s) may all result in inadequate corn rootworm control. Furthermore, the continual use of insecticides may select for insecticide-resistant rootworm strains, as well as raise significant environmental concerns due to the toxicity of many of them to non-target species.

[0011] RNA interference (RNAi) is a process utilizing endogenous cellular pathways, whereby an interfering RNA (iRNA) molecule (e.g., a dsRNA molecule) that is specific for all, or any portion of adequate size, of a target gene sequence results in the degradation of the mRNA encoded thereby. In recent years, RNAi has been used to perform gene "knockdown" in a number of species and experimental systems; for example, Caenorhabitis elegans, plants, insect embryos, and cells in tissue culture. See, e.g., Fire et al. (1998) Nature 391:806-811; Martinez et al. (2002) Cell 110:563-574; McManus and Sharp (2002) Nature Rev. Genetics 3:737-747.

[0012] RNAi accomplishes degradation of mRNA through an endogenous pathway including the DICER protein complex. DICER cleaves long dsRNA molecules into short fragments of approximately 20 nucleotides, termed small interfering RNA (siRNA). The siRNA is unwound into two single-stranded RNAs: the passenger strand and the guide strand. The passenger strand is degraded, and the guide strand is incorporated into the RNA-induced silencing complex (RISC). Micro inhibitory ribonucleic acid (miRNA) molecules may be similarly incorporated into RISC. Post-transcriptional gene silencing occurs when the guide strand binds specifically to a complementary sequence of an mRNA molecule and induces cleavage by Argonaute, the catalytic component of the RISC complex. This process is known to spread systemically throughout the organism despite initially limited concentrations of siRNA and/or miRNA in some eukaryotes such as plants, nematodes, and some insects.

[0013] Only transcripts complementary to the siRNA and/or miRNA are cleaved and degraded, and thus the knock-down of mRNA expression is sequence-specific. In plants, several functional groups of DICER genes exist. The gene silencing effect of RNAi persists for days and, under experimental conditions, can lead to a decline in abundance of the targeted transcript of 90% or more, with consequent reduction in levels of the corresponding protein.

[0014] U.S. Pat. No. 7,612,194 and U.S. Patent Publication Nos. 2007/0050860, 2010/0192265, and 2011/0154545 disclose a library of 9112 expressed sequence tag (EST) sequences isolated from D. v. virgifera LeConte pupae. It is suggested in U.S. Pat. No. 7,612,194 and U.S. Patent Publication No. 2007/0050860 to operably link to a promoter a nucleic acid molecule that is complementary to one of several particular partial sequences of D. v. virgifera vacuolar-type H+-ATPase (V-ATPase) disclosed therein for the expression of anti-sense RNA in plant cells. U.S. Patent Publication No. 2010/0192265 suggests operably linking a promoter to a nucleic acid molecule that is complementary to a particular partial sequence of a D. v. virgifera gene of unknown and undisclosed function (the partial sequence is stated to be 58% identical to C56C10.3 gene product in C. elegans) for the expression of anti-sense RNA in plant cells. U.S. Patent Publication No. 2011/0154545 suggests operably linking a promoter to a nucleic acid molecule that is complementary to two particular partial sequences of D. v. virgifera coatomer beta subunit genes for the expression of anti-sense RNA in plant cells. Further, U.S. Pat. No. 7,943,819 discloses a library of 906 expressed sequence tag (EST) sequences isolated from D. v. virgifera LeConte larvae, pupae, and dissected midguts, and suggests operably linking a promoter to a nucleic acid molecule that is complementary to a particular partial sequence of a D. v. virgifera charged multivesicular body protein 4b gene for the expression of double-stranded RNA in plant cells.

[0015] No further suggestion is provided in U.S. Pat. No. 7,612,194, and U.S. Patent Publication Nos. 2007/0050860, 2010/0192265 and 2011/0154545 to use any particular sequence of the more than nine thousand sequences listed therein for RNA interference, other than the several particular partial sequences of V-ATPase and the particular partial sequences of genes of unknown function. Furthermore, none of U.S. Pat. No. 7,612,194, and U.S. Patent Publication Nos. 2007/0050860 and 2010/0192265, and 2011/0154545 provides any guidance as to which other of the over nine thousand sequences provided would be lethal, or even otherwise useful, in species of corn rootworm when used as dsRNA or siRNA. U.S. Pat. No. 7,943,819 provides no suggestion to use any particular sequence of the more than nine hundred sequences listed therein for RNA interference, other than the particular partial sequence of a charged multivesicular body protein 4b gene. Furthermore, U.S. Pat. No. 7,943,819 provides no guidance as to which other of the over nine hundred sequences provided would be lethal, or even otherwise useful, in species of corn rootworm when used as dsRNA or siRNA. U.S. Patent Application Publication No. U.S. 2013/040173 and PCT Application Publication No. WO 2013/169923 describe the use of a sequence derived from a Diabrotica virgifera Snf7 gene for RNA interference in maize. (Also disclosed in Bolognesi et al. (2012) PLos ONE 7(10): e47534. doi: 10.1371/journal.pone.0047534).

[0016] The overwhelming majority of sequences complementary to corn rootworm DNAs (such as the foregoing) are not lethal in species of corn rootworm when used as dsRNA or siRNA. For example, Baum et al. (2007, Nature Biotechnology 25:1322-1326), describe the effects of inhibiting several WCR gene targets by RNAi. These authors reported that the 8 of 26 target genes they tested were not able to provide experimentally significant coleopteran pest mortality at a very high iRNA (e.g., dsRNA) concentration of more than 520 ng/cm.sup.2.

SUMMARY OF THE DISCLOSURE

[0017] Disclosed herein are nucleic acid molecules (e.g., target genes, DNAs, iRNAs, dsRNAs, siRNAs, miRNAs, and hpRNAs), and methods of use thereof, for the control of coleopteran pests, including, for example, D. v. virgifera LeConte (western corn rootworm, "WCR"); D. barberi Smith and Lawrence (northern corn rootworm, "NCR"); D. u. howardi Barber (southern corn rootworm, "SCR"); D. v. zeae Krysan and Smith (Mexican corn rootworm, "MCR"); D. balteata LeConte; D. u. tenella; D. u. undecimpunctata Mannerheim; Meligethes aeneus Fabricius (pollen beetle, "PB"). In particular examples, exemplary nucleic acid molecules are disclosed that may be homologous to at least a portion of one or more native nucleic acid sequences in a coleopteran pest.

[0018] In these and further examples, the native nucleic acid sequence may be a target gene, the product of which may be, for example and without limitation: involved in a metabolic process; involved in a reproductive process; or involved in larval development. In some examples, post-translational inhibition of the expression of a target gene by a nucleic acid molecule comprising a sequence homologous thereto may be lethal in coleopteran pests, or result in reduced growth and/or reproduction. In specific examples, a gene encoding RNA polymerase II-140 (the encoded protein being referred to herein as RNAPII-140, and a nucleic acid encoding RNAPII-140 being referred to herein as rnapII-140), may be selected as a target gene for post-transcriptional silencing. In particular examples, a target gene useful for post-transcriptional inhibition is the novel gene referred to herein as rnapII-140. An isolated nucleic acid molecule comprising a nucleotide sequence of rnapII-140 (e.g. SEQ ID NO: 1, SEQ ID NO:73, SEQ ID NO:75, and SEQ ID NO:81); the complement of rnapII-140 (e.g. SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, and SEQ ID NO:81); and fragments of any of the foregoing is, therefore, disclosed herein.

[0019] Also disclosed are nucleic acid molecules comprising a nucleotide sequence that encodes a polypeptide that is at least 85% identical to an amino acid sequence within a target gene product (for example, RNAPII-140, the product of rnapII-140). For example, a nucleic acid molecule may comprise a nucleotide sequence encoding a polypeptide that is at least 85% identical to an amino acid sequence of SEQ ID NO:2, SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:80, or SEQ ID NO:82 (RNAPII-140). In particular examples, a nucleic acid molecule comprises a nucleotide sequence encoding a polypeptide that is at least 85% identical to an amino acid sequence within RNAPII-140. Further disclosed are nucleic acid molecules comprising a nucleotide sequence that is the reverse complement of a nucleotide sequence that encodes a polypeptide at least 85% identical to an amino acid sequence within a target gene product.

[0020] Also disclosed are nucleic acid cDNA sequences that may be used for the production of iRNA (e.g., dsRNA, siRNA, miRNA, and hpRNA) molecules that are complementary to all or part of a coleopteran pest target gene, for example: rnapII-140. In particular embodiments, dsRNAs, siRNAs, miRNAs, and/or hpRNAs may be produced in vitro, or in vivo by a genetically-modified organism, such as a plant or bacterium. In particular examples, cDNA molecules are disclosed that may be used to produce iRNA molecules that are complementary to all or part of rnapII-140 (e.g. SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, and SEQ ID NO:81).

[0021] Further disclosed are means for inhibiting expression of an essential gene in a coleopteran pest, and means for providing coleopteran pest resistance to a plant. Examples of means for inhibiting expression of an essential gene in a coleopteran pest, include, but are not limited to, a single- or double-stranded RNA molecule consisting of at least one of SEQ ID NO:3 (rnapII-140 region 1; herein sometimes referred to as rnapII reg1), SEQ ID NO:4 (rnapII-140 region 2, herein sometimes referred to as rnapII reg2), SEQ ID NO:5 (rnapII-140 region 3, herein sometimes referred to as rnapII reg3), SEQ ID NO:77 (rnapII-140 region 1; herein sometimes referred to as PB rnapII reg1), or the complement thereof. Functional equivalents of means for inhibiting expression of an essential gene in a coleopteran pest include, but are not limited to, single- or double-stranded RNA molecules that are substantially homologous to all or part of a WCR gene comprising SEQ ID NO: 1. Functional equivalents of means for inhibiting expression of an essential gene in a coleopteran pest include, but are not limited to, single- or double-stranded RNA molecules that are substantially homologous to all or part of a PB gene comprising SEQ ID NO:73, SEQ ID NO:75, or SEQ ID NO:81. A means for providing coleopteran pest resistance to a plant may be a DNA molecule comprising a nucleic acid sequence encoding a means for inhibiting expression of an essential gene in a coleopteran pest operably linked to a promoter, wherein the DNA molecule is capable of being integrated into the genome of a maize plant.

[0022] Disclosed are methods for controlling a population of a coleopteran pest, comprising providing to a coleopteran pest an iRNA (e.g., dsRNA, siRNA, miRNA, and hpRNA) molecule that functions upon being taken up by the coleopteran pest to inhibit a biological function within the coleopteran pest, wherein the iRNA molecule comprises all or part of a nucleotide sequence selected from the group consisting of: SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; the complement of SEQ ID NO: 1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; a native coding sequence of a Diabrotica organism (e.g., WCR) comprising all or part of any of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; the complement of a native coding sequence of a Diabrotica organism comprising all or part of any of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising all or part of any of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; and the complement of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising all or part of any of SEQ ID NO: 1, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; a native coding sequence of a Meligethes organism (e.g., PB) comprising all or part of any of SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; the complement of a native coding sequence of a Meligethes organism comprising all or part of any of SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising all or part of any of SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; and the complement of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising all or part of any of SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81.

[0023] In particular examples, methods are disclosed for controlling a population of a coleopteran pest, comprising providing to a coleopteran pest an iRNA (e.g., dsRNA, siRNA, miRNA, and hpRNA) molecule that functions upon being taken up by the coleopteran pest to inhibit a biological function within the coleopteran pest, wherein the iRNA molecule comprises a nucleotide sequence selected from the group consisting of: all or part of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; the complement of all or part of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; all or part of a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; all or part of the complement of a native coding sequence of a Diabrotica organism comprising SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; all or part of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; and all or part of the complement of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO: 1, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5; all or part of a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; all or part of the complement of a native coding sequence of a Meligethes organism comprising SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; all or part of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81; and all or part of the complement of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81.

[0024] Also disclosed herein are methods wherein dsRNAs, siRNAs, miRNAs, and/or hpRNAs may be provided to a coleopteran pest by injection assay, diet, being sprayed onto plants, or in genetically-modified plant cells expressing the dsRNAs, siRNAs, miRNAs, and/or hpRNAs. In these and further examples, the dsRNAs, siRNAs, miRNAs, and/or hpRNAs may be ingested by coleopteran pest larvae and/or adults. Ingestion of dsRNAs, siRNA, miRNAs, and/or hpRNAs disclosed herein may then result in RNAi in the larvae and/or adults, which in turn may result in silencing of a gene essential for viability of the coleopteran pest and leading ultimately to larval and/or adult mortality. Thus, methods are disclosed wherein nucleic acid molecules comprising exemplary nucleic acid sequence(s) useful for control of coleopteran pests are provided to a coleopteran pest. In particular examples, the coleopteran pest controlled by use of nucleic acid molecules described herein may be WCR, NCR, SCR, or PB. The foregoing and other features will become more apparent from the following Detailed Description of several embodiments, which proceeds with reference to the accompanying figures.

BRIEF DESCRIPTION OF THE FIGURES

[0025] FIGS. 1 and 2 include depictions of the strategies used to provide specific templates for dsRNA production.

SEQUENCE LISTING

[0026] The nucleic acid sequences listed in the accompanying sequence listing are shown using standard letter abbreviations for nucleotide bases, as defined in 37 C.F.R. .sctn. 1.822. Only one strand of each nucleic acid sequence is shown, but the complementary strand and reverse complementary strand are understood as included by any reference to the displayed strand. In the accompanying sequence listing:

[0027] SEQ ID NO:1 shows a DNA sequence of rnapII-140 from Diabrotica.

[0028] SEQ ID NO:2 shows an amino acid sequence of an RNAPII-140 protein from Diabrotica.

[0029] SEQ ID NO:3 shows a DNA sequence from Diabrotica of rnapII-140 region 1 that was used for in vitro dsRNA synthesis (T7 promoter sequences at 5' and 3' ends not shown).

[0030] SEQ ID NO:4 shows a DNA sequence from Diabrotica of rnapII-140 region 2 that was used for in vitro dsRNA synthesis (T7 promoter sequences at 5' and 3' ends not shown).

[0031] SEQ ID NO:5 shows a DNA sequence from Diabrotica of rnapII-140 region 3 that was used for in vitro dsRNA synthesis (T7 promoter sequences at 5' and 3' ends not shown).

[0032] SEQ ID NO:6 shows a DNA sequence of a T7 phage promoter

[0033] SEQ ID NO:7 shows a DNA sequence of a YFP coding region segment that was used for in vitro dsRNA synthesis (T7 promoter sequences at 5' and 3' ends not shown).

[0034] SEQ ID NOs:8 to 15 show primers used to amplify portions of an rnapII-140 sequence comprising rnapII-140 region 1, rnapII-140 region 2, and rnapII-140 region 3, and primers used to amplify a YFP coding region segment.

[0035] SEQ ID NO:16 presents an rnapII-140 hairpin-RNA-forming sequence v1 as found in pDAB114524. Upper case bases are rnapII-140 sense strand, underlined lower case bases comprise an ST-LS1 intron, non-underlined lower case bases are rnapII-140 antisense strand.

TABLE-US-00001 AAATAAGAGACTCGATTTGGCTGGACCATTATTGGCTTTCCTCTTCAGAG GGCTTTTCAAGAACCTAATGAAAGAAGTTCGTATGTATGCCCAGAAGTTT ATCGATAGAGGCAAAGATTTCAATCTGGATCTGGCCATCAAAACCAAACT AATAACGGACGGTCTGAGGTATTCTCTCGCgactagtaccggttgggaaa ggtatgtttctgcttctacctttgatatatatataataattatcactaat tagtagtaatatagtatttcaagtatttttttcaaaataaaagaatgtag tatatagctattgcttttctgtagtttataagtgtgtatattttaattta taacttttctaatatatgaccaaaacatggtgatgtgcaggttgatccgc ggttagcgagagaatacctcagaccgtccgttattagtttggttttgatg gccagatccagattgaaatattgcctctatcgataaacttctgggcatac atacgaacttctttcattaggttcttgaaaagccactgaagaggaaagcc aataatggtccagccaaatcgagtacttattt

[0036] SEQ ID NO: 17 presents an rnapII-140 hairpin-RNA-forming sequence v2 as found in pDAB114525. Upper case bases are rnapII-140 sense strand, underlined lower case bases comprise an ST-LS1 intron, non-underlined lower case bases are rnapII-140 antisense strand.

TABLE-US-00002 TTCTGCAGTAGAAAGAGGATTTTTCAGATCTGTGTTTTACCGGTCTTATA AAGACGCCGAATCCAAACGTATAGGAGACCAGGAAGAACAATTCGAAAAA CCGACAAGACAGACGTGCCAGGGCATGAGGAATGCCCTTTACGATAAATT AGACGACGACgactagtaccggttgggaaaggtatgtttctgatctacct ttgatatatatataataattatcactaattagtagtaatatagtatttca agtattatttcaaaataaaagaatgtagtatatagctattgcattctgta gtttataagtgtgtatattttaatttataacttttctaatatatgaccaa aacatggtgatgtgcaggttgatccgcggttagtcgtcgtctaatttatc gtaaagggcattcctcatgccctggcacgtagtcttgtcggtttttcgaa ttgttcttcctggtacctatacgtttggattcggcgtctttataagaccg gtaaaacacagatctgaaaaatcctctttctactgcagaa

[0037] SEQ ID NO:18 presents a YFP hairpin-RNA-forming sequence v2 as found in pDAB110853. Upper case bases are YFP sense strand, underlined bases comprise an ST-LS1 intron, lower case, non-underlined bases are YFP antisense strand.

TABLE-US-00003 ATGTCATCTGGAGCACTTCTCTTTCATGGGAAGATTCCTTACGTTGTGGA GATGGAAGGGAATGTTGATGGCCACACCTTTAGCATACGTGGGAAAGGCT ACGGAGATGCCTCAGTGGGAAAGgactagtaccggttgggaaaggtatgt ttctgatctacctttgatatatatataataattatcactaattagtagta atatagtatttcaagtatttttttcaaaataaaagaatgtagtatatagc tattgcttttctgtagtttataagtgtgtatattttaatttataactttt ctaatatatgaccaaaacatggtgatgtgcaggttgatccgcggttactt tcccactgaggcatctccgtagcctttcccacgtatgctaaaggtgtggc catcaacattccatccatctccacaacgtaaggaatcttcccatgaaaga gaagtgctccagatgacat

[0038] SEQ ID NO: 19 shows a sequence of an ST-LS1 intron

[0039] SEQ ID NO:20 shows a DNA sequence that encodes a yellow fluorescent protein (YFP) as found in plasmid pDAB110556.

[0040] SEQ ID NO:21 shows a DNA sequence of Annexin region 1.

[0041] SEQ ID NO:22 shows a DNA sequence of Annexin region 2.

[0042] SEQ ID NO:23 shows a DNA sequence of Beta spectrin 2 region 1.

[0043] SEQ ID NO:24 shows a DNA sequence of Beta spectrin 2 region 2.

[0044] SEQ ID NO:25 shows a DNA sequence of mtRP-L4 region 1.

[0045] SEQ ID NO:26 shows a DNA sequence of mtRP-L4 region 2.

[0046] SEQ ID NOs:27 to 50 show primers used to amplify gene regions of Annexin, Beta spectrin 2, mtRP-L4, and YFP for dsRNA synthesis.

[0047] SEQ ID NO:51 shows a maize DNA sequence encoding a TIP41-like protein.

[0048] SEQ ID NO:52 shows a DNA sequence of oligonucleotide T20NV.

[0049] SEQ ID NOs:53 to 57 show primers and probes used to measure transcript levels in maize tissues.

[0050] SEQ ID NO:58 shows a DNA sequence of a portion of a SpecR coding region used for binary vector backbone detection.

[0051] SEQ ID NO:59 shows a DNA sequence of a portion of an AAD1 coding region used for genomic copy number analysis.

[0052] SEQ ID NO:60 shows a DNA sequence of a maize invertase gene.

[0053] SEQ ID NOs:61 to 72 show sequences of primers and probes used for gene copy number analyses and binary vector plasmid backbone detection.

[0054] SEQ ID NO:73 shows a DNA sequence comprising RpII140 from Meligethes aeneus.

[0055] SEQ ID NO:74 shows an amino acid sequence of a RpII140 protein from Meligethes aeneus.

[0056] SEQ ID NO:75 shows a DNA sequence comprising RpII140 from Meligethes aeneus.

[0057] SEQ ID NO:76 shows an amino acid sequence of a RpII140 protein from Meligethes aeneus.

[0058] SEQ ID NO:77 shows the RpII140 reg1 used for dsRNA production.

[0059] SEQ ID NOs:78 and 79 show primers used to amplify portions of a RpII140 sequence comprising Meligethes aeneus RpII 140 reg1

[0060] SEQ ID NO:80 shows an amino acid sequence of RpII140 protein from Meligethes aeneus.

[0061] SEQ ID NO:81 shows a DNA sequence comprising RpII140 from Meligethes aeneus.

[0062] SEQ ID NO:82 shows an amino acid sequence of a RpII140 protein from Meligethes aeneus.

DETAILED DESCRIPTION

I. Overview of Several Embodiments

[0063] Disclosed herein are methods and compositions for genetic control of coleopteran pest infestations. Methods for identifying one or more gene(s) essential to the lifecycle of a coleopteran pest for use as a target gene for RNAi-mediated control of a coleopteran pest population are also provided. DNA plasmid vectors encoding one or more dsRNA, siRNA, miRNA and/or hpRNA molecules may be designed to suppress one or more target gene(s) essential for growth, survival, development, and/or reproduction. In some embodiments, methods are provided for post-transcriptional repression of expression or inhibition of a target gene via nucleic acid molecules that are complementary to a coding or non-coding sequence of the target gene in a coleopteran pest. In these and further embodiments, a coleopteran pest may ingest one or more dsRNA, siRNA, miRNA, and/or hpRNA molecules transcribed from all or a portion of a nucleic acid molecule that is complementary to a coding or non-coding sequence of a target gene, thereby providing a plant-protective effect.

[0064] Thus, some embodiments involve sequence-specific inhibition of expression of target gene products, using dsRNA, siRNA, miRNA and/or hpRNA that is complementary to coding and/or non-coding sequences of the target gene(s) to achieve at least partial control of a coleopteran pest. Disclosed is a set of isolated and purified nucleic acid molecules comprising a nucleotide sequence, for example, as set forth in any of SEQ ID NO: 1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, and SEQ ID NO:81, and fragments thereof. In some embodiments, a stabilized dsRNA molecule may be expressed from this sequence, fragments thereof, or a gene comprising one of these sequences, for the post-transcriptional silencing or inhibition of a target gene. In certain embodiments, isolated and purified nucleic acid molecules comprise all or part of SEQ ID NO:1. In other embodiments, isolated and purified nucleic acid molecules comprise all or part of SEQ ID NO:3. In other embodiments, isolated and purified nucleic acid molecules comprise all or part of SEQ ID NO:4. In yet other embodiments, isolated and purified nucleic acid molecules comprise all or part of SEQ ID NO:5. In still further embodiments, isolated and purified nucleic acid molecules comprise all or part of SEQ ID NO:73. In other embodiments, isolated and purified nucleic acid molecules comprise all or part of SEQ ID NO:75. In yet other embodiments, isolated and purified nucleic acid molecules comprise all or part of SEQ ID NO:77. In still further embodiments, isolated and purified nucleic acid molecules comprise all or part of SEQ ID NO:81.

[0065] Some embodiments involve a recombinant host cell (e.g., a plant cell) having in its genome at least one recombinant DNA sequence encoding at least one iRNA (e.g., dsRNA) molecule(s). In particular embodiments, the iRNA molecule(s) may be produced by the recombinant host cell and then ingested by a coleopteran pest to post-transcriptionally silence or inhibit the expression of a target gene in the coleopteran pest. The recombinant DNA sequence may comprise, for example, one or more of any of SEQ ID NO: 1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, or SEQ ID NO:81; fragments of any of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, or SEQ ID NO:81; or a partial sequence of a gene comprising one or more of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, or SEQ ID NO:81; or complements thereof.

[0066] Particular embodiments involve a recombinant host cell having in its genome a recombinant DNA sequence encoding at least one iRNA (e.g., dsRNA) molecule(s) comprising all or part of SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, and/or SEQ ID NO:81. When ingested by a coleopteran pest, the iRNA molecule(s) may silence or inhibit the expression of a target gene comprising SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, or SEQ ID NO:81, in the coleopteran pest, and thereby result in cessation of growth, development, reproduction, and/or feeding in the coleopteran pest.

[0067] In some embodiments, a recombinant host cell having in its genome at least one recombinant DNA sequence encoding at least one iRNA molecule may be a transformed plant cell. Some embodiments involve transgenic plants comprising such a transformed plant cell. In addition to such transgenic plants, progeny plants of any transgenic plant generation, transgenic seeds, and transgenic plant products, are all provided, each of which comprises recombinant DNA sequence(s). In particular embodiments, an iRNA molecule may be expressed in a transgenic plant cell. Therefore, in these and other embodiments, an iRNA molecule may be isolated from a transgenic plant cell. In particular embodiments, the transgenic plant is a plant selected from the group comprising corn (Zea mays), soybean (Glycine max), canola (Brassica spp.), and plants of the family Poaceae.

[0068] Some embodiments involve a method for modulating the expression of a target gene in a coleopteran pest cell. In these and other embodiments, a nucleic acid molecule may be provided, wherein the nucleic acid molecule comprises a nucleotide sequence encoding an iRNA molecule. In particular embodiments, a nucleotide sequence encoding an iRNA molecule may be operatively linked to a promoter, and may also be operatively linked to a transcription termination sequence. In particular embodiments, a method for modulating the expression of a target gene in a coleopteran pest cell may comprise: (a) transforming a plant cell with a vector comprising a nucleotide sequence encoding an iRNA molecule; (b) culturing the transformed plant cell under conditions sufficient to allow for development of a plant cell culture comprising a plurality of transformed plant cells; (c) selecting for a transformed plant cell that has integrated the vector into its genome; and (d) determining that the selected transformed plant cell comprises the iRNA molecule encoded by the nucleotide sequence of the vector. A plant may be regenerated from a plant cell that has the vector integrated in its genome and comprises the iRNA molecule encoded by the nucleotide sequence of the vector.

[0069] Thus, also disclosed is a transgenic plant comprising a vector having a nucleotide sequence encoding an iRNA molecule integrated in its genome, wherein the transgenic plant comprises the iRNA molecule encoded by the nucleotide sequence of the vector. In particular embodiments, expression of an iRNA molecule in the plant is sufficient to modulate the expression of a target gene in a cell of a coleopteran pest that contacts the transformed plant or plant cell, for example, by feeding on the transformed plant, a part of the plant (e.g., root) or plant cell. Transgenic plants disclosed herein may display resistance and/or enhanced tolerance to coleopteran pest infestations. Particular transgenic plants may display resistance and/or enhanced tolerance to one or more coleopteran pests selected from the group consisting of: WCR; NCR; SCR; MCR; D. balteata LeConte; D. u. tenella; D. u. undecimpunctata Mannerheim; and Meligethes aeneus Fabricius.

[0070] Also disclosed herein are methods for delivery of control agents, such as an iRNA molecule, to a coleopteran pest. Such control agents may cause, directly or indirectly, an impairment in the ability of the coleopteran pest to feed, grow or otherwise cause damage in a host. In some embodiments, a method is provided comprising delivery of a stabilized iRNA molecule to a coleopteran pest to suppress at least one target gene in the coleopteran pest, thereby reducing or eliminating plant damage by a coleopteran pest. In some embodiments, a method of inhibiting expression of a target gene in a coleopteran pest may result in the cessation of growth, development, reproduction, and/or feeding in the coleopteran pest. In some embodiments, the method may eventually result in death of the coleopteran pest.

[0071] In some embodiments, compositions (e.g., a topical composition) are provided that comprise an iRNA (e.g., dsRNA) molecule for use on or in plants, animals, and/or the environment of a plant or animal to achieve the elimination or reduction of a coleopteran pest infestation. In particular embodiments, the composition may be a nutritional composition or food source to be fed to the coleopteran pest. Some embodiments comprise making the nutritional composition or food source available to the coleopteran pest. Ingestion of a composition comprising iRNA molecules may result in the uptake of the molecules by one or more cells of the coleopteran pest, which may in turn result in the inhibition of expression of at least one target gene in cell(s) of the coleopteran pest. Ingestion of or damage to a plant or plant cell by a coleopteran pest may be limited or eliminated in or on any host tissue or environment in which the coleopteran pest is present by providing one or more compositions comprising an iRNA molecule in the host of the coleopteran pest.

[0072] The compositions and methods disclosed herein may be used together in combinations with other methods and compositions for controlling damage by coleopteran pests. For example, an iRNA molecule as described herein for protecting plants from coleopteran pests may be used in a method comprising the additional use of one or more chemical agents effective against a coleopteran pest, biopesticides effective against a coleopteran pest, crop rotation, or recombinant genetic techniques that exhibit features different from the features of the RNAi-mediated methods and RNAi compositions (e.g., recombinant production of proteins in plants that are harmful to a coleopteran pest (e.g., Bt toxins)).

II. Abbreviations

[0073] dsRNA double-stranded ribonucleic acid

[0074] GI growth inhibition

[0075] NCBI National Center for Biotechnology Information

[0076] gDNA genomic DNA

[0077] iRNA inhibitory ribonucleic acid

[0078] ORF open reading frame

[0079] RNAi ribonucleic acid interference

[0080] miRNA micro inhibitory ribonucleic acid

[0081] siRNA small inhibitory ribonucleic acid

[0082] hpRNA hairpin ribonucleic acid

[0083] UTR untranslated region

[0084] WCR western corn rootworm (Diabrotica virgifera virgifera LeConte)

[0085] NCR northern corn rootworm (Diabrotica barberi Smith and Lawrence)

[0086] MCR Mexican corn rootworm (Diabrotica virgifera zeae Krysan and Smith)

[0087] PCR Polymerase chain reaction

[0088] RISC RNA-induced Silencing Complex

[0089] SCR Southern corn rootworm (Diabrotica undecimpunctata howardi Barber)

[0090] PB Pollen beetle (Meligethes aeneus Fabricius)

III. Terms

[0091] In the description and tables which follow, a number of terms are used. In order to provide a clear and consistent understanding of the specification and claims, including the scope to be given such terms, the following definitions are provided:

[0092] Coleopteran pest: In particular examples, a coleopteran pest is selected from the list comprising D. v. virgifera LeConte (WCR); D. barber, Smith and Lawrence (NCR); D. u. howardi (SCR); D. v. zeae (MCR); D. balteata LeConte; D. u. tenella; D. u. undecimpunctata Mannerheim; and Meligethes aeneus Fabricius.

[0093] Contact (with an organism): As used herein, the term "contact with" or "uptake by" an organism (e.g., a coleopteran pest), with regard to a nucleic acid molecule, includes internalization of the nucleic acid molecule into the organism, for example and without limitation: ingestion of the molecule by the organism (e.g., by feeding); contacting the organism with a composition comprising the nucleic acid molecule; and soaking of organisms with a solution comprising the nucleic acid molecule.

[0094] Contig: As used herein, the term "contig" refers to a DNA sequence that is reconstructed from a set of overlapping DNA segments derived from a single genetic source.

[0095] Corn plant: As used herein, the term "corn plant" refers to a plant of the species, Zea mays (maize).

[0096] Encoding an iRNA: As used herein, the term "encoding an iRNA" includes a gene whose RNA transcription product is capable of forming an intramolecular dsRNA structure (e.g., a hairpin) or intermolecular dsRNA structure (e.g., by hybridizing to a target RNA molecule).

[0097] Expression: As used herein, "expression" of a coding sequence (for example, a gene or a transgene) refers to the process by which the coded information of a nucleic acid transcriptional unit (including, e.g., genomic DNA or cDNA) is converted into an operational, non-operational, or structural part of a cell, often including the synthesis of a protein. Gene expression can be influenced by external signals; for example, exposure of a cell, tissue, or organism to an agent that increases or decreases gene expression. Expression of a gene can also be regulated anywhere in the pathway from DNA to RNA to protein. Regulation of gene expression occurs, for example, through controls acting on transcription, translation, RNA transport and processing, degradation of intermediary molecules such as mRNA, or through activation, inactivation, compartmentalization, or degradation of specific protein molecules after they have been made, or by combinations thereof. Gene expression can be measured at the RNA level or the protein level by any method known in the art, including, without limitation, northern (RNA) blot, RT-PCR, western (immuno-) blot, or in vitro, in situ, or in vivo protein activity assay(s).

[0098] Genetic material: As used herein, the term "genetic material" includes all genes and nucleic acid molecules, such as DNA and RNA.

[0099] Inhibition: As used herein, the term "inhibition", when used to describe an effect on a coding sequence (for example, a gene), refers to a measurable decrease in the cellular level of mRNA transcribed from the coding sequence and/or peptide, polypeptide, or protein product of the coding sequence. In some examples, expression of a coding sequence may be inhibited such that expression is approximately eliminated. "Specific inhibition" refers to the inhibition of a target coding sequence without consequently affecting expression of other coding sequences (e.g., genes) in the cell wherein the specific inhibition is being accomplished.

[0100] Isolated: An "isolated" biological component (such as a nucleic acid or protein) has been substantially separated, produced apart from, or purified away from other biological components in the cell of the organism in which the component naturally occurs (i.e., other chromosomal and extra-chromosomal DNA and RNA, and proteins). Nucleic acid molecules and proteins that have been "isolated" include nucleic acid molecules and proteins purified by standard purification methods. The term also embraces nucleic acids and proteins prepared by recombinant expression in a host cell, as well as chemically-synthesized nucleic acid molecules, proteins, and peptides.

[0101] Nucleic acid molecule: As used herein, the term "nucleic acid molecule" may refer to a polymeric form of nucleotides, which may include both sense and anti-sense strands of RNA, cDNA, genomic DNA, and synthetic forms and mixed polymers of the above. A nucleotide may refer to a ribonucleotide, deoxyribonucleotide, or a modified form of either type of nucleotide. A "nucleic acid molecule," as used herein, is synonymous with "nucleic acid" and "polynucleotide." A nucleic acid molecule is usually at least 10 bases in length, unless otherwise specified. By convention, the nucleotide sequence of a nucleic acid molecule is read from the 5' to the 3' end of the molecule. The "complement" of a nucleotide sequence refers to the sequence, from 5' to 3', of the nucleobases which form base pairs with the nucleobases of the nucleotide sequence (i.e., A-T/U, and G-C). The "reverse complement" of a nucleic acid sequence refers to the sequence, from 3' to 5', of the nucleobases which form base pairs with the nucleobases of the nucleotide sequence.

[0102] 041 "Nucleic acid molecules" include single- and double-stranded forms of DNA; single-stranded forms of RNA; and double-stranded forms of RNA (dsRNA). The term "nucleotide sequence" or "nucleic acid sequence" refers to both the sense and antisense strands of a nucleic acid as either individual single strands or in the duplex. The term "ribonucleic acid" (RNA) is inclusive of iRNA (inhibitory RNA), dsRNA (double stranded RNA), siRNA (small interfering RNA), mRNA (messenger RNA), miRNA (micro-RNA), hpRNA (hairpin RNA), tRNA (transfer RNA, whether charged or discharged with a corresponding acylated amino acid), and cRNA (complementary RNA). iRNA, as used herein, refers to RNA molecules that are capable of inhibiting the expression of a target gene or genes and includes, but is not limited to, dsRNA, siRNA, miRNA, hpRNA, and antisense RNA. The term "deoxyribonucleic acid" (DNA) is inclusive of cDNA, genomic DNA, and DNA-RNA hybrids. The terms "nucleic acid segment" and "nucleotide sequence segment," or more generally "segment," will be understood by those in the art as a functional term that includes both genomic sequences, ribosomal RNA sequences, transfer RNA sequences, messenger RNA sequences, operon sequences, and smaller engineered nucleotide sequences that encode or may be adapted to encode, peptides, polypeptides, or proteins.

[0103] Oligonucleotide: An oligonucleotide is a short nucleic acid polymer. Oligonucleotides may be formed by cleavage of longer nucleic acid segments, or by polymerizing individual nucleotide precursors. Automated synthesizers allow the synthesis of oligonucleotides up to several hundred bases in length. Because oligonucleotides may bind to a complementary nucleotide sequence, they may be used as probes for detecting DNA or RNA. Oligonucleotides composed of DNA (oligodeoxyribonucleotides) may be used in PCR, a technique for the amplification of DNA and RNA (reverse transcribed to produce a cDNA) sequences. In PCR, the oligonucleotide is typically referred to as a "primer," which allows a DNA polymerase to extend the oligonucleotide and replicate the complementary strand.

[0104] A nucleic acid molecule may include either or both naturally occurring and modified nucleotides linked together by naturally occurring and/or non-naturally occurring nucleotide linkages. Nucleic acid molecules may be modified chemically or biochemically, or may contain non-natural or derivatized nucleotide bases, as will be readily appreciated by those of skill in the art. Such modifications include, for example, labels, methylation, substitution of one or more of the naturally occurring nucleotides with an analog, internucleotide modifications (e.g., uncharged linkages: for example, methyl phosphonates, phosphotriesters, phosphoramidates, carbamates, etc.; charged linkages: for example, phosphorothioates, phosphorodithioates, etc.; pendent moieties: for example, peptides; intercalators: for example, acridine, psoralen, etc.; chelators; alkylators; and modified linkages: for example, alpha anomeric nucleic acids, etc.). The term "nucleic acid molecule" also includes any topological conformation, including single-stranded, double-stranded, partially duplexed, triplexed, hairpinned, circular, and padlocked conformations.

[0105] As used herein, with respect to DNA, the term "coding sequence," "structural nucleotide sequence," or "structural nucleic acid molecule" refers to a nucleotide sequence, when placed under the control of appropriate regulatory sequences, that is transcribed to produce RNA (e.g. mRNA or an iRNA) and, in the case of mRNA is ultimately translated into a polypeptide. With respect to RNA, the term "coding sequence" refers to a nucleotide sequence that is translated into a peptide, polypeptide, or protein. The boundaries of a coding sequence are determined by a translation start codon at the 5'-terminus and a translation stop codon at the 3'-terminus. Coding sequences include, but are not limited to: genomic DNA; cDNA; EST; and recombinant nucleotide sequences.

[0106] Genome: As used herein, the term "genome" refers to chromosomal DNA found within the nucleus of a cell, and also refers to organelle DNA found within subcellular components of the cell. In some embodiments, a DNA molecule may be introduced into a plant cell such that the DNA molecule is integrated into the genome of the plant cell. In these and further embodiments, the DNA molecule may be either integrated into the nuclear DNA of the plant cell, or integrated into the DNA of the chloroplast or mitochondrion of the plant cell. The term "genome" as it applies to bacteria refers to both the chromosome and plasmids within the bacterial cell. In some embodiments, a DNA molecule may be introduced into a bacterium such that the DNA molecule is integrated into the genome of the bacterium. In these and further embodiments, the DNA molecule may be either chromosomally-integrated or located as or in a stable plasmid.

[0107] Sequence identity: The term "sequence identity" or "identity," as used herein, in the context of two nucleic acid or polypeptide sequences, refers to the residues in the two sequences that are the same when aligned for maximum correspondence over a specified comparison window.

[0108] As used herein, the term "percentage of sequence identity" may refer to the value determined by comparing two optimally aligned sequences (e.g., nucleic acid sequences or polypeptide sequences) over a comparison window, wherein the portion of the sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleotide or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the comparison window, and multiplying the result by 100 to yield the percentage of sequence identity. A sequence that is identical at every position in comparison to a reference sequence is said to be 100% identical to the reference sequence, and vice-versa.

[0109] Methods for aligning sequences for comparison are well-known in the art. Various programs and alignment algorithms are described in, for example: Smith and Waterman (1981) Adv. Appl. Math. 2:482; Needleman and Wunsch (1970) J. Mol. Biol. 48:443; Pearson and Lipman (1988) Proc. Natl. Acad. Sci. U.S.A. 85:2444; Higgins and Sharp (1988) Gene 73:237-244; Higgins and Sharp (1989) CABIOS 5:151-153; Corpet et al. (1988) Nucleic Acids Res. 16:10881-10890; Huang et al. (1992) Comp. Appl. Biosci. 8:155-165; Pearson et al. (1994) Methods Mol. Biol. 24:307-331; Tatiana et al. (1999) FEMS Microbiol. Lett. 174:247-250. A detailed consideration of sequence alignment methods and homology calculations can be found in, e.g., Altschul et al. (1990) J. Mol. Biol. 215:403-410.

[0110] The National Center for Biotechnology Information (NCBI) Basic Local Alignment Search Tool (BLAST.TM.; Altschul et al. (1990)) is available from several sources, including the National Center for Biotechnology Information (Bethesda, Md.), and on the internet, for use in connection with several sequence analysis programs. A description of how to determine sequence identity using this program is available on the internet under the "help" section for BLAST. For comparisons of nucleic acid sequences, the "Blast 2 sequences" function of the BLAST (Blastn) program may be employed using the default BLOSUM62 matrix set to default parameters. Nucleic acid sequences with even greater similarity to the reference sequences will show increasing percentage identity when assessed by this method.

[0111] Specifically hybridizable/Specifically complementary: As used herein, the terms "Specifically hybridizable" and "Specifically complementary" are terms that indicate a sufficient degree of complementarity such that stable and specific binding occurs between the nucleic acid molecule and a target nucleic acid molecule. Hybridization between two nucleic acid molecules involves the formation of an anti-parallel alignment between the nucleic acid sequences of the two nucleic acid molecules. The two molecules are then able to form hydrogen bonds with corresponding bases on the opposite strand to form a duplex molecule that, if it is sufficiently stable, is detectable using methods well known in the art. A nucleic acid molecule need not be 100% complementary to its target sequence to be specifically hybridizable. However, the amount of sequence complementarity that must exist for hybridization to be specific is a function of the hybridization conditions used.

[0112] Hybridization conditions resulting in particular degrees of stringency will vary depending upon the nature of the hybridization method of choice and the composition and length of the hybridizing nucleic acid sequences. Generally, the temperature of hybridization and the ionic strength (especially the Na.sup.+ and/or Mg.sup.++ concentration) of the hybridization will determine the stringency of hybridization. The ionic strength of the wash buffer and the wash temperature also influence stringency. Calculations regarding hybridization conditions required for attaining particular degrees of stringency are known to those of ordinary skill in the art, and are discussed, for example, in Sambrook et al. (ed.) Molecular Cloning: A Laboratory Manual, 2.sup.nd ed., vol. 1-3, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989, chapters 9 and 11, and updates; and Hames and Higgins (eds.) Nucleic Acid Hybridization, IRL Press, Oxford, 1985. Further detailed instruction and guidance with regard to the hybridization of nucleic acids may be found, for example, in Tijssen, "Overview of principles of hybridization and the strategy of nucleic acid probe assays," in Laboratory Techniques in Biochemistry and Molecular Bioloav-Hybridization with Nucleic Acid Probes, Part I, Chapter 2, Elsevier, N Y, 1993; and Ausubel et al., Eds., Current Protocols in Molecular Biology, Chapter 2, Greene Publishing and Wiley-Interscience, N Y, 1995, and updates.

[0113] As used herein, "stringent conditions" encompass conditions under which hybridization will occur only if there is more than 80% sequence match between the hybridization molecule and a homologous sequence within the target nucleic acid molecule. "Stringent conditions" include further particular levels of stringency. Thus, as used herein, "moderate stringency" conditions are those under which molecules with more than 80% sequence match (less than 20% mismatch) will hybridize; conditions of "high stringency" are those under which sequences with more than 90% match (less than 10% mismatch) will hybridize; and conditions of "very high stringency" are those under which sequences with more than 95% match (less than 5% mismatch) will hybridize.

[0114] The following are representative, non-limiting hybridization conditions.

[0115] High Stringency condition (detects sequences that share at least 90% sequence identity): Hybridization in 5.times.SSC buffer at 65.degree. C. for 16 hours; wash twice in 2.times.SSC buffer at room temperature for 15 minutes each; and wash twice in 0.5.times.SSC buffer at 65.degree. C. for 20 minutes each.

[0116] Moderate Stringency condition (detects sequences that share at least 80% sequence identity): Hybridization in 5.times.-6.times.SSC buffer at 65-70.degree. C. for 16-20 hours; wash twice in 2.times.SSC buffer at room temperature for 5-20 minutes each; and wash twice in 1.times.SSC buffer at 55-70.degree. C. for 30 minutes each.

[0117] Non-stringent control condition (sequences that share at least 50% sequence identity will hybridize): Hybridization in 6.times.SSC buffer at room temperature to 55.degree. C. for 16-20 hours; wash at least twice in 2.times.-3.times.SSC buffer at room temperature to 55.degree. C. for 20-30 minutes each.

[0118] As used herein, the term "substantially homologous" or "substantial homology," with regard to a contiguous nucleic acid sequence, refers to contiguous nucleotide sequences that are borne by nucleic acid molecules that hybridize under stringent conditions to a nucleic acid molecule having the reference nucleic acid sequence. For example, nucleic acid molecules having sequences that are substantially homologous to a reference nucleic acid sequence of SEQ ID NO: 1 are those nucleic acid molecules that hybridize under stringent conditions (e.g., the Moderate Stringency conditions set forth, supra) to nucleic acid molecules having the reference nucleic acid sequence of SEQ ID NO: 1. Substantially homologous sequences may have at least 80% sequence identity. For example, substantially homologous sequences may have from about 80% to 100% sequence identity, such as about 81%; about 82%; about 83%; about 84%; about 85%; about 86%; about 87%; about 88%; about 89%; about 90%; about 91%; about 92%; about 93%; about 94% about 95%; about 96%; about 97%; about 98%; about 98.5%; about 99%; about 99.5%; about 100%, 80%; 81%; 82%; 83%; 84%; 85%; 86%; 87%; 88%; 89%; 90%; 91%; 92%; 93%; 94%; 95%; 96%; 97%; 98%; 99; or 100%. The property of substantial homology is closely related to specific hybridization. For example, a nucleic acid molecule is specifically hybridizable when there is a sufficient degree of complementarity to avoid non-specific binding of the nucleic acid to non-target sequences under conditions where specific binding is desired, for example, under stringent hybridization conditions.

[0119] As used herein, the term "ortholog" refers to a gene in two or more species that has evolved from a common ancestral nucleotide sequence, and may retain the same function in the two or more species.

[0120] As used herein, two nucleic acid sequence molecules are said to exhibit "complete complementarity" when every nucleotide of a sequence read in the 5' to 3' direction is complementary to every nucleotide of the other sequence when read in the 3' to 5' direction. A nucleotide sequence that is complementary to a reference nucleotide sequence will exhibit a sequence identical to the reverse complement sequence of the reference nucleotide sequence. These terms and descriptions are well defined in the art and are easily understood by those of ordinary skill in the art.

[0121] Operably linked: A first nucleotide sequence is operably linked with a second nucleic acid sequence when the first nucleic acid sequence is in a functional relationship with the second nucleic acid sequence. When recombinantly produced, operably linked nucleic acid sequences are generally contiguous, and, where necessary, two protein-coding regions may be joined in the same reading frame (e.g., in a translationally fused ORF). However, nucleic acids need not be contiguous to be operably linked.

[0122] The term, "operably linked," when used in reference to a regulatory sequence and a coding sequence, means that the regulatory sequence affects the expression of the linked coding sequence. "Regulatory sequences," or "control elements," refer to nucleotide sequences that influence the timing and level/amount of transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters; translation leader sequences; introns; enhancers; stem-loop structures; repressor binding sequences; termination sequences; polyadenylation recognition sequences; etc. Particular regulatory sequences may be located upstream and/or downstream of a coding sequence operably linked thereto. Also, particular regulatory sequences operably linked to a coding sequence may be located on the associated complementary strand of a double-stranded nucleic acid molecule.

[0123] Promoter: As used herein, the term "promoter" refers to a region of DNA that may be upstream from the start of transcription, and that may be involved in recognition and binding of RNA polymerase and other proteins to initiate transcription. A promoter may be operably linked to a coding sequence for expression in a cell, or a promoter may be operably linked to a nucleotide sequence encoding a signal sequence which may be operably linked to a coding sequence for expression in a cell. A "plant promoter" may be a promoter capable of initiating transcription in plant cells. Examples of promoters under developmental control include promoters that preferentially initiate transcription in certain tissues, such as leaves, roots, seeds, fibers, xylem vessels, tracheids, or sclerenchyma. Such promoters are referred to as "tissue-preferred." Promoters which initiate transcription only in certain tissues are referred to as "tissue-specific." A "cell type-specific" promoter primarily drives expression in certain cell types in one or more organs, for example, vascular cells in roots or leaves. An "inducible" promoter may be a promoter which may be under environmental control. Examples of environmental conditions that may initiate transcription by inducible promoters include anaerobic conditions and the presence of light. Tissue-specific, tissue-preferred, cell type specific, and inducible promoters constitute the class of "non-constitutive" promoters. A "constitutive" promoter is a promoter which may be active under most environmental conditions or in most tissue or cell types.

[0124] Any inducible promoter can be used in some embodiments. See Ward et al. (1993) Plant Mol. Biol. 22:361-366. With an inducible promoter, the rate of transcription increases in response to an inducing agent. Exemplary inducible promoters include, but are not limited to: Promoters from the ACEI system that respond to copper; In2 gene from maize that responds to benzenesulfonamide herbicide safeners; Tet repressor from Tn10; and the inducible promoter from a steroid hormone gene, the transcriptional activity of which may be induced by a glucocorticosteroid hormone (Schena et al. (1991) Proc. Natl. Acad. Sci. USA 88:10421-10425).

[0125] Exemplary constitutive promoters include, but are not limited to: Promoters from plant viruses, such as the 35S promoter from Cauliflower Mosaic Virus (CaMV); promoters from rice actin genes; ubiquitin promoters; pEMU; MAS; maize H3 histone promoter; and the ALS promoter, XbaI/NcoI fragment 5' to the Brassica napus ALS3 structural gene (or a nucleotide sequence similar to said XbaI/NcoI fragment) (U.S. Pat. No. 5,659,026).

[0126] Additionally, any tissue-specific or tissue-preferred promoter may be utilized in some embodiments. Plants transformed with a nucleic acid molecule comprising a coding sequence operably linked to a tissue-specific promoter may produce the product of the coding sequence exclusively, or preferentially, in a specific tissue. Exemplary tissue-specific or tissue-preferred promoters include, but are not limited to: A seed-preferred promoter, such as that from the phaseolin gene; a leaf-specific and light-induced promoter such as that from cab or rubisco; an anther-specific promoter such as that from LAT52; a pollen-specific promoter such as that from Zm13; and a microspore-preferred promoter such as that from apg.

[0127] Transformation: As used herein, the term "transformation" or "transduction" refers to the transfer of one or more nucleic acid molecule(s) into a cell. A cell is "transformed" by a nucleic acid molecule transduced into the cell when the nucleic acid molecule becomes stably replicated by the cell, either by incorporation of the nucleic acid molecule into the cellular genome, or by episomal replication. As used herein, the term "transformation" encompasses all techniques by which a nucleic acid molecule can be introduced into such a cell. Examples include, but are not limited to: transfection with viral vectors; transformation with plasmid vectors; electroporation (Fromm et al. (1986) Nature 319:791-793); lipofection (Felgner et al. (1987) Proc. Natl. Acad. Sci. USA 84:7413-7417); microinjection (Mueller et al. (1978) Cell 15:579-585); Agrobacterium-mediated transfer (Fraley et al. (1983) Proc. Natl. Acad. Sci. USA 80:4803-4807); direct DNA uptake; and microprojectile bombardment (Klein et al. (1987) Nature 327:70).

[0128] Transgene: An exogenous nucleic acid sequence. In some examples, a transgene may be a sequence that encodes one or two strand(s) of a iRNA molecule that comprises a nucleotide sequence that is complementary to a nucleic acid molecule found in a coleopteran pest. In further examples, a transgene may be an antisense nucleic acid sequence, wherein expression of the antisense nucleic acid sequence inhibits expression of a target nucleic acid sequence. In still further examples, a transgene may be a gene sequence (e.g., a herbicide-resistance gene), a gene encoding an industrially or pharmaceutically useful compound, or a gene encoding a desirable agricultural trait. In these and other examples, a transgene may contain regulatory sequences operably linked to a coding sequence of the transgene (e.g., a promoter).

[0129] Vector: A nucleic acid molecule as introduced into a cell, for example, to produce a transformed cell. A vector may include nucleic acid sequences that permit it to replicate in the host cell, such as an origin of replication. Examples of vectors include, but are not limited to: a plasmid; cosmid; bacteriophage; or virus that carries exogenous DNA into a cell. A vector may also be an RNA molecule. A vector may also include one or more genes, antisense sequences, and/or selectable marker genes and other genetic elements known in the art. A vector may transduce, transform, or infect a cell, thereby causing the cell to express the nucleic acid molecules and/or proteins encoded by the vector. A vector optionally includes materials to aid in achieving entry of the nucleic acid molecule into the cell (e.g., a liposome, protein coating, etc.).

[0130] Yield: A stabilized yield of about 100% or greater relative to the yield of check varieties in the same growing location growing at the same time and under the same conditions. In particular embodiments, "improved yield" or "improving yield" means a cultivar having a stabilized yield of 105% to 115% or greater relative to the yield of check varieties in the same growing location containing significant densities of coleopteran pests that are injurious to that crop growing at the same time and under the same conditions.

[0131] Unless specifically indicated or implied, the terms "a," "an," and "the" signify "at least one," as used herein.

[0132] Unless otherwise specifically explained, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which this disclosure belongs. Definitions of common terms in molecular biology can be found in, for example, Lewin's Genes X, Jones & Bartlett Publishers, 2009 (ISBN 10 0763766321); Krebs et al. (eds.), The Encyclopedia of Molecular Biology, Blackwell Science Ltd., 1994 (ISBN 0-632-02182-9); and Meyers R. A. (ed.), Molecular Biology and Biotechnology: A Comprehensive Desk Reference, VCH Publishers, Inc., 1995 (ISBN 1-56081-569-8). All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted. All temperatures are in degrees Celsius.

IV. Nucleic Acid Molecules Comprising a Coleopteran Pest Sequence

[0133] A. Overview

[0134] Described herein are nucleic acid molecules useful for the control of coleopteran pests. Described nucleic acid molecules include target sequences (e.g., native genes, and non-coding sequences), dsRNAs, siRNAs, hpRNAs, and miRNAs. For example, dsRNA, siRNA, miRNA and/or hpRNA molecules are described in some embodiments that may be specifically complementary to all or part of one or more native nucleic acid sequences in a coleopteran pest. In these and further embodiments, the native nucleic acid sequence(s) may be one or more target gene(s), the product of which may be, for example and without limitation: involved in a metabolic process; involved in a reproductive process; or involved in larval development. Nucleic acid molecules described herein, when introduced into a cell comprising at least one native nucleic acid sequence(s) to which the nucleic acid molecules are specifically complementary, may initiate RNAi in the cell, and consequently reduce or eliminate expression of the native nucleic acid sequence(s). In some examples, reduction or elimination of the expression of a target gene by a nucleic acid molecule comprising a sequence specifically complementary thereto may be lethal in coleopteran pests, or result in reduced growth and/or reproduction.

[0135] In some embodiments, at least one target gene in a coleopteran pest may be selected, wherein the target gene comprises a nucleotide sequence comprising rnapII-140 (e.g. SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, or SEQ ID NO:81). In particular examples, a target gene in a coleopteran pest is selected, wherein the target gene comprises a novel nucleotide sequence comprising rnapII-140 (e.g. SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, or SEQ ID NO:81).

[0136] In some embodiments, a target gene may be a nucleic acid molecule comprising a nucleotide sequence that encodes a polypeptide comprising a contiguous amino acid sequence that is at least 85% identical (e.g., about 90%, about 95%, about 96%, about 97%, about 98%, about 99%, about 100%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% identical) to the amino acid sequence of RNAPII-140 (e.g. SEQ ID NO:2, SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:80, or SEQ ID NO:82). A target gene may be any nucleic acid sequence in a coleopteran pest, the post-transcriptional inhibition of which has a deleterious effect on the coleopteran pest, or provides a protective benefit against the coleopteran pest to a plant. In particular examples, a target gene is a nucleic acid molecule comprising a nucleotide sequence that encodes a polypeptide comprising a contiguous amino acid sequence that is at least 85% identical, about 90% identical, about 95% identical, about 96% identical, about 97% identical, about 98% identical, about 99% identical, about 100% identical, 85% identical, 86% identical, 87% identical, 88% identical, 89% identical, 90% identical, 91% identical, 92% identical, 93% identical, 94% identical, 95% identical, 96% identical, 97% identical, 98% identical, 99% identical, or 100% identical to the amino acid sequence of SEQ ID NO:2, SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:80, or SEQ ID NO:82.

[0137] Provided herein are nucleotide sequences, the expression of which results in an RNA molecule comprising a nucleotide sequence that is specifically complementary to all or part of a native RNA molecule that is encoded by a coding sequence in a coleopteran pest. In some embodiments, after ingestion of the expressed RNA molecule by a coleopteran pest, down-regulation of the coding sequence in cells of the coleopteran pest may be obtained. In particular embodiments, down-regulation of the coding sequence in cells of the coleopteran pest may result in a deleterious effect on the growth, viability, proliferation, and/or reproduction of the coleopteran pest.

[0138] In some embodiments, target sequences include transcribed non-coding RNA sequences, such as 5'UTRs; 3'UTRs; spliced leader sequences; intron sequences; outron sequences (e.g., 5'UTR RNA subsequently modified in trans splicing); donatron sequences (e.g., non-coding RNA required to provide donor sequences for trans splicing); and other non-coding transcribed RNA of target coleopteran pest genes. Such sequences may be derived from both mono-cistronic and poly-cistronic genes.

[0139] Thus, also described herein in connection with some embodiments are iRNA molecules (e.g., dsRNAs, siRNAs, miRNAs and hpRNAs) that comprise at least one nucleotide sequence that is specifically complementary to all or part of a target sequence in a coleopteran pest. In some embodiments an iRNA molecule may comprise nucleotide sequence(s) that are complementary to all or part of a plurality of target sequences; for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more target sequences. In particular embodiments, an iRNA molecule may be produced in vitro, or in vivo by a genetically-modified organism, such as a plant or bacterium. Also disclosed are cDNA sequences that may be used for the production of dsRNA molecules, siRNA molecules, miRNA and/or hpRNA molecules that are specifically complementary to all or part of a target sequence in a coleopteran pest. Further described are recombinant DNA constructs for use in achieving stable transformation of particular host targets. Transformed host targets may express effective levels of dsRNA, siRNA, miRNA and/or hpRNA molecules from the recombinant DNA constructs. Therefore, also described is a plant transformation vector comprising at least one nucleotide sequence operably linked to a heterologous promoter functional in a plant cell, wherein expression of the nucleotide sequence(s) results in an RNA molecule comprising a nucleotide sequence that is specifically complementary to all or part of a target sequence in a coleopteran pest.

[0140] In some embodiments, nucleic acid molecules useful for the control of coleopteran pests may include: all or part of a native nucleic acid sequence isolated from Diabrotica comprising rnapII-140 (SEQ ID NO: 1); all or part of a native nucleic acid sequence isolated from Meligethes comprising rnapII-140 (e.g. SEQ ID NO:73, SEQ ID NO:75, or SEQ ID NO:81); nucleotide sequences that when expressed result in an RNA molecule comprising a nucleotide sequence that is specifically complementary to all or part of a native RNA molecule that is encoded by rnapII-140 (e.g. SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, or SEQ ID NO:81); iRNA molecules (e.g., dsRNAs, siRNAs, miRNAs and hpRNAs) that comprise at least one nucleotide sequence that is specifically complementary to all or part of rnapII-140 (e.g. SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, or SEQ ID NO:81); cDNA sequences that may be used for the production of dsRNA molecules, siRNA molecules, miRNA and/or hpRNA molecules that are specifically complementary to all or part of rnapII-140 (e.g. SEQ ID NO:1, SEQ ID NO:73, SEQ ID NO:75, or SEQ ID NO:81); and recombinant DNA constructs for use in achieving stable transformation of particular host targets, wherein a transformed host target comprises one or more of the foregoing nucleic acid molecules.

[0141] B. Nucleic Acid Molecules

[0142] The present disclosure provides, inter alia, iRNA (e.g., dsRNA, siRNA, miRNA and hpRNA) molecules that inhibit target gene expression in a cell, tissue, or organ of a coleopteran pest; and DNA molecules capable of being expressed as an iRNA molecule in a cell or microorganism to inhibit target gene expression in a cell, tissue, or organ of a coleopteran pest.

[0143] Some embodiments provide an isolated nucleic acid molecule comprising at least one (e.g., one, two, three, or more) nucleotide sequence(s) selected from the group consisting of: SEQ ID NOs:1, 3, 4, 5, 73, 75, 77, or 81; the complement of SEQ ID NOs:1, 3, 4, 5, 73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of SEQ ID NOs:1, 3, 4, 5, 73, 75, 77, or 81; the complement of a fragment of at least 15 contiguous nucleotides of SEQ ID NOs:1, 3, 4, 5, 73, 75, 77, or 81; a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NOs: 1, 3, 4, or 5; the complement of a native coding sequence of a Diabrotica organism comprising SEQ ID NOs:1, 3, 4, or 5; a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 1, 3, 4, or 5; the complement of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs:1, 3, 4, or 5; a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Diabrotica organism comprising SEQ ID NOs: 1, 3, 4, or 5; the complement of a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Diabrotica organism comprising SEQ ID NOs:1, 3, 4, or 5; a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs:1, 3, 4, or 5; and the complement of a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs:1, 3, 4, or 5; a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NOs:73, 75, 77, or 81; the complement of a native coding sequence of a Meligethes organism comprising SEQ ID NOs: 73, 75, 77, or 81; a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 73, 75, 77, or 81; the complement of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Meligethes organism comprising SEQ ID NOs: 73, 75, 77, or 81; the complement of a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Meligethes organism comprising SEQ ID NOs: 73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 73, 75, 77, or 81; and the complement of a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 73, 75, 77, or 81. In particular embodiments, contact with or uptake by a coleopteran pest of the isolated nucleic acid sequence inhibits the growth, development, reproduction and/or feeding of the coleopteran pest.

[0144] In some embodiments, a nucleic acid molecule may comprise at least one (e.g., one, two, three, or more) DNA sequence(s) capable of being expressed as an iRNA molecule in a cell or microorganism to inhibit target gene expression in a cell, tissue, or organ of a coleopteran pest. Such DNA sequence(s) may be operably linked to a promoter sequence that functions in a cell comprising the DNA molecule to initiate or enhance the transcription of the encoded RNA capable of forming a dsRNA molecule(s). In one embodiment, the at least one (e.g., one, two, three, or more) DNA sequence(s) may be derived from a nucleotide sequence comprising SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81. Derivatives of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81 include fragments of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81. In some embodiments, such a fragment may comprise, for example, at least about 15 contiguous nucleotides of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, or a complement thereof. Thus, such a fragment may comprise, for example, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 contiguous nucleotides of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, or a complement thereof. In these and further embodiments, such a fragment may comprise, for example, more than about 15 contiguous nucleotides of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, or a complement thereof. Thus, a fragment of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81 may comprise, for example, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, about 25 (e.g., 22, 23, 24, 25, 26, 27, 28, and 29), 30, about 30, 40, about 40 (e.g., 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, and 45), 50, about 50, 60, about 60, 70, about 70, 80, about 80, 90, about 90, 100, about 100, 110, about 110, 120, about 120, 130, about 130, 140, about 140, 150, about 150, 160, about 160, 170, about 170, 180, about 180, 190, about 190, 200, about 200 or more contiguous nucleotides of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, or a complement thereof.

[0145] Some embodiments comprise introducing partial- or fully-stabilized iRNA molecules into a coleopteran pest to inhibit expression of a target gene in a cell, tissue, or organ of the coleopteran pest. When expressed as an iRNA molecule (e.g., dsRNA, siRNA, miRNA, and hpRNA) and taken up by a coleopteran pest, nucleic acid sequences comprising one or more fragments of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81 may cause one or more of death, growth inhibition, change in sex ratio, reduction in brood size, cessation of infection, and/or cessation of feeding by a coleopteran pest. For example, in some embodiments, an iRNA molecule comprising a nucleotide sequence including about 15 to about 300 nucleotides that are substantially homologous to a coleopteran pest target gene sequence and comprising one or more fragments of a nucleotide sequence comprising SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81 is provided. Expression of such a dsRNA molecule may, for example, lead to mortality and/or growth inhibition in a coleopteran pest that takes up the iRNA molecule.

[0146] In certain embodiments, iRNA molecules provided herein comprise nucleotide sequences complementary to a target gene comprising SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81 and/or nucleotide sequences complementary to a fragment of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, the inhibition of which target gene in a coleopteran pest results in the reduction or removal of a protein or nucleotide sequence agent that is essential for the coleopteran pest's growth, development, or other biological function. A selected nucleotide sequence may exhibit from about 80% to about 100% sequence identity to SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, a contiguous fragment of the nucleotide sequence set forth in SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, or the complement of either of the foregoing. For example, a selected nucleotide sequence may exhibit about 81%; about 82%; about 83%; about 84%; about 85%; about 86%; about 87%; about 88%; about 89%; about 90%; about 91%; about 92%; about 93%; about 94% about 95%; about 96%; about 97%; about 98%; about 98.5%; about 99%; about 99.5%; about 100%, 80%; 81%; 82%; 83%; 84%; 85%; 86%; 87%; 88%; 89%; 90%; 91%; 92%; 93%; 94%; 95%; 96%; 97%; 98%; 99; or 1000/sequence identity to SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, a contiguous fragment of the nucleotide sequence set forth in SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81, or the complement of either of the foregoing.

[0147] In some embodiments, a DNA molecule capable of being expressed to produce an iRNA molecule in a cell or microorganism to inhibit target gene expression may comprise a single nucleotide sequence that is specifically complementary to all or part of a native nucleic acid sequence found in one or more target coleopteran pest species, or the DNA molecule can be constructed as a chimera from a plurality of such specifically complementary sequences.

[0148] In some embodiments, a nucleic acid molecule may comprise a first and a second nucleotide sequence separated by a "spacer sequence." A spacer sequence may be a region comprising any sequence of nucleotides that facilitates secondary structure formation between the first and second nucleotide sequences, where this is desired. In one embodiment, the spacer sequence is part of a sense or antisense coding sequence for mRNA. The spacer sequence may alternatively comprise any combination of nucleotides or homologues thereof that are capable of being linked covalently to a nucleic acid molecule.

[0149] For example, in some embodiments, the DNA molecule may comprise a nucleotide sequence coding for one or more different RNA molecules, wherein each of the different RNA molecules comprises a first nucleotide sequence and a second nucleotide sequence, wherein the first and second nucleotide sequences are complementary to each other. The first and second nucleotide sequences may be connected within an RNA molecule by a spacer sequence. The spacer sequence may constitute part of the first nucleotide sequence or the second nucleotide sequence. Expression of an RNA molecule comprising the first and second nucleotide sequences may lead to the formation of a dsRNA and/or hpRNA molecule, by specific base-pairing of the first and second nucleotide sequences. The first nucleotide sequence or the second nucleotide sequence may be substantially identical to or complementary to a nucleic acid sequence native to a coleopteran pest (e.g., a target gene, or transcribed non-coding sequence), a derivative thereof, or a complementary sequence thereto.

[0150] dsRNA nucleic acid molecules comprise double strands of polymerized ribonucleotide sequences, and may include modifications to either the phosphate-sugar backbone or the nucleoside. Modifications in RNA structure may be tailored to allow specific inhibition. In one embodiment, dsRNA molecules may be modified through a ubiquitous enzymatic process so that siRNA molecules may be generated. This enzymatic process may utilize an RNAse III enzyme, such as DICER in eukaryotes, either in vitro or in vivo. See Elbashir et al. (2001) Nature 411:494-498; and Hamilton and Baulcombe (1999) Science 286(5441):950-952. DICER or functionally-equivalent RNAse III enzymes cleave larger dsRNA strands and/or hpRNA molecules into smaller oligonucleotides (e.g., siRNAs), each of which is about 15-25 nucleotides in length. The siRNA molecules produced by these enzymes have 2 to 3 nucleotide 3' overhangs, and 5' phosphate and 3' hydroxyl termini. The siRNA molecules generated by RNAse III enzymes are unwound and separated into single-stranded RNA in the cell. The siRNA molecules then specifically hybridize with RNA sequences transcribed from a target gene, and both RNA molecules are subsequently degraded by an inherent cellular RNA-degrading mechanism. This process may result in the effective degradation or removal of the RNA sequence encoded by the target gene in the target organism. The outcome is post-transcriptional silencing of the targeted gene. In some embodiments, siRNA molecules produced by endogenous RNAse III enzymes from heterologous nucleic acid molecules may efficiently mediate the down-regulation of target genes in coleopteran pests.

[0151] In some embodiments, a nucleic acid molecule may include at least one non-naturally occurring nucleotide sequence that can be transcribed to produce a single-stranded RNA molecule capable of forming a dsRNA molecule in vivo through intermolecular hybridization. Such dsRNA sequences typically self-assemble, and can be provided in the nutrition source of a coleopteran pest to achieve the post-transcriptional inhibition of a target gene. In these and further embodiments, a nucleic acid molecule may comprise two different non-naturally occurring nucleotide sequences, each of which is specifically complementary to a different target gene in a coleopteran pest. When such a nucleic acid molecule is provided to a coleopteran pest, the molecule inhibits the expression of at least two different target genes in the coleopteran pest.

[0152] C. Obtaining Nucleic Acid Molecules

[0153] A variety of native sequences in coleopteran pests may be used as target sequences for the design of nucleic acid molecules, such as iRNAs and DNA molecules encoding iRNAs. Selection of native sequences is not, however, a straight-forward process. Only a small number of native sequences in the coleopteran pest will be effective targets. For example, it cannot be predicted with certainty whether a particular native sequence can be effectively down-regulated by nucleic acid molecules, or whether down-regulation of a particular native sequence will have a detrimental effect on the growth, viability, proliferation, and/or reproduction of the coleopteran pest. The vast majority of native coleopteran pest sequences, such as ESTs isolated therefrom (for example, as listed in U.S. Pat. Nos. 7,612,194 and 7,943,819), do not have a detrimental effect on the growth, viability, proliferation, and/or reproduction of the coleopteran pest, such as WCR or NCR. Neither is it predictable which of the native sequences which may have a detrimental effect on a coleopteran pest are able to be used in recombinant techniques for expressing nucleic acid molecules complementary to such native sequences in a host plant and providing the detrimental effect on the coleopteran pest upon feeding without causing harm to the host plant.

[0154] In some embodiments, nucleic acid molecules (e.g., iRNA molecules to be provided in the host plant of a coleopteran pest) are selected to target cDNA sequences that encode proteins or parts of proteins essential for coleopteran pest survival, such as amino acid sequences involved in metabolic or catabolic biochemical pathways, cell division, reproduction, energy metabolism, digestion, host plant recognition, and the like. As described herein, ingestion of compositions by a target organism containing one or more iRNAs, at least one segment of which is specifically complementary to at least a substantially identical segment of RNA produced in the cells of the target pest organism, can result in the death or other inhibition of the target. A nucleotide sequence, either DNA or RNA, derived from a coleopteran pest can be used to construct plant cells resistant to infestation by the coleopteran pests. The host plant of the coleopteran pest (e.g., Z. mays or G. max), for example, can be transformed to contain one or more of the nucleotide sequences derived from the coleopteran pest as provided herein. The nucleotide sequence transformed into the host may encode one or more iRNAs that contain or form into a dsRNA sequence in the cells or biological fluids within the transformed host, thus making the dsRNA available if/when the coleopteran pest forms a nutritional relationship with the transgenic host. This may result in the suppression of expression of one or more genes in the cells of the coleopteran pest, and ultimately death or inhibition of its growth or development.

[0155] Thus, in some embodiments, a gene is targeted that is essentially involved in the growth, development and reproduction of a coleopteran pest. Other target genes may include, for example, those that play important roles in coleopteran pest viability, movement, migration, growth, development, infectivity, establishment of feeding sites and reproduction. A target gene may, therefore, be a housekeeping gene or a transcription factor. Additionally, a native coleopteran pest nucleotide sequence for use as described herein may also be derived from a homolog (e.g., an ortholog), of a plant, viral, bacterial or insect gene, the function of which is known to those of skill in the art, and the nucleotide sequence of which is specifically hybridizable with a target gene in the genome of the target coleopteran pest. Methods of identifying a homolog of a gene with a known nucleotide sequence by hybridization are known to those of skill in the art.

[0156] In some embodiments, disclosed herein are methods for obtaining a nucleic acid molecule comprising a nucleotide sequence for producing an iRNA (e.g., dsRNA, siRNA, miRNA, and hpRNA) molecule. One such embodiment comprises: (a) analyzing one or more target gene(s) for their expression, function, and phenotype upon iRNA-mediated gene suppression in a coleopteran pest; (b) probing a cDNA or gDNA library with a probe comprising all or a portion of a nucleotide sequence or a homolog thereof from a targeted coleopteran pest that displays an altered (e.g., reduced) growth or development phenotype in an iRNA-mediated suppression analysis; (c) identifying a DNA clone that specifically hybridizes with the probe; (d) isolating the DNA clone identified in step (b); (e) sequencing the cDNA or gDNA fragment that comprises the clone isolated in step (d), wherein the sequenced nucleic acid molecule comprises all or a substantial portion of the RNA sequence or a homolog thereof; and (f) chemically synthesizing all or a substantial portion of a gene sequence, or a siRNA or miRNA or hpRNA or mRNA or dsRNA.

[0157] In further embodiments, a method for obtaining a nucleic acid fragment comprising a nucleotide sequence for producing a substantial portion of an iRNA (e.g., dsRNA, siRNA, miRNA, and hpRNA) molecule includes: (a) synthesizing first and second oligonucleotide primers specifically complementary to a portion of a native nucleotide sequence from a targeted coleopteran pest; and (b) amplifying a cDNA or gDNA insert present in a cloning vector using the first and second oligonucleotide primers of step (a), wherein the amplified nucleic acid molecule comprises a substantial portion of a siRNA or miRNA or hpRNA or mRNA or dsRNA molecule.

[0158] Nucleic acids can be isolated, amplified, or produced by a number of approaches. For example, an iRNA (e.g., dsRNA, siRNA, miRNA, and hpRNA) molecule may be obtained by PCR amplification of a target nucleic acid sequence (e.g., a target gene or a target transcribed non-coding sequence) derived from a gDNA or cDNA library, or portions thereof. DNA or RNA may be extracted from a target organism, and nucleic acid libraries may be prepared therefrom using methods known to those ordinarily skilled in the art. gDNA or cDNA libraries generated from a target organism may be used for PCR amplification and sequencing of target genes. A confirmed PCR product may be used as a template for in vitro transcription to generate sense and antisense RNA with minimal promoters. Alternatively, nucleic acid molecules may be synthesized by any of a number of techniques (See, e.g., Ozaki et al. (1992) Nucleic Acids Research, 20: 5205-5214; and Agrawal et al. (1990) Nucleic Acids Research, 18: 5419-5423), including use of an automated DNA synthesizer (for example, a P. E. Biosystems, Inc. (Foster City, Calif.) model 392 or 394 DNA/RNA Synthesizer), using standard chemistries, such as phosphoramidite chemistry. See, e.g., Beaucage et al. (1992) Tetrahedron, 48: 2223-2311; U.S. Pat. Nos. 4,415,732, 4,458,066, 4,725,677, 4,973,679, and 4,980,460. Alternative chemistries resulting in non-natural backbone groups, such as phosphorothioate, phosphoramidate, and the like, can also be employed.

[0159] An RNA, dsRNA, siRNA, miRNA, or hpRNA molecule may be produced chemically or enzymatically by one skilled in the art through manual or automated reactions, or in vive in a cell comprising a nucleic acid molecule comprising a sequence encoding the RNA, dsRNA, siRNA, miRNA, or hpRNA molecule. RNA may also be produced by partial or total organic synthesis-any modified ribonucleotide can be introduced by in vitro enzymatic or organic synthesis. An RNA molecule may be synthesized by a cellular RNA polymerase or a bacteriophage RNA polymerase (e.g., T3 RNA polymerase, T7 RNA polymerase, and SP6 RNA polymerase). Expression constructs useful for the cloning and expression of nucleotide sequences are known in the art. See, e.g., U.S. Pat. Nos. 5,593,874, 5,693,512, 5,698,425, 5,712,135, 5,789,214, and 5,804,693. RNA molecules that are synthesized chemically or by in vitro enzymatic synthesis may be purified prior to introduction into a cell. For example, RNA molecules can be purified from a mixture by extraction with a solvent or resin, precipitation, electrophoresis, chromatography, or a combination thereof. Alternatively, RNA molecules that are synthesized chemically or by in vitro enzymatic synthesis may be used with no or a minimum of purification, for example, to avoid losses due to sample processing. The RNA molecules may be dried for storage or dissolved in an aqueous solution. The solution may contain buffers or salts to promote annealing, and/or stabilization of dsRNA molecule duplex strands.

[0160] In embodiments, a dsRNA molecule may be formed by a single self-complementary RNA strand or from two complementary RNA strands. dsRNA molecules may be synthesized either in vivo or in vitro. An endogenous RNA polymerase of the cell may mediate transcription of the one or two RNA strands in vivo, or cloned RNA polymerase may be used to mediate transcription in vivo or in vitro. Post-transcriptional inhibition of a target gene in a coleopteran pest may be host-targeted by specific transcription in an organ, tissue, or cell type of the host (e.g., by using a tissue-specific promoter); stimulation of an environmental condition in the host (e.g., by using an inducible promoter that is responsive to infection, stress, temperature, and/or chemical inducers); and/or engineering transcription at a developmental stage or age of the host (e.g., by using a developmental stage-specific promoter). RNA strands that form a dsRNA molecule, whether transcribed in vitro or in vivo, may or may not be polyadenylated, and may or may not be capable of being translated into a polypeptide by a cell's translational apparatus.

[0161] D. Recombinant Vectors and Host Cell Transformation

[0162] In some embodiments, provided is a DNA molecule for introduction into a cell (e.g., a bacterial cell, a yeast cell, or a plant cell), wherein the DNA molecule comprises a nucleotide sequence that, upon expression to RNA and ingestion by a coleopteran pest, achieves suppression of a target gene in a cell, tissue, or organ of the coleopteran pest. Thus, some embodiments provide a recombinant nucleic acid molecule comprising a nucleic acid sequence capable of being expressed to produce an iRNA (e.g., dsRNA, siRNA, miRNA, and hpRNA) molecule in a plant cell to inhibit target gene expression in a coleopteran pest. In order to initiate or enhance expression, such recombinant nucleic acid molecules may comprise one or more regulatory sequences, which regulatory sequences may be operably linked to the nucleic acid sequence capable of being expressed to produce an iRNA. Methods to express a gene suppression molecule in plants are known, and may be used to express a nucleotide sequence. See, e.g., International PCT Publication No. WO06/073727; and U.S. Patent Publication No. 2006/0200878 A1).

[0163] In specific embodiments, a recombinant DNA molecule may comprise a nucleic acid sequence encoding a dsRNA molecule. Such recombinant DNA molecules may encode dsRNA molecules capable of inhibiting the expression of endogenous target gene(s) in a coleopteran pest cell upon ingestion. In many embodiments, a transcribed RNA may form a dsRNA molecule that may be provided in a stabilized form; e.g., as a hairpin and stem and loop structure.

[0164] In these and further embodiments, one strand of a dsRNA molecule may be formed by transcription from a nucleotide sequence which is substantially homologous to a nucleotide sequence consisting of SEQ ID NOs:1, 3, 4, 5, 73, 75, 77, or 81; the complement of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81; the complement of a fragment of at least 15 contiguous nucleotides of SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81; a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NOs: 1, 3, 4, or 5; the complement of a native coding sequence of a Diabrotica organism comprising SEQ ID NOs: 1, 3, 4, or 5; a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 1, 3, 4, or 5; the complement of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 1, 3, 4, or 5; a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NOs: 1, 3, 4, or 5; the complement of a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Diabrotica organism comprising SEQ ID NOs: 1, 3, 4, or 5; a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 1, 3, 4, or 5; and the complement of a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs: 1, 3, 4, or 5; a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NOs:73, 75, 77, or 81; the complement of a native coding sequence of a Meligethes organism comprising SEQ ID NOs:73, 75, 77, or 81; a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs:73, 75, 77, or 81; the complement of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs:73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NOs:73, 75, 77, or 81; the complement of a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Meligethes organism comprising SEQ ID NOs:73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs:73, 75, 77, or 81; and the complement of a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NOs:73, 75, 77, or 81.

[0165] In particular embodiments, a recombinant DNA molecule encoding a dsRNA molecule may comprise at least two nucleotide sequence segments within a transcribed sequence, such sequences arranged such that the transcribed sequence comprises a first nucleotide sequence segment in a sense orientation, and a second nucleotide sequence segment (comprising the complement of the first nucleotide sequence segment) is in an antisense orientation, relative to at least one promoter, wherein the sense nucleotide sequence segment and the antisense nucleotide sequence segment are linked or connected by a spacer sequence segment of from about five (.about.5) to about one thousand (.about.1000) nucleotides. The spacer sequence segment may form a loop between the sense and antisense sequence segments. The sense nucleotide sequence segment or the antisense nucleotide sequence segment may be substantially homologous to the nucleotide sequence of a target gene (e.g., a gene comprising SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81) or fragment thereof. In some embodiments, however, a recombinant DNA molecule may encode a dsRNA molecule without a spacer sequence. In embodiments, a sense coding sequence and an antisense coding sequence may be different lengths.

[0166] Sequences identified as having a deleterious effect on coleopteran pests or a plant-protective effect with regard to coleopteran pests may be readily incorporated into expressed iRNA molecules through the creation of appropriate expression cassettes in a recombinant nucleic acid molecule. For example, such sequences may be expressed as a hairpin with stem and loop structure by taking a first segment corresponding to a target gene sequence (e.g., SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, or 81 and fragments thereof); linking this sequence to a second segment spacer region that is not homologous or complementary to the first segment; and linking this to a third segment, wherein at least a portion of the third segment is substantially complementary to the first segment. Such a construct forms a stem and loop structure by intramolecular base-pairing of the first segment with the third segment, wherein the loop structure forms and comprises the second segment. See, e.g., U.S. Patent Publication Nos. 2002/0048814 and 2003/0018993; and International PCT Publication Nos. WO94/01550 and WO98/05770. A dsRNA molecule may be generated, for example, in the form of a double-stranded structure such as a stem-loop structure (e.g., hairpin), whereby production of siRNA targeted for a native coleopteran pest sequence is enhanced by co-expression of a fragment of the targeted gene, for instance on an additional plant expressible cassette, that leads to enhanced siRNA production, or reduces methylation to prevent transcriptional gene silencing of the dsRNA hairpin promoter.

[0167] Embodiments include introduction of a recombinant nucleic acid molecule into a plant (i.e., transformation) to achieve coleopteran pest-inhibitory levels of expression of one or more iRNA molecules. A recombinant DNA molecule may, for example, be a vector, such as a linear or a closed circular plasmid. The vector system may be a single vector or plasmid, or two or more vectors or plasmids that together contain the total DNA to be introduced into the genome of a host. In addition, a vector may be an expression vector. Nucleic acid sequences can, for example, be suitably inserted into a vector under the control of a suitable promoter that functions in one or more hosts to drive expression of a linked coding sequence or other DNA sequence. Many vectors are available for this purpose, and selection of the appropriate vector will depend mainly on the size of the nucleic acid to be inserted into the vector and the particular host cell to be transformed with the vector. Each vector contains various components depending on its function (e.g., amplification of DNA or expression of DNA) and the particular host cell with which it is compatible.

[0168] To impart coleopteran pest resistance to a transgenic plant, a recombinant DNA may, for example, be transcribed to produce an iRNA molecule (e.g., an RNA molecule that forms a dsRNA molecule) within the tissues or fluids of the recombinant plant. An iRNA molecule may comprise a nucleotide sequence that is substantially homologous and specifically hybridizable to a corresponding transcribed nucleotide sequence within a coleopteran pest that may cause damage to the host plant species. The coleopteran pest may contact the iRNA molecule that is transcribed in cells of the transgenic host plant, for example, by ingesting cells or fluids of the transgenic host plant that comprise the iRNA molecule. Thus, expression of a target gene is suppressed by the iRNA molecule within coleopteran pests that infest the transgenic host plant. In some embodiments, suppression of expression of the target gene in the target coleopteran pest may result in the plant being resistant to attack by the pest.

[0169] In order to enable delivery of iRNA molecules to a coleopteran pest in a nutritional relationship with a plant cell that has been transformed with a recombinant nucleic acid molecule, expression (i.e., transcription) of iRNA molecules in the plant cell is required. Thus, a recombinant nucleic acid molecule may comprise a nucleotide sequence operably linked to one or more regulatory sequences, such as a heterologous promoter sequence that functions in a host cell, such as a bacterial cell wherein the nucleic acid molecule is to be amplified, and a plant cell wherein the nucleic acid molecule is to be expressed.

[0170] Promoters suitable for use in nucleic acid molecules include those that are inducible, viral, synthetic, or constitutive, all of which are well known in the art. Non-limiting examples describing such promoters include U.S. Pat. No. 6,437,217 (maize RS81 promoter); U.S. Pat. No. 5,641,876 (rice actin promoter); U.S. Pat. No. 6,426,446 (maize RS324 promoter); U.S. Pat. No. 6,429,362 (maize PR-1 promoter); U.S. Pat. No. 6,232,526 (maize A3 promoter); U.S. Pat. No. 6,177,611 (constitutive maize promoters); U.S. Pat. Nos. 5,322,938, 5,352,605, 5,359,142, and 5,530,196 (CaMV 35S promoter); U.S. Pat. No. 6,433,252 (maize L3 oleosin promoter); U.S. Pat. No. 6,429,357 (rice actin 2 promoter, and rice actin 2 intron); U.S. Pat. No. 6,294,714 (light-inducible promoters); U.S. Pat. No. 6,140,078 (salt-inducible promoters); U.S. Pat. No. 6,252,138 (pathogen-inducible promoters); U.S. Pat. No. 6,175,060 (phosphorous deficiency-inducible promoters); U.S. Pat. No. 6,388,170 (bidirectional promoters); U.S. Pat. No. 6,635,806 (gamma-coixin promoter); and U.S. Patent Publication No. 2009/757,089 (maize chloroplast aldolase promoter). Additional promoters include the nopaline synthase (NOS) promoter (Ebert et al. (1987) Proc. Natl. Acad. Sci. USA 84(16):5745-5749) and the octopine synthase (OCS) promoters (which are carried on tumor-inducing plasmids of Agrobacterium tumefaciens); the caulimovirus promoters such as the cauliflower mosaic virus (CaMV) 19S promoter (Lawton et al. (1987) Plant Mol. Biol. 9:315-324); the CaMV 35S promoter (Odell et al. (1985) Nature 313:810-812; the figwort mosaic virus 35S-promoter (Walker et al. (1987) Proc. Natl. Acad. Sci. USA 84(19):6624-6628); the sucrose synthase promoter (Yang and Russell (1990) Proc. Natl. Acad. Sci. USA 87:4144-4148); the R gene complex promoter (Chandler et al. (1989) Plant Cell 1:1175-1183); the chlorophyll a/b binding protein gene promoter; CaMV 35S (U.S. Pat. Nos. 5,322,938, 5,352,605, 5,359,142, and 5,530,196); FMV 35S (U.S. Pat. Nos. 5,378,619 and 6,051,753); a PC1SV promoter (U.S. Pat. No. 5,850,019); the SCP1 promoter (U.S. Pat. No. 6,677,503); and AGRtu.nos promoters (GENBANK.RTM. Accession No. V00087; Depicker et al. (1982) J. Mol. Appl. Genet. 1:561-573; Bevan et al. (1983) Nature 304:184-187).

[0171] In particular embodiments, nucleic acid molecules comprise a tissue-specific promoter, such as a root-specific promoter. Root-specific promoters drive expression of operably-linked coding sequences exclusively or preferentially in root tissue. Examples of root-specific promoters are known in the art. See, e.g., U.S. Pat. Nos. 5,110,732; 5,459,252 and 5,837,848; and Opperman et al. (1994) Science 263:221-3; and Hirel et al. (1992) Plant Mol. Biol. 20:207-18. In some embodiments, a nucleotide sequence or fragment for coleopteran pest control may be cloned between two root-specific promoters oriented in opposite transcriptional directions relative to the nucleotide sequence or fragment, and which are operable in a transgenic plant cell and expressed therein to produce RNA molecules in the transgenic plant cell that subsequently may form dsRNA molecules, as described, supra. The iRNA molecules expressed in plant tissues may be ingested by a coleopteran pest so that suppression of target gene expression is achieved.

[0172] Additional regulatory sequences that may optionally be operably linked to a nucleic acid molecule of interest include 5'UTRs that function as a translation leader sequence located between a promoter sequence and a coding sequence. The translation leader sequence is present in the fully-processed mRNA, and it may affect processing of the primary transcript, and/or RNA stability. Examples of translation leader sequences include maize and petunia heat shock protein leaders (U.S. Pat. No. 5,362,865), plant virus coat protein leaders, plant rubisco leaders, and others. See, e.g., Turner and Foster (1995) Molecular Biotech. 3(3):225-36. Non-limiting examples of 5'UTRs include GmHsp (U.S. Pat. No. 5,659,122); PhDnaK (U.S. Pat. No. 5,362,865); AtAnt1; TEV (Carrington and Freed (1990) J. Virol. 64:1590-7); and AGRtunos (GENBANK.RTM. Accession No. V00087; and Bevan et al. (1983) Nature 304:184-7).

[0173] Additional regulatory sequences that may optionally be operably linked to a nucleic acid molecule of interest also include 3' non-translated sequences, 3' transcription termination regions, or poly-adenylation regions. These are genetic elements located downstream of a nucleotide sequence, and include polynucleotides that provide polyadenylation signal, and/or other regulatory signals capable of affecting transcription or mRNA processing. The polyadenylation signal functions in plants to cause the addition of polyadenylate nucleotides to the 3' end of the mRNA precursor. The polyadenylation sequence can be derived from a variety of plant genes, or from T-DNA genes. A non-limiting example of a 3' transcription termination region is the nopaline synthase 3' region (nos 3'; Fraley et al. (1983) Proc. Natl. Acad. Sci. USA 80:4803-7). An example of the use of different 3' nontranslated regions is provided in Ingelbrecht et al., (1989) Plant Cell 1:671-80. Non-limiting examples of polyadenylation signals include one from a Pisum sativum RbcS2 gene (Ps.RbcS2-E9; Coruzzi et al. (1984) EMBO J. 3:1671-9) and AGRtu.nos (GENBANK.RTM. Accession No. E01312).

[0174] Some embodiments may include a plant transformation vector that comprises an isolated and purified DNA molecule comprising at least one of the above-described regulatory sequences operatively linked to one or more nucleotide sequences described herein. When expressed, the one or more nucleotide sequences result in one or more RNA molecule(s) comprising a nucleotide sequence that is specifically complementary to all or part of a native RNA molecule in a coleopteran pest. Thus, the nucleotide sequence(s) may comprise a segment encoding all or part of a ribonucleotide sequence present within a targeted coleopteran pest RNA transcript, and may comprise inverted repeats of all or a part of a targeted coleopteran pest transcript. A plant transformation vector may contain sequences specifically complementary to more than one target sequence, thus allowing production of more than one iRNA for inhibiting expression of two or more genes in cells of one or more populations or species of target coleopteran pests. Segments of nucleotide sequence specifically complementary to nucleotide sequences present in different genes can be combined into a single composite nucleic acid molecule for expression in a transgenic plant. Such segments may be contiguous or separated by a spacer sequence.

[0175] In some embodiments, a plasmid already containing at least one nucleotide sequence(s) can be modified by the sequential insertion of additional nucleotide sequence(s) in the same plasmid, wherein the additional nucleotide sequence(s) are operably linked to the same regulatory elements as the original at least one nucleotide sequence(s). In some embodiments, a nucleic acid molecule may be designed for the inhibition of multiple target genes. In some embodiments, the multiple genes to be inhibited can be obtained from the same coleopteran pest species, which may enhance the effectiveness of the nucleic acid molecule. In other embodiments, the genes can be derived from different coleopteran pests, which may broaden the range of coleopteran pests against which the agent(s) is/are effective. When multiple genes are targeted for suppression or a combination of expression and suppression, a polycistronic DNA element can be fabricated.

[0176] A recombinant nucleic acid molecule or vector may comprise a selectable marker that confers a selectable phenotype on a transformed cell, such as a plant cell. Selectable markers may also be used to select for plants or plant cells that comprise a recombinant nucleic acid molecule. The marker may encode biocide resistance, antibiotic resistance (e.g., kanamycin, Geneticin (G418), bleomycin, hygromycin, etc.), or herbicide resistance (e.g., glyphosate, etc.). Examples of selectable markers include, but are not limited to: a neo gene which codes for kanamycin resistance and can be selected for using kanamycin, G418, etc.; a bar gene which codes for bialaphos resistance; a mutant EPSP synthase gene which encodes glyphosate resistance; a nitrilase gene which confers resistance to bromoxynil; a mutant acetolactate synthase (ALS) gene which confers imidazolinone or sulfonylurea resistance; and a methotrexate resistant DHFR gene. Multiple selectable markers are available that confer resistance to ampicillin, bleomycin, chloramphenicol, gentamycin, hygromycin, kanamycin, lincomycin, methotrexate, phosphinothricin, puromycin, spectinomycin, rifampicin, streptomycin and tetracycline, and the like. Examples of such selectable markers are illustrated in, e.g., U.S. Pat. Nos. 5,550,318; 5,633,435; 5,780,708 and 6,118,047.

[0177] A recombinant nucleic acid molecule or vector may also include a screenable marker. Screenable markers may be used to monitor expression. Exemplary screenable markers include a .beta.-glucuronidase or uidA gene (GUS) which encodes an enzyme for which various chromogenic substrates are known (Jefferson et al. (1987) Plant Mol. Biol. Rep. 5:387-405); an R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues (Dellaporta et al. (1988) "Molecular cloning of the maize R-nj allele by transposon tagging with Ac." In 18.sup.th Stadler Genetics Symposium, P. Gustafson and R. Appels, eds. (New York: Plenum), pp. 263-82); a .beta.-lactamase gene (Sutcliffe et al. (1978) Proc. Natl. Acad. Sci. USA 75:3737-41); a gene which encodes an enzyme for which various chromogenic substrates are known (e.g., PADAC, a chromogenic cephalosporin); a luciferase gene (Ow et al. (1986) Science 234:856-9); an xylE gene that encodes a catechol dioxygenase that can convert chromogenic catechols (Zukowski et al. (1983) Gene 46(2-3):247-55); an amylase gene (Ikatu et al. (1990) Bio/Technol. 8:241-2); a tyrosinase gene which encodes an enzyme capable of oxidizing tyrosine to DOPA and dopaquinone which in turn condenses to melanin (Katz et al. (1983) J. Gen. Microbiol. 129:2703-14); and an .alpha.-galactosidase.

[0178] In some embodiments, recombinant nucleic acid molecules, as described, supra, may be used in methods for the creation of transgenic plants and expression of heterologous nucleic acids in plants to prepare transgenic plants that exhibit reduced susceptibility to coleopteran pests. Plant transformation vectors can be prepared, for example, by inserting nucleic acid molecules encoding iRNA molecules into plant transformation vectors and introducing these into plants.

[0179] Suitable methods for transformation of host cells include any method by which DNA can be introduced into a cell, such as by transformation of protoplasts (See, e.g., U.S. Pat. No. 5,508,184), by desiccation/inhibition-mediated DNA uptake (See, e.g., Potrykus et al. (1985) Mol. Gen. Genet. 199:183-8), by electroporation (See, e.g., U.S. Pat. No. 5,384,253), by agitation with silicon carbide fibers (See, e.g., U.S. Pat. Nos. 5,302,523 and 5,464,765), by Agrobacterium-mediated transformation (See, e.g., U.S. Pat. Nos. 5,563,055; 5,591,616; 5,693,512; 5,824,877; 5,981,840; and 6,384,301) and by acceleration of DNA-coated particles (See, e.g., U.S. Pat. Nos. 5,015,580, 5,550,318, 5,538,880, 6,160,208, 6,399,861, and 6,403,865), etc. Techniques that are particularly useful for transforming corn are described, for example, in U.S. Pat. Nos. 5,591,616, 7,060,876 and 7,939,328. Through the application of techniques such as these, the cells of virtually any species may be stably transformed. In some embodiments, transforming DNA is integrated into the genome of the host cell. In the case of multicellular species, transgenic cells may be regenerated into a transgenic organism. Any of these techniques may be used to produce a transgenic plant, for example, comprising one or more nucleic acid sequences encoding one or more iRNA molecules in the genome of the transgenic plant.

[0180] The most widely utilized method for introducing an expression vector into plants is based on the natural transformation system of various Agrobacterium species. A. tumefaciens and A. rhizogenes are plant pathogenic soil bacteria which genetically transform plant cells. The Ti and Ri plasmids of A. tumefaciens and A. rhizogenes, respectively, carry genes responsible for genetic transformation of the plant. The Ti (tumor-inducing)-plasmids contain a large segment, known as T-DNA, which is transferred to transformed plants. Another segment of the Ti plasmid, the Vir region, is responsible for T-DNA transfer. The T-DNA region is bordered by terminal repeats. In modified binary vectors, the tumor-inducing genes have been deleted, and the functions of the Vir region are utilized to transfer foreign DNA bordered by the T-DNA border sequences. The T-region may also contain a selectable marker for efficient recovery of transgenic cells and plants, and a multiple cloning site for inserting sequences for transfer such as a dsRNA encoding nucleic acid.

[0181] Thus, in some embodiments, a plant transformation vector is derived from a Ti plasmid of A. tumefaciens (See, e.g., U.S. Pat. Nos. 4,536,475, 4,693,977, 4,886,937, and 5,501,967; and European Patent No. EP 0 122 791) or a Ri plasmid of A. rhizogenes. Additional plant transformation vectors include, for example and without limitation, those described by Herrera-Estrella et al. (1983) Nature 303:209-13; Bevan et al. (1983) Nature 304:184-7; Klee et al. (1985) Bio/Technol. 3:637-42; and in European Patent No. EP 0 120 516, and those derived from any of the foregoing. Other bacteria such as Sinorhizobium, Rhizobium, and Mesorhizobium that interact with plants naturally can be modified to mediate gene transfer to a number of diverse plants. These plant-associated symbiotic bacteria can be made competent for gene transfer by acquisition of both a disarmed Ti plasmid and a suitable binary vector.

[0182] After providing exogenous DNA to recipient cells, transformed cells are generally identified for further culturing and plant regeneration. In order to improve the ability to identify transformed cells, one may desire to employ a selectable or screenable marker gene, as previously set forth, with the transformation vector used to generate the transformant. In the case where a selectable marker is used, transformed cells are identified within the potentially transformed cell population by exposing the cells to a selective agent or agents. In the case where a screenable marker is used, cells may be screened for the desired marker gene trait.

[0183] Cells that survive the exposure to the selective agent, or cells that have been scored positive in a screening assay, may be cultured in media that supports regeneration of plants. In some embodiments, any suitable plant tissue culture media (e.g., MS and N6 media) may be modified by including further substances, such as growth regulators. Tissue may be maintained on a basic medium with growth regulators until sufficient tissue is available to begin plant regeneration efforts, or following repeated rounds of manual selection, until the morphology of the tissue is suitable for regeneration (e.g., typically about 2 weeks), then transferred to media conducive to shoot formation. Cultures are transferred periodically until sufficient shoot formation has occurred. Once shoots are formed, they are transferred to media conducive to root formation. Once sufficient roots are formed, plants can be transferred to soil for further growth and maturation.

[0184] To confirm the presence of a nucleic acid molecule of interest (for example, a DNA sequence encoding one or more iRNA molecules that inhibit target gene expression in a coleopteran pest) in the regenerating plants, a variety of assays may be performed. Such assays include, for example: molecular biological assays, such as Southern and northern blotting, PCR, and nucleic acid sequencing; biochemical assays, such as detecting the presence of a protein product, e.g., by immunological means (ELISA and/or immuno blots) or by enzymatic function; plant part assays, such as leaf or root assays; and analysis of the phenotype of the whole regenerated plant.

[0185] Integration events may be analyzed, for example, by PCR amplification using, e.g., oligonucleotide primers specific for a nucleic acid molecule of interest. PCR genotyping is understood to include, but not be limited to, polymerase-chain reaction (PCR) amplification of genomic DNA derived from isolated host plant callus tissue predicted to contain a nucleic acid molecule of interest integrated into the genome, followed by standard cloning and sequence analysis of PCR amplification products. Methods of PCR genotyping have been well described (for example, Rios, G. et al. (2002) Plant J. 32:243-53) and may be applied to genomic DNA derived from any plant species (e.g., Z. mays or G. max) or tissue type, including cell cultures.

[0186] A transgenic plant formed using Agrobacterium-dependent transformation methods typically contains a single recombinant DNA sequence inserted into one chromosome. The single recombinant DNA sequence is referred to as a "transgenic event" or "integration event." Such transgenic plants are hemizygous for the inserted exogenous sequence. In some embodiments, a transgenic plant homozygous with respect to a transgene may be obtained by sexually mating (selfing) an independent segregant transgenic plant that contains a single exogenous gene sequence to itself, for example a T.sub.0 plant, to produce T.sub.1 seed. One fourth of the T.sub.1 seed produced will be homozygous with respect to the transgene. Germinating T.sub.1 seed results in plants that can be tested for heterozygosity, typically using an SNP assay or a thermal amplification assay that allows for the distinction between heterozygotes and homozygotes (i.e., a zygosity assay).

[0187] In particular embodiments, at least 2, 3, 4, 5, 6, 7, 8, 9 or 10 or more different iRNA molecules that have a coleopteran pest-inhibitory effect are produced in a plant cell. The iRNA molecules (e.g., dsRNA molecules) may be expressed from multiple nucleic acid sequences introduced in different transformation events, or from a single nucleic acid sequence introduced in a single transformation event. In some embodiments, a plurality of iRNA molecules is expressed under the control of a single promoter. In other embodiments, a plurality of iRNA molecules is expressed under the control of multiple promoters. Single iRNA molecules may be expressed that comprise multiple nucleic acid sequences that are each homologous to different loci within one or more coleopteran pests (for example, the locus defined by SEQ ID NOs:1, 3, 4, 5, 73, 75, 77, and 81), both in different populations of the same species of coleopteran pest, or in different species of coleopteran pests.

[0188] In addition to direct transformation of a plant with a recombinant nucleic acid molecule, transgenic plants can be prepared by crossing a first plant having at least one transgenic event with a second plant lacking such an event. For example, a recombinant nucleic acid molecule comprising a nucleotide sequence that encodes an iRNA molecule may be introduced into a first plant line that is amenable to transformation to produce a transgenic plant, which transgenic plant may be crossed with a second plant line to introgress the nucleotide sequence that encodes the iRNA molecule into the second plant line.

[0189] Also included are commodity products containing one or more of the sequences described herein. Particular embodiments include commodity products produced from a recombinant plant or seed containing one or more of the nucleotide sequences described herein. A commodity product containing one or more of the sequences described herein is intended to include, but not be limited to, meals, oils, crushed or whole grains or seeds of a plant, or any food or animal feed product comprising any meal, oil, or crushed or whole grain of a recombinant plant or seed containing one or more of the sequences disclosed herein. The detection of one or more of the sequences disclosed herein in one or more commodity or commodity products contemplated herein is de facto evidence that the commodity or commodity product is produced from a transgenic plant designed to express one or more of the nucleotides sequences disclosed herein for the purpose of controlling coleopteran plant pests using iRNA-mediated gene suppression methods.

[0190] In some aspects, seeds and commodity products produced by transgenic plants derived from transformed plant cells are included, wherein the seeds or commodity products comprise a detectable amount of a nucleic acid sequence disclosed herein. In some embodiments, such commodity products may be produced, for example, by obtaining transgenic plants and preparing food or feed from them. Commodity products comprising one or more of the nucleic acid sequences disclosed herein includes, for example and without limitation: meals, oils, crushed or whole grains or seeds of a plant, and any food product comprising any meal, oil, or crushed or whole grain of a recombinant plant or seed comprising one or more of the nucleic acid sequences disclosed herein. The detection of one or more of the sequences disclosed herein in one or more commodity or commodity products is de facto evidence that the commodity or commodity product is produced from a transgenic plant designed to express one or more of the iRNA molecules disclosed herein for the purpose of controlling coleopteran pests.

[0191] In some embodiments, a transgenic plant or seed comprising a nucleic acid molecule disclosed herein also may comprise at least one other transgenic event in its genome, including without limitation: a transgenic event from which is transcribed an iRNA molecule targeting a locus in a coleopteran pest other than the ones defined by SEQ ID NOs: 1, 3, 4, 5, 73, 75, 77, and 81, such as, for example, one or more loci selected from the group consisting of Caf1-180 (U.S. Patent Application Publication No. 2012/0174258), VatpaseC (U.S. Patent Application Publication No. 2012/0174259), Rho1 (U.S. Patent Application Publication No. 2012/0174260), VatpaseH (U.S. Patent Application Publication No. 2012/0198586), PPI-87B (U.S. Patent Application Publication No. 2013/0091600), RPA70 (U.S. Patent Application Publication No. 2013/0091601), and RPS6 (U.S. Patent Application Publication No. 2013/0097730); a transgenic event from which is transcribed an iRNA molecule targeting a gene in an organism other than a coleopteran pest (e.g., a plant-parasitic nematode); a gene encoding an insecticidal protein (e.g., a Bacillus thuringiensis insecticidal protein, such as, for example, Cry34Ab1 (U.S. Pat. Nos. 6,127,180, 6,340,593, and 6,624,145), Cry35Ab1 (U.S. Pat. Nos. 6,083,499, 6,340,593, and 6,548,291), a "Cry34/35Ab1" combination in a single event (e.g., maize event DAS-59122-7; U.S. Pat. No. 7,323,556), Cry3A (e.g., U.S. Pat. No. 7,230,167), Cry3B (e.g., U.S. Pat. No. 8,101,826), Cry6A (e.g., U.S. Pat. No. 6,831,062), and combinations thereof (e.g., U.S. Patent Application Nos. 2013/0167268, 2013/0167269, and 2013/0180016); an herbicide tolerance gene (e.g., a gene providing tolerance to glyphosate, glufosinate, dicamba or 2,4-D (e.g., U.S. Pat. No. 7,838,733)); and a gene contributing to a desirable phenotype in the transgenic plant, such as increased yield, altered fatty acid metabolism, or restoration of cytoplasmic male sterility). In particular embodiments, sequences encoding iRNA molecules disclosed herein may be combined with other insect control or with disease resistance traits in a plant to achieve desired traits for enhanced control of insect damage and plant disease. Combining insect control traits that employ distinct modes-of-action may provide protected transgenic plants with superior durability over plants harboring a single control trait, for example, because of the reduced probability that resistance to the trait(s) will develop in the field.

V. Target Gene Suppression in a Coleopteran Pest

[0192] A. Overview

[0193] In some embodiments, at least one nucleic acid molecule useful for the control of coleopteran pests may be provided to a coleopteran pest, wherein the nucleic acid molecule leads to RNAi-mediated gene silencing in the coleopteran pest. In particular embodiments, an iRNA molecule (e.g., dsRNA, siRNA, miRNA, and hpRNA) may be provided to the coleopteran pest. In some embodiments, a nucleic acid molecule useful for the control of coleopteran pests may be provided to a coleopteran pest by contacting the nucleic acid molecule with the coleopteran pest. In these and further embodiments, a nucleic acid molecule useful for the control of coleopteran pests may be provided in a feeding substrate of the coleopteran pest, for example, a nutritional composition. In these and further embodiments, a nucleic acid molecule useful for the control of coleopteran pests may be provided through ingestion of plant material comprising the nucleic acid molecule that is ingested by the coleopteran pest. In certain embodiments, the nucleic acid molecule is present in plant material through expression of a recombinant nucleic acid sequence introduced into the plant material, for example, by transformation of a plant cell with a vector comprising the recombinant nucleic acid sequence and regeneration of a plant material or whole plant from the transformed plant cell.

[0194] B. RNAi-mediated Target Gene Suppression

[0195] In embodiments, provided are iRNA molecules (e.g., dsRNA, siRNA, miRNA, and hpRNA) that may be designed to target essential native nucleotide sequences (e.g., essential genes) in the transcriptome of a coleopteran pest (e.g., WCR or NCR or PB), for example by designing an iRNA molecule that comprises at least one strand comprising a nucleotide sequence that is specifically complementary to the target sequence. The sequence of an iRNA molecule so designed may be identical or completely complementary to the target sequence, or may incorporate mismatches that do not prevent specific hybridization between the iRNA molecule and its target sequence.

[0196] iRNA molecules as disclosed herein may be used in methods for gene suppression in a coleopteran pest, thereby reducing the level or incidence of damage caused by the pest on a plant (for example, a protected transformed plant comprising an iRNA molecule). As used herein, the term "gene suppression" refers to any of the well-known methods for reducing the levels of protein produced as a result of gene transcription to mRNA and subsequent translation of the mRNA, including the reduction of protein expression from a gene or a coding sequence including post-transcriptional inhibition of expression and transcriptional suppression. Post-transcriptional inhibition is mediated by specific homology between all or a part of an mRNA transcribed from a gene targeted for suppression and the corresponding iRNA molecule used for suppression. Additionally, post-transcriptional inhibition refers to the substantial and measurable reduction of the amount of mRNA available in the cell for binding by ribosomes.

[0197] In embodiments wherein an iRNA molecule is a dsRNA molecule, the dsRNA molecule may be cleaved by the enzyme, DICER, into short siRNA molecules (approximately 20 nucleotides in length). The double-stranded siRNA molecule generated by DICER activity upon the dsRNA molecule may be separated into two single-stranded siRNAs; the "passenger strand" and the "guide strand." The passenger strand may be degraded, and the guide strand may be incorporated into RISC. Post-transcriptional inhibition occurs by specific hybridization of the guide strand with a specifically complementary sequence of an mRNA molecule, and subsequent cleavage by the enzyme, Argonaute (catalytic component of the RISC complex).

[0198] In embodiments, any form of iRNA molecule may be used. Those of skill in the art will understand that dsRNA molecules typically are more stable than are single-stranded RNA molecules, during preparation and during the step of providing the iRNA molecule to a cell, and are typically also more stable in a cell. Thus, while siRNA and miRNA molecules, for example, may be equally effective in some embodiments, a dsRNA molecule may be chosen due to its stability.

[0199] In particular embodiments, a nucleic acid molecule is provided that comprises a nucleotide sequence, which nucleotide sequence may be transcribed in vitro to produce an iRNA molecule that is substantially homologous to a nucleic acid molecule encoded by a nucleotide sequence within the genome of a coleopteran pest. In certain embodiments, the in vitro transcribed iRNA molecule may be a stabilized dsRNA molecule that comprises a stem-loop structure. After a coleopteran pest contacts the in vitro transcribed iRNA molecule, post-transcriptional inhibition of a target gene in the coleopteran pest (for example, an essential gene) may occur.

[0200] In some embodiments, expression of a nucleic acid molecule comprising at least 15 contiguous nucleotides of a nucleotide sequence is used in a method for post-transcriptional inhibition of a target gene in a coleopteran pest, wherein the nucleotide sequence is selected from the group consisting of: SEQ ID NO:1, 3, 4, 5, 73, 75, 77, or 81; the complement of SEQ ID NO: 1, 3, 4, 5, 73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of SEQ ID NO:1, 3, 4, 5, 73, 75, 77, or 81; the complement of a fragment of at least 15 contiguous nucleotides of SEQ ID NO:1, 3, 4, 5, 73, 75, 77, or 81; a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NO:1, 3, 4, or 5; the complement of a native coding sequence of a Diabrotica organism comprising SEQ ID NO:1, 3, 4, or 5; a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO: 1, 3, 4, or 5; the complement of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO: 1, 3, 4, or 5; the complement of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO: 1, 3, 4, or 5; a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NO:1, 3, 4, or 5; the complement of a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Diabrotica organism comprising SEQ ID NO:1, 3, 4, or 5; a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:1, 3, 4, or 5; and the complement of a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:1, 3, 4, or 5; a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NO:73, 75, 77, or 81; the complement of a native coding sequence of a Meligethes organism comprising SEQ ID NO:73, 75, 77, or 81; a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81; the complement of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81; the complement of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NO:73, 75, 77, or 81; the complement of a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Meligethes organism comprising SEQ ID NO:73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81; and the complement of a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81. In certain embodiments, expression of a nucleic acid molecule that is at least 80% identical (e.g., 80%, about 81%, about 82%, about 83%, about 84%, about 85%, about 86%, about 87%, about 88%, about 89%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, about 100%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, and 100%) with any of the foregoing may be used. In these and further embodiments, a nucleic acid molecule may be expressed that specifically hybridizes to an RNA molecule present in at least one cell of a coleopteran pest.

[0201] In some embodiments, expression of at least one nucleic acid molecule comprising at least 15 contiguous nucleotides of a nucleotide sequence may be used in a method for post-transcriptional inhibition of a target gene in a coleopteran pest, wherein the nucleotide sequence is selected from the group consisting of: SEQ ID NO:1, 3, 4, 5, 73, 75, 77, or 81; the complement of SEQ ID NO:1, 3, 4, 5, 73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of SEQ ID NO:1, 3, 4, 5, 73, 75, 77, or 81; the complement of a fragment of at least 15 contiguous nucleotides of SEQ ID NO:1, 3, 4, 5, 73, 75, 77, or 81; a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NO:1, 3, 4, or 5; the complement of a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NO: 1, 3, 4, or 5 a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:1, 3, 4, or 5; the complement of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO: 1, 3, 4, or 5; a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Diabrotica organism (e.g., WCR) comprising SEQ ID NO:1, 3, 4, or 5; the complement of a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Diabrotica organism comprising SEQ ID NO:1, 3, 4, or 5; a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO: 1, 3, 4, or 5; and the complement of a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Diabrotica organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO: 1, 3, 4, or 5; a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NO:73, 75, 77, or 81; the complement of a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NO:73, 75, 77, or 81; a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81; the complement of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Meligethes organism (e.g., PB) comprising SEQ ID NO:73, 75, 77, or 81; the complement of a fragment of at least 15 contiguous nucleotides of a native coding sequence of a Meligethes organism comprising SEQ ID NO:73, 75, 77, or 81; a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81; and the complement of a fragment of at least 15 contiguous nucleotides of a native non-coding sequence of a Meligethes organism that is transcribed to produce a native RNA molecule comprising SEQ ID NO:73, 75, 77, or 81. In certain embodiments, expression of a nucleic acid molecule that is at least 80% identical (e.g., 80%, about 81%, about 82%, about 83%, about 84%, about 85%, about 86%, about 87%, about 88%, about 89%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, about 100%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, and 100%) with any of the foregoing may be used. In these and further embodiments, a nucleic acid molecule may be expressed that specifically hybridizes to an RNA molecule present in at least one cell of a coleopteran pest. In particular examples, such a nucleic acid molecule may comprise a nucleotide sequence comprising SEQ ID NO: 1, 3, 4, 5, 73, 75, 77, or 81.

[0202] It is an important feature of some embodiments that the RNAi post-transcriptional inhibition system is able to tolerate sequence variations among target genes that might be expected due to genetic mutation, strain polymorphism, or evolutionary divergence. The introduced nucleic acid molecule may not need to be absolutely homologous to either a primary transcription product or a fully-processed mRNA of a target gene, so long as the introduced nucleic acid molecule is specifically hybridizable to either a primary transcription product or a fully-processed mRNA of the target gene. Moreover, the introduced nucleic acid molecule may not need to be full-length, relative to either a primary transcription product or a fully processed mRNA of the target gene.

[0203] Inhibition of a target gene using the iRNA technology disclosed herein is sequence-specific; i.e., nucleotide sequences substantially homologous to the iRNA molecule(s) are targeted for genetic inhibition. In some embodiments, an RNA molecule comprising a nucleotide sequence identical to or complementary to a portion of a target gene sequence may be used for inhibition. In these and further embodiments, an RNA molecule comprising a nucleotide sequence with one or more insertion, deletion, and/or point mutations relative to a target gene sequence may be used. In particular embodiments, an iRNA molecule and a portion of a target gene may share, for example, at least from about 80%, at least from about 81%, at least from about 82%, at least from about 83%, at least from about 84%, at least from about 85%, at least from about 86%, at least from about 87%, at least from about 88%, at least from about 89%, at least from about 90%, at least from about 91%, at least from about 92%, at least from about 93%, at least from about 94%, at least from about 95%, at least from about 96%, at least from about 97%, at least from about 98%, at least from about 99%, at least from about 100%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, and 100% sequence identity. Alternatively, the duplex region of a dsRNA molecule may be specifically hybridizable with a portion of a target gene transcript. In specifically hybridizable molecules, a less than full length sequence exhibiting a greater homology compensates for a longer, less homologous sequence. The length of the nucleotide sequence of a duplex region of a dsRNA molecule that is identical to or complementary to a portion of a target gene transcript may be at least about 15, 20, 25, 50, 100, 200, 300, 400, 500, or at least about 1000, or 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 50, 100, 200, 300, 400, 500, or 1000 bases. In some embodiments, a sequence of greater than 20 to 100 nucleotides may be used. In particular embodiments, a sequence of greater than about 100 to 200 nucleotides, 200 to 300 nucleotides, or 300 to 500 nucleotides may be used. In particular embodiments, a sequence of greater than about 500 to 1000 nucleotides may be used, depending on the size of the target gene.

[0204] In certain embodiments, expression of a target gene in a coleopteran pest may be inhibited by at least 10%; at least 33%; at least 50%; or at least 80% within a cell of the coleopteran pest, such that a significant inhibition takes place. Significant inhibition refers to inhibition over a threshold that results in a detectable phenotype (e.g., cessation of growth, cessation of feeding, cessation of development, induced mortality, etc.), or a detectable decrease in RNA and/or gene product corresponding to the target gene being inhibited. Although in certain embodiments inhibition occurs in substantially all cells of the coleopteran pest, in other embodiments inhibition occurs only in a subset of cells expressing the target gene.

[0205] In some embodiments, transcriptional suppression in a cell is mediated by the presence of an iRNA molecule exhibiting substantial sequence identity to a promoter DNA sequence or the complement thereof, to effect what is referred to as "promoter trans suppression." Gene suppression may be effective against target genes in a coleopteran pest that may ingest or contact such iRNA molecules, for example, by ingesting or contacting plant material containing the dsRNA molecules. iRNA molecules for use in promoter trans suppression may be specifically designed to inhibit or suppress the expression of one or more homologous or complementary sequences in the cells of the coleopteran pest. Post-transcriptional gene suppression by antisense or sense oriented RNA to regulate gene expression in plant cells is disclosed in U.S. Pat. Nos. 5,107,065, 5,231,020, 5,283,184, and 5,759,829.

[0206] C. Expression of iRNA Molecules Provided to a Coleopteran Pest

[0207] Expression of iRNA molecules for RNAi-mediated gene inhibition in a coleopteran pest may be carried out in any one of many in vitro or in vivo formats. The iRNA molecules may then be provided to a coleopteran pest, for example, by contacting the iRNA molecules with the pest, or by causing the pest to ingest or otherwise internalize the iRNA molecules. Some embodiments include transformed host plants of a coleopteran pest, transformed plant cells, and progeny of transformed plants. The transformed plant cells and transformed plants may be engineered to express one or more of the iRNA molecules, for example, under the control of a heterologous promoter, to provide a pest-protective effect. Thus, when a transgenic plant or plant cell is consumed by a coleopteran pest during feeding, the pest may ingest iRNA molecules expressed in the transgenic plants or cells. The nucleotide sequences disclosed herein may also be introduced into a wide variety of prokaryotic and eukaryotic microorganism hosts to produce iRNA molecules. The term "microorganism" includes prokaryotic and eukaryotic species, such as bacteria and fungi.

[0208] Modulation of gene expression may include partial or complete suppression of such expression. In another embodiment, a method for suppression of gene expression in a coleopteran pest comprises providing in the tissue of the host of the pest a gene-suppressive amount of at least one iRNA molecule formed following transcription of a nucleotide sequence as described herein, at least one segment of which is complementary to an mRNA sequence within the cells of the coleopteran pest. An iRNA molecule, including its modified form such as a dsRNA, siRNA, miRNA, or hpRNA molecule, ingested by a coleopteran pest, may be at least from about 80%, about 81%, about 82%, about 83%, about 84%, about 85%, about 86%, about 87%, about 88%, about 89%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, about 100%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%. or 100% identical to or complementary to an RNA molecule transcribed from a nucleic acid molecule comprising a nucleotide sequence comprising SEQ ID NO:1, 3, 4, 5, 73, 75, 77, or 81. Isolated and substantially purified nucleic acid molecules including, but not limited to, non-naturally occurring nucleotide sequences and recombinant DNA constructs for providing iRNA molecules are, therefore, provided, which suppress or inhibit the expression of an endogenous coding sequence or a target coding sequence in the coleopteran pest when introduced thereto.

[0209] Particular embodiments provide a delivery system for the delivery of iRNA molecules for the post-transcriptional inhibition of one or more target gene(s) in a coleopteran plant pest and control of a population of the coleopteran plant pest. In some embodiments, the delivery system comprises ingestion of a host transgenic plant cell or contents of the host cell comprising RNA molecules transcribed in the host cell. In these and further embodiments, a transgenic plant cell or a transgenic plant is created that contains a recombinant DNA construct providing a stabilized dsRNA molecule. Transgenic plant cells and transgenic plants comprising nucleic acid sequences encoding a particular iRNA molecule may be produced by employing recombinant DNA technologies (which basic technologies are well-known in the art) to construct a plant transformation vector comprising a nucleotide sequence encoding an iRNA molecule (e.g., a stabilized dsRNA molecule); to transform a plant cell or plant; and to generate the transgenic plant cell or the transgenic plant that contains the transcribed iRNA molecule.

[0210] To impart coleopteran pest resistance to a transgenic plant, a recombinant DNA molecule may, for example, be transcribed to produce an iRNA molecule, such as a dsRNA molecule, an siRNA molecule, an miRNA molecule, or an hpRNA molecule. In some embodiments, an RNA molecule transcribed from a recombinant DNA molecule may form a dsRNA molecule within the tissues or fluids of the recombinant plant or within the tissues or fluids of an organism contacted or ingesting the RNA molecule. Such an iRNA molecule may be comprised in part of a nucleotide sequence that is identical to or complementary to a corresponding nucleotide sequence transcribed from a DNA sequence within a coleopteran pest of a type that may infest the host plant. Expression of a target gene within the coleopteran pest is suppressed by the ingested iRNA molecule, and the suppression of expression of the target gene in the coleopteran pest results in, for example, cessation of feeding by the coleopteran pest, with an ultimate result being, for example, that the transgenic plant is protected from further damage by the coleopteran pest. The modulatory effects of iRNA molecules have been shown to be applicable to a variety of genes expressed in pests, including, for example, endogenous genes responsible for cellular metabolism or cellular transformation, including house-keeping genes; transcription factors; molting-related genes; and other genes which encode polypeptides involved in cellular metabolism or normal growth and development.

[0211] For transcription from a transgene in vivo or an expression construct, a regulatory region (e.g., promoter, enhancer, silencer, and polyadenylation signal) may be used in some embodiments to regulate the production of the RNA strand (or strands). Therefore, in some embodiments, as set forth, supra, a nucleotide sequence for use in producing iRNA molecules may be operably linked to one or more promoter sequences functional in a plant host cell. The promoter may be an endogenous promoter, normally resident in the host genome. The nucleotide sequence, under the control of an operably linked promoter sequence, may further be flanked by additional sequences that advantageously affect its transcription and/or the stability of a resulting transcript. Such sequences may be located upstream of the operably linked promoter, downstream of the 3' end of the expression construct, and may occur both upstream of the promoter and downstream of the 3' end of the expression construct.

[0212] Some embodiments provide methods for reducing the damage to a host plant (e.g., a corn plant) caused by a coleopteran pest that feeds on the plant, wherein the method comprises providing in the host plant a transformed plant cell expressing at least one nucleic acid molecule disclosed herein, wherein the nucleic acid molecule(s) functions upon being taken up by the coleopteran pest to inhibit the expression of a target sequence within the coleopteran pest, which inhibition of expression results in mortality, reduced growth, and/or reduced reproduction of the coleopteran pest, thereby reducing the damage to the host plant caused by the coleopteran pest. In some embodiments, the nucleic acid molecule(s) comprise iRNA molecules. In these and further embodiments, the nucleic acid molecule(s) encode iRNA molecules that each comprise more than one nucleotide sequence that is specifically hybridizable to a nucleic acid molecule expressed in a coleopteran pest cell. In some embodiments, the nucleic acid molecule(s) consist of one nucleotide sequence that is specifically hybridizable to a nucleic acid molecule expressed in a coleopteran pest cell.

[0213] In some embodiments, a method for increasing the yield of a corn crop is provided, wherein the method comprises introducing into a corn plant at least one nucleic acid molecule disclosed herein; cultivating the corn plant to allow the expression of an iRNA molecule comprising the nucleic acid sequence, wherein expression of an iRNA molecule comprising the nucleic acid sequence inhibits coleopteran pest growth and/or coleopteran pest damage, thereby reducing or eliminating a loss of yield due to coleopteran pest infestation. In some embodiments, the iRNA molecule is a dsRNA molecule. In these and further embodiments, the nucleic acid molecule(s) encode iRNA molecules that each comprise more than one nucleotide sequence that is specifically hybridizable to a nucleic acid molecule expressed in a coleopteran pest cell. In some embodiments, the nucleic acid molecule(s) consists of one nucleotide sequence that is specifically hybridizable to a nucleic acid molecule expressed in a coleopteran pest cell.

[0214] In some embodiments, a method for modulating the expression of a target gene in a coleopteran pest is provided, the method comprising: transforming a plant cell with a vector comprising a nucleic acid sequence encoding at least one nucleic acid molecule, wherein the nucleotide sequence is operatively-linked to a promoter and a transcription termination sequence; culturing the transformed plant cell under conditions sufficient to allow for development of a plant cell culture including a plurality of transformed plant cells; selecting for transformed plant cells that have integrated the nucleic acid molecule into their genomes; screening the transformed plant cells for expression of an iRNA molecule encoded by the integrated nucleic acid molecule; selecting a transgenic plant cell that expresses the iRNA molecule; and feeding the selected transgenic plant cell to the coleopteran pest. Plants may also be regenerated from transformed plant cells that express an iRNA molecule encoded by the integrated nucleic acid molecule. In some embodiments, the iRNA molecule is a dsRNA molecule. In these and further embodiments, the nucleic acid molecule(s) comprise dsRNA molecules that each comprise more than one nucleotide sequence that is specifically hybridizable to a nucleic acid molecule expressed in a coleopteran pest cell. In some embodiments, the nucleic acid molecule(s) consists of one nucleotide sequence that is specifically hybridizable to a nucleic acid molecule expressed in a coleopteran pest cell.

[0215] iRNA molecules can be incorporated within the seeds of a plant species (e.g., corn), either as a product of expression from a recombinant gene incorporated into a genome of the plant cells, or as incorporated into a coating or seed treatment that is applied to the seed before planting. A plant cell comprising a recombinant gene is considered to be a transgenic event. Also included in embodiments are delivery systems for the delivery of iRNA molecules to coleopteran pests. For example, the iRNA molecules may be directly introduced into the cells of a coleopteran pest. Methods for introduction may include direct mixing of iRNA with plant tissue from a host for the coleopteran pest, as well as application of compositions comprising iRNA to host plant tissue. For example, iRNA molecules may be sprayed onto a plant surface. Alternatively, an iRNA molecule may be expressed by a microorganism, and the microorganism may be applied onto the plant surface, or introduced into a root or stem by a physical means such as an injection. As discussed, supra, a transgenic plant may also be genetically engineered to express at least one iRNA molecule in an amount sufficient to kill the coleopteran pests known to infest the plant. iRNA molecules produced by chemical or enzymatic synthesis may also be formulated in a manner consistent with common agricultural practices, and used as spray-on products for controlling plant damage by a coleopteran pest. The formulations may include the appropriate stickers and wetters required for efficient foliar coverage, as well as UV protectants to protect iRNA molecules (e.g., dsRNA molecules) from UV damage. Such additives are commonly used in the bioinsecticide industry, and are well known to those skilled in the art. Such applications may be combined with other spray-on insecticide applications (biologically based or otherwise) to enhance plant protection from coleopteran pests.

[0216] All references, including publications, patents, and patent applications, cited herein are hereby incorporated by reference to the extent they are not inconsistent with the explicit details of this disclosure, and are so incorporated to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein. The references discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the inventors are not entitled to antedate such disclosure by virtue of prior invention.

[0217] The following EXAMPLES are provided to illustrate certain particular features and/or aspects. These EXAMPLES should not be construed to limit the disclosure to the particular features or aspects described.

EXAMPLES

Example 1

Identification of Candidate Target Genes

[0218] Multiple stages of WCR (Diabrotica virgifera virgifera LeConte) development were selected for pooled transcriptome analysis to provide candidate target gene sequences for control by RNAi transgenic plant insect resistance technology.

[0219] In one exemplification, total RNA was isolated from about 0.9 gm whole first-instar WCR larvae; (4 to 5 days post-hatch; held at 16.degree. C.), and purified using the following phenol/TRI REAGENT.RTM.-based method (MOLECULAR RESEARCH CENTER, Cincinnati, Ohio):

[0220] Larvae were homogenized at room temperature in a 15 mL homogenizer with 10 mL of TRI REAGENT.RTM. until a homogenous suspension was obtained. Following 5 min. incubation at room temperature, the homogenate was dispensed into 1.5 mL microfuge tubes (1 mL per tube), 200 .mu.L of chloroform was added, and the mixture was vigorously shaken for 15 seconds. After allowing the extraction to sit at room temperature for 10 min, the phases were separated by centrifugation at 12,000.times.g at 4.degree. C. The upper phase (comprising about 0.6 mL) was carefully transferred into another sterile 1.5 mL tube, and an equal volume of room temperature isopropanol was added. After incubation at room temperature for 5 to 10 min, the mixture was centrifuged 8 min at 12,000.times.g (4.degree. C. or 25.degree. C.).

[0221] The supernatant was carefully removed and discarded, and the RNA pellet was washed twice by vortexing with 75% ethanol, with recovery by centrifugation for 5 min at 7,500.times.g (4.degree. C. or 25.degree. C.) after each wash. The ethanol was carefully removed, the pellet was allowed to air-dry for 3 to 5 min, and then was dissolved in nuclease-free sterile water. RNA concentration was determined by measuring the absorbance (A) at 260 nm and 280 nm. A typical extraction from about 0.9 gm of larvae yielded over 1 mg of total RNA, with an A.sub.260/A.sub.280 ratio of 1.9. The RNA thus extracted was stored at -80.degree. C. until further processed.

[0222] RNA quality was determined by running an aliquot through a 1% agarose gel. The agarose gel solution was made using autoclaved 10.times. TAE buffer (Tris-acetate EDTA; 1.times. concentration is 0.04 M Tris-acetate, 1 mM EDTA (ethylenediamine tetra-acetic acid sodium salt), pH 8.0) diluted with DEPC (diethyl pyrocarbonate)-treated water in an autoclaved container. 1.times. TAE was used as the running buffer. Before use, the electrophoresis tank and the well-forming comb were cleaned with RNASE AWAY.RTM. (INVITROGEN INC., Carlsbad, Calif.). Two .mu.L of RNA sample were mixed with 8 .mu.L of TE buffer (10 mM Tris HCl pH 7.0; 1 mM EDTA) and 10 .mu.L of RNA sample buffer (NOVAGEN.RTM. Catalog No 70606; EMD4 Bioscience, Gibbstown, N.J.). The sample was heated at 70.degree. C. for 3 min, cooled to room temperature, and 5 .mu.L (containing 1 .mu.g to 2 .mu.g RNA) were loaded per well. Commercially available RNA molecular weight markers were simultaneously run in separate wells for molecular size comparison. The gel was run at 60 volts for 2 hr.

[0223] A normalized cDNA library was prepared from the larval total RNA by a commercial service provider (EUROFINS MWG Operon, Huntsville, Ala.), using random priming. The normalized larval cDNA library was sequenced at 1/2 plate scale by GS FLX 454 Titanium.TM. series chemistry at EUROFINS MWG Operon, which resulted in over 600,000 reads with an average read length of 348 bp. 350,000 reads were assembled into over 50,000 contigs. Both the unassembled reads and the contigs were converted into BLASTable databases using the publicly available program, FORMATDB (available from NCBI).

[0224] Total RNA and normalized cDNA libraries were similarly prepared from materials harvested at other WCR developmental stages. A pooled transcriptome library for target gene screening was constructed by combining cDNA library members representing the various developmental stages.

[0225] Candidate genes for RNAi targeting were selected using information regarding lethal RNAi effects of particular genes in other insects such as Drosophila and Tribolium. These genes were hypothesized to be essential for survival and growth in coleopteran insects. Selected target gene homologs were identified in the transcriptome sequence database as described below. Full-length or partial sequences of the target genes were amplified by PCR to prepare templates for double-stranded RNA (dsRNA) production.

[0226] TBLASTN searches using candidate protein coding sequences were run against BLASTable databases containing the unassembled Diabrotica sequence reads or the assembled contigs. Significant hits to a Diabrotica sequence (defined as better than e.sup.-20 for contigs homologies and better than e.sup.-10 for unassembled sequence reads homologies) were confirmed using BLASTX against the NCBI non-redundant database. The results of this BLASTX search confirmed that the Diabrotica homolog candidate gene sequences identified in the TBLASTN search indeed comprised Diabrotica genes, or were the best hit to the non-Diabrotica candidate gene sequence present in the Diabrotica sequences. In most cases, Tribolium candidate genes which were annotated as encoding a protein gave an unambiguous sequence homology to a sequence or sequences in the Diabrotica transcriptome sequences. In a few cases, it was clear that some of the Diabrotica contigs or unassembled sequence reads selected by homology to a non-Diabrotica candidate gene overlapped, and that the assembly of the contigs had failed to join these overlaps. In those cases, Sequencher.TM. v4.9 (GENE CODES CORPORATION, Ann Arbor, Mich.) was used to assemble the sequences into longer contigs.

[0227] A candidate target gene encoding Diabrotica rnapII-140 (SEQ ID NO:1) was identified as a gene that may lead to coleopteran pest mortality, inhibition of growth, inhibition of development, or inhibition of reproduction in WCR.

[0228] Genes with Homology to WCR rnapII-140

[0229] In eukaryotes three classes of RNA polymerases (RNAP) exist: RNAPI, which transcribes ribosomal RNA; RNAPII, which transcribes all the protein coding genes, and RNAPIII, which transcribes 5S rRNA and tRNA genes. These complex structures consist of 9 to 14 subunits, some of them are common among all three forms of polymerases in all species, whereas others are class- and species-specific. RNAPII of Drosophila melanogaster consists of at least 12 electrophoretically separable subunits (Kramer and Bautz (1981) European Journal Biochemistry 117:449-455). The genes for the two largest subunits are RpII140 (which codes for a 140-kDa Beta subunit) and RpII215 (which codes for a 215-kDa subunit). Both genes have been shown to be essential for viability of Drosophila, which is also true for the gene encoding a smaller (15-kDa) subunit encoded by RpII15 (Falkenburg et al. (1987) Journal Molecular Biology 195:929-937; Jokerst et al. (1989) Molecular General Genetics 215:266-275; Harrison et al. (1992) Molecular and Cell Biology 12:928-935). Another subunit gene, (RpII18; Hamilton et al. (1993) Genetics 134:517-529), for which there are no known mutations, codes for an 18-kDa protein.

[0230] Disclosed here are target sequences and lethal effects of RNAi on Diabrotica virgifera virgifera rnapII-140 (Beta subunit).

[0231] Genes with homology to rnapII-140 provide a functional grouping for RNAi targets. Other subunits of RNAPII are also RNAi targets. RNAPII dsRNA transgenes can be combined with other dsRNA molecules to provide redundant RNAi targeting and synergistic RNAi effects. Transgenic corn events expressing dsRNA that targets RNAPII-140 production are useful for preventing root feeding damage by corn rootworm. rnapII-140 dsRNA transgenes represent new modes of action for combining with Bacillus thuringiensis insecticidal protein technology in Insect Resistance Management gene pyramids to mitigate against the development of rootworm populations resistant to either of these rootworm control technologies.

[0232] Full-length or partial clones of sequences of a Diabrotica candidate gene, herein referred to as rnapII-140, were used to generate PCR amplicons for dsRNA synthesis.

[0233] SEQ ID NO:1 shows a 3745 bp DNA sequence of Diabrotica rnapII-140.

[0234] SEQ ID NO:3 shows a 468 bp DNA sequence of rnapII reg1.

[0235] SEQ ID NO:4 shows a 180 bp DNA sequence of rnapII reg2.

[0236] SEQ ID NO:5 shows a 161 bp DNA sequence of rnapII reg3.

Example 2

Amplification of Target Genes to Produce dsRNA

[0237] Primers were designed to amplify portions of coding regions of each target gene by PCR See Table 1. Where appropriate, a T7 phage promoter sequence (TTAATACGACTCACTATAGGGAGA; SEQ ID NO:6) was incorporated into the 5' ends of the amplified sense or antisense strands. See Table 1. Total RNA was extracted from WCR, and first-strand cDNA was used as template for PCR reactions using opposing primers positioned to amplify all or part of the native target gene sequence. dsRNA was also amplified from a DNA clone comprising the coding region for a yellow fluorescent protein (YFP) (SEQ ID NO:7; Shagin et al. (2004) Mol. Biol. Evol. 21(5):841-50).

TABLE-US-00004 TABLE 1 Primers and Primer Pairs used to amplify portions of coding regions of exemplary rnapII-140 target gene and YFP negative control gene. SEQ ID Gene ID Primer ID NO: Sequence Pair 1 rnapII reg1 RNAPreg1- 8 TTAATACGACTCACTATAGGGAGA F1T7 CCTACCCATTGGGAGAAAGAC RNAPreg1- 9 TTAATACGACTCACTATAGGGAGA R1T7 AGCAGCTTTTTTGATGGCC Pair 2 rnapII reg2 RNAPreg2- 10 TTAATACGACTCACTATAGGGAGA F1T7 AAATAAGAGACTCGATTTGGCTG RNAPreg2- 11 TTAATACGACTCACTATAGGGAGA R1T7 GCGAGAGAATACCTCAGACC Pair 3 rnapII reg3 RNAPreg3- 12 TTAATACGACTCACTATAGGGAGA F2T7 TTCTGCAGTAGAAAGAGGATTTTTC RNAPreg3- 13 TTAATACGACTCACTATAGGGAGA R2T7 GTCGTCGTCTAATTTATCGTAAAGG Pair 4 YFP YFP-F_T7 14 TTAATACGACTCACTATAGGGAGA CACCATGGGCTCCAGCGGCGCCC YFP-R_T7 15 TTAATACGACTCACTATAGGGAGA AGATCTTGAAGGCGCTCTTCAGG

Example 3

RNAi Constructs

[0238] Template Preparation by PCR and dsRNA Synthesis.

[0239] A strategy used to provide specific templates for rnapII-140 and YFP dsRNA production is shown in FIG. 1. Template DNAs intended for use in rnapII-140 dsRNA synthesis were prepared by PCR using the primer pairs in Table 1 and (as PCR template) first-strand cDNA prepared from total RNA isolated from WCR first-instar larvae (YFP was amplified from a DNA clone of a YFP coding region). For each selected rnapII-140 and YFP target gene region, PCR amplifications introduced a T7 promoter sequence at the 5' ends of the amplified sense and antisense strands. The two PCR amplified fragments for each region of the target genes were then mixed in approximately equal amounts, and the mixture was used as transcription template for dsRNA production. See FIG. 1. The sequences of the dsRNA templates amplified with the particular primer pairs were: SEQ ID NO:3 (rnapII reg1), SEQ ID NO:4 (rnapII reg2), SEQ ID NO:5 (rnapII reg3) and YFP (SEQ ID NO:7). Double-stranded RNA for insect bioassay was synthesized and purified using an AMBION.RTM. MEGASCRIPT.RTM. RNAi kit following the manufacturer's instructions (INVITROGEN). The concentrations of dsRNAs were measured using a NANODROP.RTM. 8000 spectrophotometer (THERMO SCIENTIFIC, Wilmington, Del.).

[0240] Construction of Plant Transformation Vectors

[0241] Entry vectors (pDAB115762 and pDAB115763) harboring a target gene construct for hairpin formation comprising segments of rnapII-140 (SEQ ID NO:1) were assembled using a combination of chemically synthesized fragments (DNA2.0, Menlo Park, Calif.) and standard molecular cloning methods. Intramolecular hairpin formation by RNA primary transcripts was facilitated by arranging (within a single transcription unit) two copies of a target gene segment in opposite orientation to one another, the two segments being separated by an ST-LS1 intron sequence (SEQ ID NO:19; Vancanneyt et al. (1990) Mol. Gen. Genet. 220(2):245-50). Thus, the primary mRNA transcript contains the two rnapII-140 gene segment sequences as large inverted repeats of one another, separated by the intron sequence. A copy of a maize ubiquitin 1 promoter (U.S. Pat. No. 5,510,474) was used to drive production of the primary mRNA hairpin transcript, and a fragment comprising a 3' untranslated region from a maize peroxidase 5 gene (ZmPer5 3'UTR v2; U.S. Pat. No. 6,699,984) was used to terminate transcription of the hairpin-RNA-expressing gene.

[0242] Entry vector pDAB115762 comprises a hairpin-RNA construct (SEQ ID NO:16) that comprises a segment of rnapII-140 (SEQ ID NO:1)

[0243] Entry vector pDAB115763 comprises a hairpin-RNA construct (SEQ ID NO:17) that comprises a segment of rnapII-140 (SEQ ID NO:1) distinct from that found in pDAB115762.

[0244] Entry vectors pDAB115762 and pDAB115763 described above were used in standard GATEWAY.RTM. recombination reactions with a typical binary destination vector (pDAB109805) to produce hairpin RNA expression transformation vectors for Agrobacterium-mediated maize embryo transformations (pDAB114524 and pDAB114525, respectively).

[0245] A negative control binary vector, pDAB110853, which comprises a gene that expresses a YFP hairpin dsRNA, was constructed by means of standard GATEWAY.RTM. recombination reactions with a typical binary destination vector (pDAB109805) and entry vector pDAB101670. Entry Vector pDAB101670 comprises a YFP hairpin sequence (SEQ ID NO: 18) under the expression control of a maize ubiquitin 1 promoter (as above) and a fragment comprising a 3' untranslated region from a maize peroxidase 5 gene (as above).

[0246] Binary destination vector pDAB109805 comprises a herbicide resistance gene (aryloxyalknoate dioxygenase; AAD-1 v3) (U.S. Pat. No. 7,838,733(B2), and Wright et al. (2010) Proc. Natl. Acad. Sci. U.S.A. 107:20240-5) under the regulation of a strong sugarcane bacilliform badnavirus (ScBV) promoter (Schenk et al. (1999) Plant Molec. Biol. 39:1221-30). A synthetic 5'UTR sequence, comprised of sequences from a Maize Streak Virus (MSV) coat protein gene 5'UTR and intron 6 from a maize Alcohol Dehydrogenase 1 (ADH1) gene, is positioned between the 3' end of the SCBV promoter segment and the start codon of the AAD-1 coding region. A fragment comprising a 3' untranslated region from a maize lipase gene (ZmLip 3'UTR; U.S. Pat. No. 7,179,902) was used to terminate transcription of the AAD-1 mRNA.

[0247] A further negative control binary vector, pDAB110556, which comprises a gene that expresses a YFP protein, was constructed by means of standard GATEWAY.RTM. recombination reactions with a typical binary destination vector (pDAB9989) and entry vector pDAB100287. Binary destination vector pDAB9989 comprises a herbicide resistance gene (aryloxyalknoate dioxygenase; AAD-1 v3) (as above) under the expression regulation of a maize ubiquitin 1 promoter (as above) and a fragment comprising a 3' untranslated region from a maize lipase gene (ZmLip 3'UTR; as above). Entry Vector pDAB100287 comprises a YFP coding region (SEQ ID NO:20) under the expression control of a maize ubiquitin 1 promoter (as above) and a fragment comprising a 3' untranslated region from a maize peroxidase 5 gene (as above).

[0248] SEQ ID NO: 16 presents an rnapII-140 hairpin-RNA-forming sequence version 1 as found in pDAB114524.

[0249] SEQ ID NO:17 presents an rnapII-140 hairpin-RNA-forming sequence version 2 as found in pDAB114525.

Example 4

Insect Diet Bioassays

[0250] Sample Preparation and Bioassays

[0251] A number of dsRNA molecules (including those corresponding to rnapII reg1 (SEQ ID NO:3), rnapII reg2 (SEQ ID NO:4), and rnapII reg3 (SEQ ID NO:5) were synthesized and purified using a MEGASCRIPT.RTM. RNAi kit. The purified dsRNA molecules were prepared in TE buffer, and all bioassays contained a control treatment consisting of this buffer, which served as a background check for mortality or growth inhibition of WCR (Diabrotica virgifera virgifera LeConte). The concentrations of dsRNA molecules in the bioassay buffer were measured using a NANODROP.RTM. 8000 spectrophotometer (THERMO SCIENTIFIC, Wilmington, Del.).

[0252] Samples were tested for insect activity in bioassays conducted with neonate insect larvae on artificial insect diet. WCR eggs were obtained from CROP CHARACTERISTICS, INC. (Farmington, Minn.).

[0253] The bioassays were conducted in 128-well plastic trays specifically designed for insect bioassays (C-D INTERNATIONAL, Pitman, N.J.). Each well contained approximately 1.0 mL of an artificial diet designed for growth of coleopteran insects. A 60 .mu.L aliquot of dsRNA sample was delivered by pipette onto the surface of the diet of each well (40 .mu.L/cm.sup.2). dsRNA sample concentrations were calculated as the amount of dsRNA per square centimeter (ng/cm.sup.2) of surface area (1.5 cm.sup.2) in the well. The treated trays were held in a fume hood until the liquid on the diet surface evaporated or were absorbed into the diet.

[0254] Within a few hours of exclusion, individual larvae were picked up with a moistened camel hair brush and deposited on the treated diet (one or two larvae per well). The infested wells of the 128-well plastic trays were then sealed with adhesive sheets of clear plastic, and vented to allow gas exchange. Bioassay trays were held under controlled environmental conditions (28.degree. C., .about.40% Relative Humidity, 16:8 (Light:Dark)) for 9 days, after which time the total number of insects exposed to each sample, the number of dead insects, and the weight of surviving insects were recorded. Average percent mortality and average growth inhibition were calculated for each treatment. Growth inhibition (GI) was calculated as follows:

GI=[1-(TWIT/TNIT)/(TWIBC/TNIBC)]

[0255] where TWIT is the Total Weight of live Insects in the Treatment;

[0256] TNIT is the Total Number of Insects in the Treatment;

[0257] TWIBC is the Total Weight of live Insects in the Background Check (Buffer control); and

[0258] TNIBC is the Total Number of Insects in the Background Check (Buffer control).

[0259] Statistical analysis was done using JMP.RTM. software (SAS, Cary, N.C.).

[0260] LC.sub.50 (Lethal Concentration) is defined as the dosage at which 50% of the test insects are killed. GI.sub.50 (Growth Inhibition) is defined as the dosage at which the mean growth (e.g. live weight) of the test insects is 50% of the mean value seen in Background Check samples.

[0261] Replicated bioassays demonstrated that ingestion of particular samples resulted in a surprising and unexpected mortality and growth inhibition of corn rootworm larvae.

Example 5

Screening of Candidate Target Genes

[0262] Synthetic dsRNA designed to inhibit target gene sequences identified in EXAMPLE 1 caused mortality and growth inhibition when administered to WCR in diet-based assays. rnapII reg1, rnapII reg2, and rnapII reg3 were observed to exhibit greatly increased efficacy in this assay over other dsRNAs screened.

[0263] Replicated bioassays demonstrated that ingestion of dsRNA preparations derived from rnapII reg1, rnapII reg2, and rnapII reg3 each resulted in mortality and/or growth inhibition of western corn rootworm larvae. Table 2 and Table 3 show the results of diet-based feeding bioassays of WCR larvae following 9-day exposure to these dsRNAs, as well as the results obtained with a negative control sample of dsRNA prepared from a yellow fluorescent protein (YFP) coding region (SEQ ID NO:7).

TABLE-US-00005 TABLE 2 Results of rnapII-140 dsRNA diet feeding assays obtained with western corn rootworm larvae after 9 days of feeding. ANOVA analysis found significance differences in Mean % Mortality and Mean % Growth Inhibition (GI). Means were separated using the Tukey-Kramer test. Dose Mean % Gene Name (ng/cm.sup.2) No. Rows Mortality .+-. SEM* Mean GI .+-. SEM RNAPII reg1 500 4 97.06 .+-. 1.70 A 0.99 .+-. 0.00 A RNAPII reg2 500 10 85.23 .+-. 2.97 A 0.94 .+-. 0.02 A RNAPII reg3 500 10 89.35 .+-. 3.00 A 0.97 .+-. 0.02 A TE buffer 0 12 7.27 .+-. 4.17 B 0.01 .+-. 0.04 B WATER 0 13 5.81 .+-. 2.11 B 0.01 .+-. 0.03 B YFP 500 10 4.90 .+-. 1.80 B -0.08 .+-. 0.18 B *SEM = Standard Error of the Mean. Letters in parentheses designate statistical levels. Levels not connected by same letter are significantly different (P < 0.05). **TE = Tris HCl (10 mM) plus EDTA (1 mM) buffer, pH8. ***YFP = Yellow Fluorescent Protein

TABLE-US-00006 TABLE 3 Summary of oral potency of rnapII-140 dsRNAs on WCR larvae (ng/cm.sup.2). Sample Name LC.sub.50 LC.sub.50 Range GI.sub.50 GI.sub.50 Range RNAPII reg1 103.65 68.4-167.26 20.49 11.64-36.06 RNAPII reg2 6.71 4.37-9.83 4.29 1.76-10.45 RNAPII reg3 2.72 1.72-4.01 1.30 0.75-2.27

[0264] It has previously been suggested that certain genes of Diabrotica spp. may be exploited for RNAi-mediated insect control. See U.S. Patent Publication No. 2007/0124836, which discloses 906 sequences, and U.S. Pat. No. 7,612,194, which discloses 9,112 sequences. However, it was determined that many genes suggested to have utility for RNAi-mediated insect control are not efficacious in controlling Diabrotica. It was also determined that sequences rnapII reg1, rnapII reg2 and rnapII reg3 each provide surprising and unexpected superior control of Diabrotica, compared to other genes suggested to have utility for RNAi-mediated insect control.

[0265] For example, Annexin, Beta spectrin 2, and mtRP-L4 were each suggested in U.S. Pat. No. 7,612,194 to be efficacious in RNAi-mediated insect control. SEQ ID NO:21 is the DNA sequence of Annexin region 1 (Reg 1), and SEQ ID NO:22 is the DNA sequence of Annexin region 2 (Reg 2). SEQ ID NO:23 is the DNA sequence of Beta spectrin 2 region 1 (Reg 1), and SEQ ID NO:24 is the DNA sequence of Beta spectrin 2 region 2 (Reg2). SEQ ID NO:25 is the DNA sequence of mtRP-L4 region 1 (Reg 1), and SEQ ID NO:26 is the DNA sequence of mtRP-L4 region 2 (Reg 2). A YFP sequence (SEQ ID NO:7) was also used to produce dsRNA as a negative control.

[0266] Each of the aforementioned sequences was used to produce dsRNA by the methods of EXAMPLE 3. The strategy used to provide specific templates for dsRNA production is shown in FIG. 2. Template DNAs intended for use in dsRNA synthesis were prepared by PCR using the primer pairs in Table 4 and (as PCR template) first-strand cDNA prepared from total RNA isolated from WCR first-instar larvae. (YFP was amplified from a DNA clone.) For each selected target gene region, two separate PCR amplifications were performed. The first PCR amplification introduced a T7 promoter sequence at the 5' end of the amplified sense strands. The second reaction incorporated the T7 promoter sequence at the 5' ends of the antisense strands. The two PCR amplified fragments for each region of the target genes were then mixed in approximately equal amounts, and the mixture was used as transcription template for dsRNA production. See FIG. 2. Double-stranded RNA was synthesized and purified using an AMBION.RTM. MEGAscript.RTM. RNAi kit following the manufacturer's instructions (INVITROGEN). The concentrations of dsRNAs were measured using a NANODROP.RTM. 8000 spectrophotometer (THERMO SCIENTIFIC, Wilmington, Del.). and the dsRNAs were each tested by the same diet-based bioassay methods described above. Table 4 lists the sequences of the primers used to produce the Annexin Reg1, Annexin Reg2, Beta spectrin 2 Reg1, Beta spectrin 2 Reg2, mtRP-L4 Reg1, and mtRP-L4 Reg2 dsRNA molecules. YFP primer sequences for use in the method depicted in FIG. 2 are also listed in Table 4. Table 5 presents the results of diet-based feeding bioassays of WCR larvae following 9-day exposure to these dsRNA molecules. Replicated bioassays demonstrated that ingestion of these dsRNAs resulted in no mortality or growth inhibition of western corn rootworm larvae above that seen with control samples of TE buffer, Water, or YFP protein.

TABLE-US-00007 TABLE 4 Primers and Primer Pairs used to amplify portions of coding regions of genes. Gene SEQ ID (Region) Primer ID NO: Sequence Pair 5 Annexin Ann-F1_T7 27 TTAATACGACTCACTATAGGGAGA (Reg 1) GCTCCAACAGTGGTTCCTTATC Annexin Ann-R1 28 CTAATAATTCTTTTTTAATGTTCCT (Reg 1) GAGG Pair 6 Annexin Ann-F1 29 GCTCCAACAGTGGTTCCTTATC (Reg 1) Annexin Ann-R1_T7 30 TTAATACGACTCACTATAGGGAGA (Reg 1) CTAATAATTCTTTTTTAATGTTCCT GAGG Pair 7 Annexin Ann-F2_T7 31 TTAATACGACTCACTATAGGGAGA (Reg 2) TTGTTACAAGCTGGAGAACTTCTC Annexin Ann-R2 32 CTTAACCAACAACGGCTAATAAGG (Reg 2) Pair 8 Annexin Ann-F2 33 TTGTTACAAGCTGGAGAACTTCTC (Reg 2) Annexin Ann-R2T7 34 TTAATACGACTCACTATAGGGAGA (Reg 2) CTTAACCAACAACGGCTAATAAGG Pair 9 Beta-spect2 Betasp2-F1_T7 35 TTAATACGACTCACTATAGGGAGA (Reg 1) AGATGTTGGCTGCATCTAGAGAA Beta-spect2 Betasp2-R1 36 GTCCATTCGTCCATCCACTGCA (Reg 1) Pair 10 Beta-spect2 Betasp2-F1 37 AGATGTTGGCTGCATCTAGAGAA (Reg 1) Beta-spect2 Betasp2-R1_T7 38 TTAATACGACTCACTATAGGGAGA (Reg 1) GTCCATTCGTCCATCCACTGCA Pair 11 Beta-spect2 Betasp2-F2_T7 39 TTAATACGACTCACTATAGGGAGA (Reg 2) GCAGATGAACACCAGCGAGAAA Beta-spect2 Betasp2-R2 40 CTGGGCAGCTTCTTGTTTCCTC (Reg 2) Pair 12 Beta-spect2 Betasp2-F2 41 GCAGATGAACACCAGCGAGAAA (Reg 2) Beta-spect2 Betasp2-R2_T7 42 TTAATACGACTCACTATAGGGAGA (Reg 2) CTGGGCAGCTTCTTGTTTCCTC Pair 13 mtRP-L4 L4-F1_T7 43 TTAATACGACTCACTATAGGGAGA (Reg 1) AGTGAAATGTTAGCAAATATAACA TCC mtRP-L4 L4-R1 44 ACCTCTCACTTCAAATCTTGACTTT (Reg 1) G Pair 14 mtRP-L4 L4-F1 45 AGTGAAATGTTAGCAAATATAACA (Reg 1) TCC mtRP-L4 L4-R1_T7 46 TTAATACGACTCACTATAGGGAGA (Reg 1) ACCTCTCACTTCAAATCTTGACTTT G Pair 15 mtRP-L4 L4-F2_T7 47 TTAATACGACTCACTATAGGGAGA (Reg 2) CAAAGTCAAGATTTGAAGTGAGA GGT mtRP-L4 L4-R2 48 CTACAAATAAAACAAGAAGGACC (Reg 2) CC Pair 16 mtRP-L4 L4-F2 49 CAAAGTCAAGATTTGAAGTGAGA (Reg 2) GGT mtRP-L4 L4-R2_T7 50 TTAATACGACTCACTATAGGGAGA (Reg 2) CTACAAATAAAACAAGAAGGACC CC

TABLE-US-00008 TABLE 5 Results of diet feeding assays obtained with western corn rootworm larvae after 9 days. Mean Live Larval Mean Dose Weight Mean % Growth Gene Name (ng/cm.sup.2) (mg) Mortality Inhibition Annexin-Reg 1 1000 0.545 0 -0.262 Annexin-Reg 2 1000 0.565 0 -0.301 Beta spectrin2 Reg 1 1000 0.340 12 -0.014 Beta spectrin2 Reg 2 1000 0.465 18 -0.367 mtRP-L4 Reg 1 1000 0.305 4 -0.168 mtRP-L4 Reg 2 1000 0.305 7 -0.180 IL buffer* 0 0.430 13 0.000 Water 0 0.535 12 0.000 YFP** 1000 0.480 9 -0.386 *TE = Tris HCl (10 mM) plus EDTA (1 mM) buffer, pH8. **YFP = Yellow Fluorescent Protein

Example 6

Production of Transgenic Maize Tissues Comprising Insecticidal Hairpin dsRNAs

[0267] Agrobacterium-Mediated Transformation:

[0268] Transgenic maize cells, tissues, and plants that produce one or more insecticidal dsRNA molecules (for example, at least one dsRNA molecule including a dsRNA molecule targeting a gene comprising rnapII-140; SEQ ID NO:1) through expression of a chimeric gene stably-integrated into the plant genome were produced following Agrobacterium-mediated transformation. Maize transformation methods employing superbinary or binary transformation vectors are known in the art, as described, for example, in U.S. Pat. No. 8,304,604, which is herein incorporated by reference in its entirety. Transformed tissues were selected by their ability to grow on Haloxyfop-containing medium and were screened for dsRNA production, as appropriate. Portions of such transformed tissue cultures may be presented to neonate corn rootworm larvae for bioassay, essentially as described in EXAMPLE 1.

[0269] Agrobacterium Culture Initiation:

[0270] Glycerol stocks of Agrobacterium strain DAt13192 cells (WO 2012/016222A2) harboring a binary transformation vector pDAB114524, pDAB114525, pDAB110853 or pDAB110556 described above (EXAMPLE 4) were streaked on AB minimal medium plates (Watson, et al., (1975) J. Bacteriol. 123:255-264) containing appropriate antibiotics and were grown at 20.degree. C. for 3 days. The cultures were then streaked onto YEP plates (gm/L: yeast extract, 10; Peptone, 10; NaCl 5) containing the same antibiotics and were incubated at 20.degree. C. for 1 day.

[0271] Agrobacterium Culture:

[0272] On the day of an experiment, a stock solution of Inoculation Medium and acetosyringone was prepared in a volume appropriate to the number of constructs in the experiment and pipetted into a sterile, disposable, 250 mL flask. Inoculation Medium (Frame et al. (2011) Genetic Transformation Using Maize Immature Zygotic Embryos. IN Plant Embryo Culture Methods and Protocols: Methods in Molecular Biology. T. A. Thorpe and E. C. Yeung, (Eds), Springer Science and Business Media, LLC. pp 327-341) contained: 2.2 gm/L MS salts; 1.times. ISU Modified MS Vitamins (Frame et al., ibid) 68.4 gm/L sucrose; 36 gm/L glucose; 115 mg/L L-proline; and 100 mg/L myo-inositol; at pH 5.4.) Acetosyringone was added to the flask containing Inoculation Medium to a final concentration of 200 .mu.M from a 1 M stock solution in 100% dimethyl sulfoxide and the solution was thoroughly mixed.

[0273] For each construct, 1 or 2 inoculating loops-full of Agrobacterium from the YEP plate were suspended in 15 mL of the Inoculation Medium/acetosyringone stock solution in a sterile, disposable, 50 mL centrifuge tube, and the optical density of the solution at 550 nm (OD.sub.550) was measured in a spectrophotometer. The suspension was then diluted to OD.sub.550 of 0.3 to 0.4 using additional Inoculation Medium/acetosyringone mixture. The tube of Agrobacterium suspension was then placed horizontally on a platform shaker set at about 75 rpm at room temperature and shaken for 1 to 4 hours while embryo dissection was performed.

[0274] Ear Sterilization and Embryo Isolation:

[0275] Maize immature embryos were obtained from plants of Zea mays inbred line B 104 (Hallauer et al. (1997) Crop Science 37:1405-1406) grown in the greenhouse and self- or sib-pollinated to produce ears. The ears were harvested approximately 10 to 12 days post-pollination. On the experimental day, de-husked ears were surface-sterilized by immersion in a 20% solution of commercial bleach (ULTRA CLOROX.RTM. Germicidal Bleach, 6.15% sodium hypochlorite; with two drops of TWEEN 20) and shaken for 20 to 30 min, followed by three rinses in sterile deionized water in a laminar flow hood. Immature zygotic embryos (1.8 to 2.2 mm long) were aseptically dissected from each ear and randomly distributed into microcentrifuge tubes containing 2.0 mL of a suspension of appropriate Agrobacterium cells in liquid Inoculation Medium with 200 .mu.M acetosyringone, into which 2 .mu.L of 10% BREAK-THRU.RTM. S233 surfactant (EVONIK INDUSTRIES; Essen, Germany) had been added. For a given set of experiments, embryos from pooled ears were used for each transformation.

[0276] Agrobacterium Co-Cultivation:

[0277] Following isolation, the embryos were placed on a rocker platform for 5 minutes. The contents of the tube were then poured onto a plate of Co-cultivation Medium, which contained 4.33 gm/L MS salts; 1.times.ISU Modified MS Vitamins; 30 gm/L sucrose; 700 mg/L L-proline; 3.3 mg/L Dicamba in KOH (3,6-dichloro-o-anisic acid or 3,6-dichloro-2-methoxybenzoic acid); 100 mg/L myo-inositol; 100 mg/L Casein Enzymatic Hydrolysate; 15 mg/L AgNO.sub.3; 200 .mu.M acetosyringone in DMSO; and 3 gm/L GELZAN.TM., at pH 5.8. The liquid Agrobacterium suspension was removed with a sterile, disposable, transfer pipette. The embryos were then oriented with the scutellum facing up using sterile forceps with the aid of a microscope. The plate was closed, sealed with 3M.RTM. MICROPORE.RTM. medical tape, and placed in an incubator at 25.degree. C. with continuous light at approximately 60 .mu.mol m.sup.-2 s.sup.-1 of Photosynthetically Active Radiation (PAR).

[0278] Callus Selection and Regeneration of Transgenic Events:

[0279] Following the Co-Cultivation period, embryos were transferred to Resting Medium, which was composed of 4.33 gm/L MS salts; 1.times. ISU Modified MS Vitamins; 30 gm/L sucrose; 700 mg/L L-proline; 3.3 mg/L Dicamba in KOH; 100 mg/L myo-inositol; 100 mg/L Casein Enzymatic Hydrolysate; 15 mg/L AgNO.sub.3; 0.5 gm/L MES (2-(N-morpholino)ethanesulfonic acid monohydrate; PHYTOTECHNOLOGIES LABR.; Lenexa, Kans.); 250 mg/L Carbenicillin; and 2.3 gm/L GELZAN.TM.; at pH 5.8. No more than 36 embryos were moved to each plate. The plates were placed in a clear plastic box and incubated at 27.degree. C. with continuous light at approximately 50 .mu.mol m.sup.-2 s.sup.-1 PAR for 7 to 10 days. Callused embryos were then transferred (<18/plate) onto Selection Medium I, which was comprised of Resting Medium (above) with 100 nM R-Haloxyfop acid (0.0362 mg/L; for selection of calli harboring the AAD-1 gene). The plates were returned to clear boxes and incubated at 27.degree. C. with continuous light at approximately 50 .mu.mol m.sup.-2 s.sup.-1 PAR for 7 days. Callused embryos were then transferred (<12/plate) to Selection Medium II, which is comprised of Resting Medium (above) with 500 nM R-Haloxyfop acid (0.181 mg/L). The plates were returned to clear boxes and incubated at 27.degree. C. with continuous light at approximately 50 .mu.mol m.sup.-2 s.sup.-1 PAR for 14 days. This selection step allowed transgenic callus to further proliferate and differentiate.

[0280] Proliferating, embryogenic calli were transferred (<9/plate) to Pre-Regeneration medium. Pre-Regeneration Medium contained 4.33 gm/L MS salts; 1.times. ISU Modified MS Vitamins; 45 gm/L sucrose; 350 mg/L L-proline; 100 mg/L myo-inositol; 50 mg/L Casein Enzymatic Hydrolysate; 1.0 mg/L AgNO.sub.3; 0.25 gm/L MES; 0.5 mg/L naphthaleneacetic acid in NaOH; 2.5 mg/L abscisic acid in ethanol; 1 mg/L 6-benzylaminopurine; 250 mg/L Carbenicillin; 2.5 gm/L GELZAN.TM.; and 0.181 mg/L Haloxyfop acid; at pH 5.8. The plates were stored in clear boxes and incubated at 27.degree. C. with continuous light at approximately 50 .mu.mol m.sup.-2 s.sup.-1 PAR for 7 days. Regenerating calli were then transferred (<6/plate) to Regeneration Medium in PHYTATRAYS.TM. (SIGMA-ALDRICH) and incubated at 28.degree. C. with 16 hours light/8 hours dark per day (at approximately 160 .mu.mol m.sup.-2 s.sup.-1 PAR) for 14 days or until shoots and roots developed. Regeneration Medium contained 4.33 gm/L MS salts; 1.times. ISU Modified MS Vitamins; 60 gm/L sucrose; 100 mg/L myo-inositol; 125 mg/L Carbenicillin; 3 gm/L GELLAN.TM. gum; and 0.181 mg/L R-Haloxyfop acid; at pH 5.8. Small shoots with primary roots were then isolated and transferred to Elongation Medium without selection. Elongation Medium contained 4.33 gm/L MS salts; 1.times. ISU Modified MS Vitamins; 30 gm/L sucrose; and 3.5 gm/L GELRITE.RTM.: at pH 5.8.

[0281] Transformed plant shoots selected by their ability to grow on medium containing Haloxyfop were transplanted from PHYTATRAYS.TM. to small pots filled with growing medium (PROMIX BX; PREMIER TECH HORTICULTURE), covered with cups or HUMI-DOMES (ARCO PLASTICS), and then hardened-off in a CONVIRON growth chamber (27.degree. C. day/24.degree. C. night, 16-hour photoperiod, 50-70% RH, 200 .mu.mol m.sup.-2 s.sup.-1 PAR). In some instances, putative transgenic plantlets were analyzed for transgene relative copy number by quantitative real-time PCR assays using primers designed to detect the AAD1 herbicide tolerance gene integrated into the maize genome. Further, RNA qPCR assays were used to detect the presence of the ST-LS1 intron sequence in expressed dsRNAs of putative transformants. Selected transformed plantlets were then moved into a greenhouse for further growth and testing.

[0282] Transfer and Establishment of to Plants in the Greenhouse for Bioassay and Seed Production:

[0283] When plants reached the V3-V4 stage, they were transplanted into IE CUSTOM BLEND (PROFILE/METRO MIX 160) soil mixture and grown to flowering in the greenhouse (Light Exposure Type: Photo or Assimilation; High Light Limit: 1200 PAR; 16-hour day length; 27.degree. C. day/24.degree. C. night).

[0284] Plants to be used for insect bioassays were transplanted from small pots to TINUS.TM. 350-4 ROOTRAINERS.RTM. (SPENCER-LEMAIRE INDUSTRIES, Acheson, Alberta, Canada) (one plant per event per ROOTRAINER.RTM.). Approximately four days after transplanting to ROOTRAINERS.RTM., plants were infested for bioassay.

[0285] Plants of the T.sub.1 generation were obtained by pollinating the silks of T.sub.0 transgenic plants with pollen collected from plants of non-transgenic elite inbred line B104 or other appropriate pollen donors, and planting the resultant seeds. Reciprocal crosses were performed when possible.

Example 7

Molecular Analyses of Transgenic Maize Tissues

[0286] Molecular analyses (e.g. RNA qPCR) of maize tissues were performed on samples from leaves and roots that were collected from greenhouse grown plants on the same days that root feeding damage was assessed.

[0287] Results of RNA qPCR assays for the Per5 3'UTR were used to validate expression of hairpin transgenes. (A low level of Per5 3'UTR detection is expected in nontransformed maize plants, since there is usually expression of the endogenous Per5 gene in maize tissues.) Results of RNA qPCR assays for the ST-LS1 intron sequence (which is integral to the formation of dsRNA hairpin molecules) in expressed RNAs were used to validate the presence of hairpin transcripts. Transgene RNA expression levels were measured relative to the RNA levels of an endogenous maize gene.

[0288] DNA qPCR analyses to detect a portion of the AAD1 coding region in genomic DNA were used to estimate transgene insertion copy number. Samples for these analyses were collected from plants grown in environmental chambers. Results were compared to DNA qPCR results of assays designed to detect a portion of a single-copy native gene, and simple events (having one or two copies of the transgenes) were advanced for further studies in the greenhouse.

[0289] Additionally, qPCR assays designed to detect a portion of the spectinomycin-resistance gene (SpecR; harbored on the binary vector plasmids outside of the T-DNA) were used to determine if the transgenic plants contained extraneous integrated plasmid backbone sequences.

[0290] Hairpin RNA Transcript Expression Level: Per 5 3'UTR qPCR:

[0291] Callus cell events or transgenic plants were analyzed by real time quantitative PCR (qPCR) of the Per 5 3'UTR sequence to determine the relative expression level of the full length hairpin transcript, as compared to the transcript level of an internal maize gene (SEQ ID NO:51; GENBANK.RTM. Accession No. BT069734), which encodes a TIP41-like protein (i.e. a maize homolog of GENBANK.RTM. Accession No. AT4G34270; having a tBLASTX score of 74% identity). RNA was isolated using an RNAEASY.TM. 96 kit (QIAGEN, Valencia, Calif.). Following elution, the total RNA was subjected to a DNAsel treatment according to the kit's suggested protocol. The RNA was then quantified on a NANODROP.RTM. 8000 spectrophotometer (THERMO SCIENTIFIC) and concentration was normalized to 25 ng/.mu.L. First strand cDNA was prepared using a HIGH CAPACITY cDNA SYNTHESIS KIT (INVITROGEN) in a 10 .mu.L reaction volume with 5 .mu.L denatured RNA, substantially according to the manufacturer's recommended protocol. The protocol was modified slightly to include the addition of 10 .mu.L of 100 .mu.M T20VN oligonucleotide (IDT) (SEQ ID NO:52; TTTTTTTTTTTTTTTTTTTTVN, where V is A, C, or G, and N is A, C, G, or T/U) into the 1 mL tube of random primer stock mix, in order to prepare a working stock of combined random primers and oligo dT.

[0292] Following cDNA synthesis, samples were diluted 1:3 with nuclease-free water, and stored at -20.degree. C. until assayed.

[0293] Separate real-time PCR assays for the Per5 3' UTR and TIP41-like transcript were performed on a LIGHTCYCLER.RTM. 480 (ROCHE DIAGNOSTICS, Indianapolis, Ind.) in 10 .mu.L reaction volumes. For the Per5 3UTR assay, reactions were run with Primers P5U76S (F) (SEQ ID NO:53) and P5U76A (R) (SEQ ID NO:54), and a ROCHE UNIVERSAL PROBE.TM. (UPL76; Catalog No. 4889960001; labeled with FAM). For the TIP41-like reference gene assay, primers TIPmxF (SEQ ID NO:55) and TIPmxR (SEQ ID NO:56), and Probe HXTIP (SEQ ID NO:57) labeled with HEX (hexachlorofluorescein) were used.

[0294] All assays included negative controls of no-template (mix only). For the standard curves, a blank (water in source well) was also included in the source plate to check for sample cross-contamination. Primer and probe sequences are set forth in Table 6. Reaction components recipes for detection of the various transcripts are disclosed in Table 7, and PCR reactions conditions are summarized in Table 8. The FAM (6-Carboxy Fluorescein Amidite) fluorescent moiety was excited at 465 nm and fluorescence was measured at 510 nm; the corresponding values for the HEX (hexachlorofluorescein) fluorescent moiety were 533 nm and 580 nm.

TABLE-US-00009 TABLE 6 Oligonucleotide sequences used for molecular analyses of transcript levels in transgenic maize. Oligo- SEQ ID Target nucleotide NO. Sequence Per5 3'UTR P5U76S (F) 53 TTGTGATGTTGGTGGCGTAT Per5 3'UTR P5U76A (R) 54 TGTTAAATAAAACCCCAAAGATCG Per5 3'UTR Roche UPL76 NAv** Roche Diagnostics Catalog Number 488996001 (FAM-Probe) TIP41 TIPmxF 55 TGAGGGTAATGCCAACTGGTT TIP41 TIPmxR 56 GCAATGTAACCGAGTGTCTCTCAA TIP41 HXTIP 57 TTTTTGGCTTAGAGTTGATGGTGTACTGA (HEX-Probe) TGA *TIP414ike protein. **NAv Sequence Not Available from the supplier.

TABLE-US-00010 TABLE 7 PCR reaction recipes for transcript detection. Per5 3'UTR TIP-like Gene Component Final Concentration Roche Buffer 1X 1X P5U76S (F) 0.4 .mu.M 0 P5U76A (R) 0.4 .mu.M 0 Roche UPL76 (FAM) 0.2 .mu.M 0 HEXtipZM F 0 0.4 .mu.M HEXtipZM R 0 0.4 .mu.M HEXtipZMP (HEX) 0 0.2 .mu.M cDNA (2.0 .mu.L) NA NA Water To 10 .mu.L To10 .mu.L

TABLE-US-00011 TABLE 8 Thermocycler conditions for RNA qPCR. Per5 3'UTR and TIP41-like Gene Detection No. Process Temp. Time Cycles Target Activation 95.degree. C. 10 min 1 Denature 95.degree. C. 10 sec 40 Extend 60.degree. C. 40 sec Acquire FAM or HEX 72.degree. C. 1 sec Cool 40.degree. C. 10 sec 1

[0295] Data were analyzed using LIGHTCYCLER.RTM. Software v1.5 by relative quantification using a second derivative max algorithm for calculation of Cq values according to the supplier's recommendations. For expression analyses, expression values were calculated using the .DELTA..DELTA.Ct method (i.e., 2-(Cq TARGET-Cq REF)), which relies on the comparison of differences of Cq values between two targets, with the base value of 2 being selected under the assumption that, for optimized PCR reactions, the product doubles every cycle.

[0296] Hairpin Transcript Size and Integrity--Northern Blot Assay:

[0297] In some instances, additional molecular characterization of the transgenic plants is obtained by the use of Northern Blot (RNA blot) analysis to determine the molecular size of the rnapII-140 hairpin RNA in transgenic plants expressing a rnapII-140 hairpin dsRNA.

[0298] All materials and equipment are treated with RNAZAP (AMBION/INVITROGEN) before use. Tissue samples (100 mg to 500 mg) are collected in 2 mL SAFELOCK EPPENDORF tubes, disrupted with a KLECKO.TM. tissue pulverizer (GARCIA MANUFACTURING, Visalia, Calif.) with three tungsten beads in 1 mL of TRIZOL (INVITROGEN) for 5 min, then incubated at room temperature (RT) for 10 min. Optionally, the samples are centrifuged for 10 min at 4.degree. C. at 11,000 rpm and the supernatant is transferred into a fresh 2 mL SAFELOCK EPPENDORF tube. After 200 .mu.L of chloroform are added to the homogenate, the tube is mixed by inversion for 2 to 5 min, incubated at RT for 10 minutes, and centrifuged at 12,000.times.g for 15 min at 4.degree. C. The top phase is transferred into a sterile 1.5 mL EPPENDORF tube, 600 .mu.L of 100% isopropanol are added, followed by incubation at RT for 10 min to 2 hr, then centrifuged at 12,000.times.g for 10 min at 4.degree. to 25.degree. C. The supernatant is discarded and the RNA pellet is washed twice with 1 mL of 70% ethanol, with centrifugation at 7,500.times.g for 10 min at 4.degree. to 25.degree. C. between washes. The ethanol is discarded and the pellet is briefly air dried for 3 to 5 min before resuspending in 50 .mu.L of nuclease-free water.

[0299] Total RNA is quantified using the NANODROP.RTM. 8000 (THERMO-FISHER) and samples are normalized to 5 .mu.g/10 .mu.L. 10 .mu.L of glyoxal (AMBION/INVITROGEN) are then added to each sample. Five to 14 ng of DIG RNA standard marker mix (ROCHE APPLIED SCIENCE, Indianapolis, Ind.) are dispensed and added to an equal volume of glyoxal. Samples and marker RNAs are denatured at 50.degree. C. for 45 min and stored on ice until loading on a 1.25% SEAKEM GOLD agarose (LONZA, Allendale, N.J.) gel in NORTHERNMAX 10.times. glyoxal running buffer (AMBION/INVITROGEN) RNAs are separated by electrophoresis at 65 volts/30 mA for 2 hr and 15 min.

[0300] Following electrophoresis, the gel is rinsed in 2.times.SSC for 5 min and imaged on a GEL DOC station (BIORAD, Hercules, Calif.), then the RNA is passively transferred to a nylon membrane (MILLIPORE) overnight at RT, using 10.times.SSC as the transfer buffer (20.times.SSC consists of 3 M sodium chloride and 300 mM trisodium citrate, pH 7.0). Following the transfer, the membrane is rinsed in 2.times.SSC for 5 minutes, the RNA is UV-crosslinked to the membrane (AGILENT/STRATAGENE), and the membrane is allowed to dry at RT for up to 2 days.

[0301] The membrane is prehybridized in ULTRAHYB buffer (AMBION/INVITROGEN) for 1 to 2 hr. The probe consists of a PCR amplified product containing the sequence of interest, (for example, the antisense sequence portion of SEQ ID NO:16 or SEQ ID NO:17, as appropriate) labeled with digoxygenin by means of a ROCHE APPLIED SCIENCE DIG procedure. Hybridization in recommended buffer is overnight at a temperature of 60.degree. C. in hybridization tubes. Following hybridization, the blot is subjected to DIG washes, wrapped, exposed to film for 1 to 30 minutes, then the film is developed, all by methods recommended by the supplier of the DIG kit.

[0302] Trans Ene Copy Number Determination

[0303] Maize leaf pieces approximately equivalent to 2 leaf punches were collected in 96-well collection plates (QIAGEN). Tissue disruption was performed with a KLECKO.TM. tissue pulverizer (GARCIA MANUFACTURING, Visalia, Calif.) in BIOSPRINT96 API lysis buffer (supplied with a BIOSPRINT96 PLANT KIT; QIAGEN) with one stainless steel bead. Following tissue maceration, genomic DNA (gDNA) was isolated in high throughput format using a BIOSPRINT96 PLANT KIT and a BIOSPRINT96 extraction robot. Genomic DNA was diluted 2:3 DNA:water prior to setting up the qPCR reaction.

[0304] qPCR Analysis

[0305] Transgene detection by hydrolysis probe assay was performed by real-time PCR using a LIGHTCYCLER.RTM. 480 system. Oligonucleotides to be used in hydrolysis probe assays to detect the ST-LS1 intron sequence (SEQ ID NO:19), or to detect a portion of the SpecR gene (i.e. the spectinomycin resistance gene borne on the binary vector plasmids; SEQ ID NO:58; SPC1 oligonucleotides in Table 9), were designed using LIGHTCYCLER.RTM. PROBE DESIGN SOFTWARE 2.0. Further, oligonucleotides to be used in hydrolysis probe assays to detect a segment of the AAD-1 herbicide tolerance gene (SEQ ID NO:59; GAAD1 oligonucleotides in Table 9) were designed using PRIMER EXPRESS software (APPLIED BIOSYSTEMS). Table 9 shows the sequences of the primers and probes. Assays were multiplexed with reagents for an endogenous maize chromosomal gene (Invertase (SEQ ID NO:60); GENBANK.RTM. Accession No: U16123; referred to herein as IVR1), which served as an internal reference sequence to ensure gDNA was present in each assay. For amplification, LIGHTCYCLER.RTM. 480 PROBES MASTER mix (ROCHE APPLIED SCIENCE) was prepared at 1.times. final concentration in a 10 .mu.L volume multiplex reaction containing 0.4 .mu.M of each primer and 0.2 .mu.M of each probe (Table 10). A two step amplification reaction was performed as outlined in Table 11. Fluorophore activation and emission for the FAM- and HEX-labeled probes were as described above; CY5 conjugates are excited maximally at 650 nm and fluoresce maximally at 670 nm.

[0306] Cp scores (the point at which the fluorescence signal crosses the background threshold) were determined from the real time PCR data using the fit points algorithm (LIGHTCYCLER.RTM. SOFTWARE release 1.5) and the Relative Quant module (based on the .DELTA..DELTA.Ct method). Data were handled as described previously (above, RNA qPCR).

TABLE-US-00012 TABLE 9 Sequences of primers and probes (with fluorescent conjugate) used for gene copy number determ- inations and binary vector plasmid backbone detection. SEQ ID Name NO: Sequence GAAD1-F 64 TGTTCGGTTCCCTCTACCAA GAAD1-R 65 CAACATCCATCACCTTGACTGA GAAD1-P (FAM) 66 CACAGAACCGTCGCTTCAGCAACA IVR1-F 67 TGGCGGACGACGACTTGT IVR1-R 68 AAAGTTTGGAGGCTGCCGT IVR1-P (HEX) 69 CGAGCAGACCGCCGTGTACTTCTACC SPC1A 70 CTTAGCTGGATAACGCCAC SPC1S 71 GACCGTAAGGCTTGATGAA TQSPEC (CY5*) 72 CGAGATTCTCCGCGCTGTAGA CY5 = Cyanine-5

TABLE-US-00013 TABLE 10 Reaction components for gene copy number analyses and binary vector plasmid backbone detection.. Amt. Final Component (uL) Stock Conc'n 2x Buffer 5.0 2x 1x Appropriate Forward Primer 0.4 10 .mu.M 0.4 Appropriate Reverse Primer 0.4 10 .mu.M 0.4 Appropriate Probe 0.4 5 .mu.M 0.2 IVR1-Forward Primer 0.4 10 .mu.M 0.4 IVR1-Reverse Primer 0.4 10 .mu.M 0.4 IVR1-Probe 0.4 5 .mu.M 0.2 H.sub.2O 0.6 NA* NA gDNA 2.0 ND** ND Total 10.0 *NA = Not Applicable **ND = Not Determined

TABLE-US-00014 TABLE 11 Thermocycler conditions for DNA qPCR Genomic copy number analyses No. Process Temp. Time Cycles Target Activation 95.degree. C. 10 min 1 Denature 95.degree. C. 10 sec 40 Extend & Acquire 60.degree. C 40 sec FAM, HEX, or CY5 Cool 40.degree. C. 10 sec 1

Example 8

Bioassay of Transgenic Maize

[0307] In Vitro Insect Bioassays:

[0308] Bioactivity of dsRNA produced in plant cells is demonstrated by bioassay methods. See, e.g., Baum et al. (2007) Nat. Biotechnol. 25(11):1322-1326. One is able to demonstrate efficacy, for example, by feeding various plant tissues or tissue pieces derived from a plant producing an insecticidal dsRNA to target insects in a controlled feeding environment. Alternatively, extracts are prepared from various plant tissues derived from a plant producing the insecticidal dsRNA and the extracted nucleic acids are dispensed on top of artificial diets for bioassays as previously described herein. The results of such feeding assays are compared to similarly conducted bioassays that employ appropriate control tissues from host plants that do not produce an insecticidal dsRNA, or to other control samples.

[0309] In Vivo Insect Bioassays with Transgenic Maize Events

[0310] Two western corn rootworm larvae (1 to 3 days old) hatched from washed eggs are selected and placed into each well of the bioassay tray. The wells are then covered with a "PULL N' PEEL" tab cover (BIO-CV-16, BIO-SERV) and placed in a 28.degree. C. incubator with an 18 hr/6 hr light/dark cycle. Nine days after the initial infestation, the larvae are assessed for mortality, which is calculated as the percentage of dead insects out of the total number of insects in each treatment. The insect samples are frozen at -20.degree. C. for two days, then the insect larvae from each treatment are pooled and weighed. The percent of growth inhibition is calculated as the mean weight of the experimental treatments divided by the mean of the average weight of two control well treatments. The data are expressed as a Percent Growth Inhibition (of the Negative Controls). Mean weights that exceed the control mean weight are normalized to zero.

[0311] Insect Bioassays in the Greenhouse:

[0312] Western corn rootworm (WCR, Diabrotica virgifera virgifera LeConte) eggs were received in soil from CROP CHARACTERISTICS (Farmington, Minn.). WCR eggs were incubated at 28.degree. C. for 10 to 11 days. Egg were washed from the soil, placed into a 0.15% agar solution, and the concentration was adjusted to approximately 75 to 100 eggs per 0.25 mL aliquot. A hatch plate was set up in a Petri dish with an aliquot of egg suspension to monitor hatch rates.

[0313] The soil around the maize plants growing in ROOTRAINERS.RTM. was infested with 150 to 200 WCR eggs. The insects were allowed to feed for 2 weeks, after which time a "Root Rating" was given to each plant. A Node-Injury Scale was utilized for grading essentially according to Oleson et al. (2005) J. Econ. Entomol. 98(1):1-8. Plants which passed this bioassay were transplanted to 5-gallon pots for seed production. Transplants were treated with insecticide to prevent further rootworm damage and insect release in the greenhouses. Plants were hand pollinated for seed production. Seeds produced by these plants were saved for evaluation at the T.sub.1 and subsequent generations of plants.

[0314] Greenhouse bioassays included two kinds of negative control plants. Transgenic negative control plants were generated by transformation with vectors harboring genes designed to produce a yellow fluorescent protein (YFP) or a YFP hairpin dsRNA (See Example 4). Nontransformed negative control plants were grown from seeds of lines 7sh382 or B 104. Bioassays were conducted on two separate dates, with negative controls included in each set of plant materials.

[0315] Table 12 shows the combined results of molecular analyses and bioassays for rnapII-140 hairpin plants. Examination of the bioassay results summarized in Table 12 reveals the surprising and unexpected observation that most transgenic maize plants harboring constructs that express an rnapII-140 hairpin dsRNA comprising segments of SEQ ID NO:1, for example, as exemplified in SEQ ID NO:16 and SEQ ID NO:17, are protected against root damage incurred by feeding of western corn rootworm larvae. Only six of the 36 graded events had a root rating of 0.75 or higher. Table 13 shows the combined results of molecular analyses and bioassays for negative control plants. Most of the plants had no protection against WCR larvae feeding, although five of the 34 graded plants had a root rating of 0.75 or lower. The presence of some plants having low root ratings scores amongst the negative control plant set is sometimes observed and reflects the variability and difficulty of conducting this type of bioassay in a greenhouse setting.

TABLE-US-00015 TABLE 12 Greenhouse bioassay and molecular analyses results of rnapII-140 hairpin-expressing maize plants. Leaf Tissue Root Tissue ST-LS1 PER5 UTR ST-LS1 PER5 UTR Root Sample ID RTL* RTL RTL* RTL Rating RNAPII v1 Events 114524[1]-001.001 0.089 72.5 0.023 95.0 0.1 114524[1]-002.001 0.093 91.8 0.093 174.9 0.1 114524[1]-004.001 0.179 110.7 0.245 105.4 0.01 114524[1]-005.001 0.073 76.6 0.126 209.4 0.01 114524[1]-007.001 0.103 62.2 0.147 73.0 0.05 114524[1]-008.001 0.147 71.5 0.151 106.9 0.01 114524[1]-009.001 0.240 157.6 0.151 213.8 0.25 114524[1]-011.001 0.299 160.9 0.158 108.4 0.5 114524[1]-012.001 0.361 176.1 0.127 227.5 0.25 114524[1]-013.001 15.455 266.9 0.035 144.0 1 114524[1]-015.001 0.737 205.1 0.064 206.5 0.25 114524[1]-016.001 0.758 171.3 0.045 148.1 0.05 114524[1]-017.001 0.435 458.3 0.066 203.7 0.01 114524[1]-018.001 0.521 221.3 0.156 254.2 0.1 114524[1]-022.001 0.330 224.4 0.166 151.2 0.01 114524[1]-023.001 0.429 219.8 0.055 150.1 0.1 114524[1]-024.001 0.683 261.4 0.901 369.6 0.1 114524[1]-025.001 0.266 179.8 0.063 170.1 0.01 114524[1]-027.001 0.106 45.9 0.026 33.6 1 114524[1]-029.001 0.321 152.2 0.088 125.4 0.1 114524[1]-030.001 0.248 112.2 0.060 192.7 NG** RNAPII v2 Events 114525[1]-001.001 0.132 97.0 0.019 50.6 0.1 114525[1]-002.001 0.118 109.1 0.144 121.1 0.01 114525[1]-006.001 0.257 150.1 0.107 229.1 0.05 114525[1]-012.001 0.221 75.6 0.082 179.8 0.01 114525[1]-014.001 0.090 44.3 0.060 70.0 0.01 114525[1]-015.001 0.768 136.2 0.057 43.1 0.05 114525[1]-016.001 0.096 54.2 0.209 93.1 0.75 114525[1]-017.001 0.376 65.3 0.268 61.0 NG** 114525[1]-018.001 0.476 125.4 0.132 64.9 NG** 114525[1]-019.001 0.134 0.1 0.000 1.7 1 114525[1]-020.001 0.655 141.0 0.060 127.1 0.1 114525[1]-021.001 0.683 176.1 1.670 227.5 1 114525[1]-023.001 0.438 134.4 0.059 199.5 0.25 114525[1]-025.001 0.785 171.3 0.145 150.1 0.01 114525[1]-030.001 0.000 0.1 0.000 0.6 1 114525[1]-032.001 0.737 202.3 0.143 69.6 0.05 114525[1]-034.001 1.376 233.9 0.071 113.0 0.05 114525[1]-035.001 0.611 118.6 0.067 111.4 0.05 *RTL = Relative Transcript Level as measured against TIP4-like gene transcript levels. **NG = Not Graded due to small plant size

TABLE-US-00016 TABLE 13 Greenhouse bioassay and molecular analyses results of negative control plants comprising transgenic and nontransformed maize plants. Leaf Tissue Root Tissue PER5 PER5 ST-LS1 UTR ST-LS1 UTR Root Sample ID RTL* RTL RTL* RTL Rating YFP protein Events 101556[679]-10513.001 0.000 0.0 0.000 32.7 1 101556[679]-10514.001 0.173 171.3 0.240 202.3 1 101556[679]-10515.001 0.000 42.5 0.000 45.6 1 101556[679]-10516.001 0.000 18.9 0.000 65.3 0.75 101556[677]-10524.001 0.000 315.2 0.000 364.6 1 101556[677]-10525.001 0.000 184.8 0.000 95.0 1 101556[677]-10526.001 0.000 0.2 0.000 0.3 1 101556[677]-10527.001 0.000 170.1 0.000 128.0 1 101556[677]-10528.001 0.000 179.8 0.067 104.0 1 101556[677]-10529.001 0.000 98.4 0.000 38.9 1 YFP hairpin Events 110853[8]-289.001 0.117 97.0 0.122 65.3 0.5 110853[8]-290.001 0.098 70.0 0.272 79.3 1 110853[8]-291.001 0.084 36.3 0.107 86.2 1 110853[8]-293.001 0.088 79.9 0.624 101.1 0.05 110853[8]-294.001 0.079 35.8 0.117 54.2 1 110853[8]-295.001 0.095 82.7 0.114 145.0 1 110853[8]-296.001 0.097 59.7 0.158 79.9 1 110853[8]-297.001 0.106 0.1 0.000 2.5 1 110853[8]-298.001 0.000 0.1 0.000 32.9 1 110853[8]-299.001 0.354 143.0 0.308 101.8 1 110853[8]-300.001 0.500 159.8 0.085 139.1 1 110853[8]-301.001 0.304 174.9 1.007 111.4 1 Nontransformed Plants 7sh382 0.000 0.1 0.000 0.2 0.75 7sh382 0.000 0.1 0.000 0.1 1 7sh382 0.000 0.1 0.000 6.1 NG** 7sh382 0.000 0.4 0.000 1.6 1 7sh382 0.287 0.0 0.000 ND*** 1 7sh382 0.000 0.2 0.000 0.3 0.75 B104 0.000 0.2 0.000 0.2 1 B104 0.000 0.0 0.000 0.6 1 B104 0.000 0.1 0.000 0.3 1 B104 0.000 0.4 1.000 1.0 1 B104 0.000 0.1 0.000 0.5 1 B104 0.000 0.0 0.000 205.1 1 B104 0.077 0.1 0.000 4.4 1 *RTL = Relative Transcript Level as measured against TIP4-like gene transcript levels. **NG = Not Graded due to small plant size. ***ND = Not Done

Example 9

Transgenic Zea mays Comprising Coleopteran Pest Sequences

[0316] Ten to 20 transgenic T.sub.0 Zea mays plants are generated as described in EXAMPLE 6. A further 10-20 T.sub.1 Zea mays independent lines expressing iRNA are obtained for corn rootworm challenge. The iRNA include SEQ ID NO:16, SEQ ID NO: 17, or otherwise further comprise SEQ ID NO: 1, 3, 4, or 5. Additional hairpin iRNAs are derived from coleopteran pest sequences including Caf1-180 (U.S. Patent Application Publication No. 2012/0174258), VatpaseC (U.S. Patent Application Publication No. 2012/0174259), Rho1 (U.S. Patent Application Publication No. 2012/0174260), VatpaseH (U.S. Patent Application Publication No. 2012/0198586), PPI-87B (U.S. Patent Application Publication No. 2013/0091600), RPA70 (U.S. Patent Application Publication No. 2013/0091601), or RPS6 (U.S. Patent Application Publication No. 2013/0097730). These are confirmed through RT-PCR or other molecular analysis methods. Total RNA preparations from selected independent T.sub.1 lines where the iRNA contains an ST-LS1 intron are used for RT-PCR with primers designed to bind in the ST-LS1 intron. In addition, specific primers for each target gene in an RNAi construct are used to amplify and confirm the production of the pre-processed mRNA required for siRNA production inplanta where appropriate. The amplification of the desired bands for each target gene confirms the expression of the iRNA in each transgenic Zea mays plant. Processing of the iRNA into siRNA is subsequently confirmed in independent transgenic lines using RNA blot hybridizations.

[0317] RNAi molecules having mismatch sequences with more than 80% sequence identity to target genes affect corn rootworms in a way similar to that seen with RNAi molecules having 100% sequence identity to the target genes The pairing of mismatch sequence with native sequences to form dsRNA delivers plant-processed siRNAs that affects the growth, development and viability of feeding coleopteran pests.

[0318] In planta delivery of dsRNA, siRNA or miRNA corresponding to target genes and the subsequent uptake by coleopteran pests through feeding results in down-regulation of the target genes in the coleopteran pest through RNA-mediated gene silencing. When the function of a target gene is important at one or more stages of development, the growth, development, and reproduction of the coleopteran pest is affected, and in the case of at least one of WCR, NCR, SCR, MCR, D. balteata LeConte, D. u. tenella, and D. u. undecimpunctata Mannerheim, leads to failure to successfully infest, feed, develop, and/or reproduce, or leads to death of the coleopteran pest. The choice of target genes and the successful application of RNAi is then used to control coleopteran pests.

[0319] Phenotypic Comparison of Transgenic RNAi Lines and Nontransformed Zea mays

[0320] Target coleopteran pest genes or sequences selected for creating iRNA have no substantial similarity to any other known plant gene sequence. Hence, the production or the activation of (systemic) RNAi by constructs targeting these coleopteran pest genes or sequences has no deleterious effect on transgenic plants. Development and morphological characteristics of transgenic lines are compared with nontransformed plants, as well as those of transgenic lines transformed with an "empty" vector having no hairpin-expressing gene. Plant root, shoot, foliage and reproduction characteristics are compared. There is no observable difference in root length and growth patterns of transgenic and nontransformed plants. Plant shoot characteristics such as height, leaf numbers and sizes, time of flowering, floral size and appearance are similar. In general, there are no observable morphological differences between transgenic lines and those without expression of target iRNA molecules when cultured in vitro and in soil in the glasshouse.

Example 10

Transgenic Zea mays Comprising a Coleopteran Pest Sequence and Additional RNAi Constructs

[0321] A transgenic Zea mays plant comprising a heterologous coding sequence in its genome that is transcribed to produce an iRNA molecule that targets an organism other than a coleopteran pest is secondarily transformed via Agrobacterium or WHISKERS.TM. methodologies (see Petolino and Arnold (2009) Methods Mol. Biol. 526:59-67) to produce one or more insecticidal iRNA molecules (for example, at least one dsRNA molecule including a dsRNA molecule targeting a gene comprising SEQ ID NO:1, 3, 4, or 5). Plant transformation plasmid vectors prepared essentially as described in EXAMPLE 4 are delivered via Agrobacterium or WHISKERS.TM.-mediated transformation methods into maize suspension cells or immature maize embryos obtained from a transgenic Hi II or B104 Zea mays plant comprising a heterologous coding sequence in its genome that is transcribed to produce an iRNA molecule that targets an organism other than a coleopteran pest. The resulting transformed embryos are used to regenerate whole plants which are demonstrated to have resistance to a coleopteran pest and the organism other than a coleopteran pest.

Example 11

Transgenic Zea mays Comprising an RNAi Construct and Additional Coleopteran Pest Control Sequences

[0322] A transgenic Zea mays plant comprising a heterologous coding sequence in its genome that is transcribed to produce an iRNA molecule that targets a coleopteran pest organism (for example, at least one dsRNA molecule including a dsRNA molecule targeting a gene comprising SEQ ID NO: 1, 3, 4, or 5) is secondarily transformed via Agrobacterium or WHISKERS.TM. methodologies to produce one or more insecticidal protein molecules, for example, Cry 3, Cry34 and Cry 35 insecticidal proteins. Plant transformation plasmid vectors prepared essentially as described in EXAMPLE 4 are delivered via Agrobacterium or WHISKERS.TM.-mediated transformation methods into maize suspension cells or immature maize embryos obtained from a transgenic B104 Zea mays plant comprising a heterologous coding sequence in its genome that is transcribed to produce an iRNA molecule that targets a coleopteran pest organism. Doubly-transformed plants are obtained that produce iRNA molecules and insecticidal proteins for control of coleopteran pests.

Example 12

Pollen Beetle Transcriptome

[0323] Insects:

[0324] Larvae and adult pollen beetles were collected from fields with flowering rapeseed plants (Giessen, Germany). Young adult beetles (each per treatment group: n=20; 3 replicates) were challenged by injecting a mixture of two different bacteria (Staphylococcus aureus and Pseudomonas aeruginosa), one yeast (Saccharomyces cerevisiae) and bacterial LPS. Bacterial cultures were grown at 37.degree. C. with agitation, and the optical density was monitored at 600 nm (OD600). The cells were harvested at OD600 .about.1 by centrifugation and resuspended in phosphate-buffered saline. The mixture was introduced ventrolaterally by pricking the abdomen of pollen beetle imagoes using a dissecting needle dipped in an aqueous solution of 10 mg/ml LPS (purified E. coli endotoxin; Sigma, Taufkirchen, Germany) and the bacterial and yeast cultures. Along with the immune challenged beetles naive beetles and larvae were collected (n=20 per and 3 replicates each) at the same time point.

[0325] RNA Isolation:

[0326] Total RNA was extracted 8 h after immunization from frozen beetles and larvae using TriReagent (Molecular Research Centre, Cincinnati, Ohio, USA) and purified using the RNeasy Micro Kit (Qiagen, Hilden, Germany) in each case following the manufacturers' guidelines. The integrity of the RNA was verified using an Agilent 2100 Bioanalyzer and a RNA 6000 Nano Kit (Agilent Technologies, Palo Alto, Calif., USA). The quantity of RNA was determined using a NANODROP.RTM. ND-1000 spectrophotometer. RNA was extracted from each of the adult immune-induced treatment groups, adult control groups, and larval groups individually and equal amounts of total RNA were subsequently combined in one pool per sample (immune-challenged adults, control adults and larvae) for sequencing.

[0327] Transcriptome Information:

[0328] RNA-Seq data generation and assembly Single-read 100-bp RNA-Seq was carried out separately on 5 .mu.g total RNA isolated from immune-challenged adult beetles, naive (control) adult beetles and untreated larvae. Sequencing was carried out by Eurofins MWG Operon using the Illumina HiSeq-2000 platform. This yielded 20.8 million reads for the adult control beetle sample, 21.5 million reads for the LPS-challenged adult beetle sample and 25.1 million reads for the larval sample. The pooled reads (67.5 million) were assembled using Velvet/Oases assembler software (M. H. Schulz et al. (2012) Bioinformatics. 28:1086-92; Zerbino & E. Birney (2008) Genome Research. 18:821-9). The transcriptome contained 55648 sequences.

[0329] Pollen Beetle RNAPII Identification:

[0330] A tBLASTn search of the transcriptome was used to identify matching contigs. As a query the peptide sequence of DNA-directed RNA polymerase II subunit RPB2 from Tribolium castaneum was used (GENBANK.RTM. XP_974653.1). Nine contigs were identified (RGK_contig35101, RGK_contig15220, RGK_contig54586, RGK_contig33671, RGK_contig54748, RGK_contig50449, RGK_contig26724, RGK_contig40010, RGK_contig14232). Gaps between the contigs were completed with unassembled reads using an in-house tool. GAPS (Bonfield J K & Whitwham (2010). Bioinformatics 26: 1699-1703 was used for verification of sequences.

Example 13

Mortality of Pollen Beetle (Meligethes aeneus) Following Treatment with rnapII RNAi

[0331] Gene-specific primers including the T7 polymerase promoter sequence at the 5' end were used to create PCR products of approximate 500 bp by PCR (SEQ ID NOs: 78 and 79). PCR fragments were cloned in the pGEM T easy vector according to the manufacturer's protocol and sent to a sequencing company to verify the sequence. The dsRNA was then produced by the T7 RNA polymerase (MEGAscript.RTM. RNAi Kit, Applied Biosystems) from a PCR construct generated from the sequenced plasmid according to the manufacturer's protocol.

[0332] Injection of .about.100 nl dsRNA (1 ug/ul) (SEQ ID NO:77) into larvae and adult beetles (n=10; 3 biological replications) was performed with a micromanipulator under a dissecting stereomicroscope. Animals were anaesthetized on ice before they were affixed to double-stick tape. Controls received the same volume of water. A negative control dsRNA of IMPI (insect metalloproteinase inhibitor gene of the lepidopteran Galleria mellonella) was conducted. All controls in all stages could not be tested due to a lack of animals.

[0333] Pollen beetles were maintained in Petri dishes with dried pollen and a wet tissue. The larvae were reared in plastic boxes on inflorescence of canola in an agar/water media.

TABLE-US-00017 TABLE 14 Results of adult pollen beetle injection bioassay. % Survival Mean .+-. SD* Treatment Day 0 Day 2 Day 4 Day 6 Day 8 rnapII 100 .+-. 0 100 .+-. 0 97 .+-. 6 93 .+-. 6 90 .+-. 0 water 100 .+-. 0 100 .+-. 0 100 .+-. 0 100 .+-. 0 97 .+-. 6 Day 10 Day 12 Day 14 Day 16 rnapII 87 .+-. 6 83 .+-. 12 73 .+-. 29 73 .+-. 29 water 90 .+-. 10 90 .+-. 10 90 .+-. 10 90 .+-. 10 *Standard deviation

TABLE-US-00018 TABLE 15 Results of larval pollen beetle injection bioassay. % Survival Mean .+-. SD* Treatment Day 0 Day 2 Day 4 Day 6 rnapII 100 .+-. 0 70 .+-. 10 13 .+-. 12 10 .+-. 10 Negative control 100 .+-. 0 100 .+-. 0 97 .+-. 6 73 .+-. 21 *Standard deviation

[0334] Controls were performed on a different date due to the limited availability of insects.

[0335] Feeding assay: Beetles were kept without access to water in empty falcon tubes 24 h before treatment. A droplet of dsRNA (.about.5 .mu.l) was placed in a small Petri dish and 5 to 8 beetles were added to the Petri dish. Animals were observed under a stereomicroscope and those that ingested dsRNA containing diet solution were selected for the bioassay. Beetles were transferred into petri dishes with dried pollen and a wet tissue. Controls received the same volume of water. A negative control dsRNA of IMPI (insect metalloproteinase inhibitor gene of the lepidopteran Galleria mellonella) was conducted. All controls in all stages could not be tested due to a lack of animals.

TABLE-US-00019 TABLE 16 Results of adult feeding bioassay. % Survival Mean .+-. SD* Treatment Day 0 Day 2 Day 4 Day 6 Day 8 rnapII 100 .+-. 0 97 .+-. 6 90 .+-. 10 87 .+-. 6 87 .+-. 6 Negative control 100 .+-. 0 93 .+-. 5.8 90 .+-. 10 87 .+-. 5.8 83 .+-. 5.8 water 100 .+-. 0 100 .+-. 0 100 .+-. 0 93 .+-. 3.8 93 .+-. 3.8 Day 10 Day 12 Day 14 Day 16 rnapII 80 .+-. 10 70 .+-. 10 67 .+-. 15 60 .+-. 10 Negative control 80 .+-. 10 80 .+-. 10 80 .+-. 10 77 .+-. 12 water 93 .+-. 3.8 87 .+-. 10 80 .+-. 13 80 .+-. 13 *Standard deviation

[0336] Controls were performed on a different date due to the limited availability of insects.

Example 14

Agrobacterium-Mediated Transformation of Canola (Brassica napus) Hypocotyls

[0337] Agrobacterium Preparation

[0338] The Agrobacterium strain containing a binary plasmid is streaked out on YEP media (Bacto Peptone.TM. 20.0 gm/L and Yeast Extract 10.0 gm/L) plates containing streptomycin (100 mg/ml) and spectinomycin (50 mg/mL) and incubated for 2 days at 28.degree. C. The propagated Agrobacterium strain containing the binary plasmid is scraped from the 2-day streak plate using a sterile inoculation loop. The scraped Agrobacterium strain containing the binary plasmid is then inoculated into 150 mL modified YEP liquid with streptomycin (100 mg/ml) and spectinomycin (50 mg/ml) into sterile 500 mL baffled flask(s) and shaken at 200 rpm at 28.degree. C. The cultures are centrifuged and resuspended in M-medium (LS salts, 3% glucose, modified B5 vitamins, 1 .mu.M kinetin, 1 .mu.M 2,4-D, pH 5.8) and diluted to the appropriate density (50 Klett Units as measured using a spectrophotometer) prior to transformation of canola hypocotyls.

[0339] Canola Transformation

[0340] Seed Germination:

[0341] Canola seeds (var. NEXERA 710.TM.) are surface-sterilized in 10% Clorox.TM. for 10 minutes and rinsed three times with sterile distilled water (seeds are contained in steel strainers during this process). Seeds are planted for germination on 1/2 MS Canola medium (1/2 MS, 2% sucrose, 0.8% agar) contained in Phytatrays.TM. (25 seeds per Phytatray.TM.) and placed in a Percival.TM. growth chamber with growth regime set at 25.degree. C., photoperiod of 16 hours light and 8 hours dark for 5 days of germination.

[0342] Pre-Treatment:

[0343] On day 5, hypocotyl segments of about 3 mm in length are aseptically excised, the remaining root and shoot sections are discarded (drying of hypocotyl segments is prevented by immersing the hypocotyls segments into 10 mL of sterile milliQ.TM. water during the excision process). Hypocotyl segments are placed horizontally on sterile filter paper on callus induction medium, MSK1D1 (MS, 1 mg/L kinetin, 1 mg/L 2,4-D, 3.0% sucrose, 0.7% phytagar) for 3 days pre-treatment in a Percival.TM. growth chamber with growth regime of 22-23.degree. C., and a photoperiod of 16 hours light, 8 hours dark.

[0344] Co-Cultivation with Agrobacterium:

[0345] The day before Agrobacterium co-cultivation, flasks of YEP medium containing the appropriate antibiotics, are inoculated with the Agrobacterium strain containing the binary plasmid. Hypocotyl segments are transferred from filter paper callus induction medium, MSK1D1 to an empty 100.times.25 mm Petri.TM. dishes containing 10 mL of liquid M-medium to prevent the hypocotyl segments from drying. A spatula is used at this stage to scoop the segments and transfer the segments to new medium. The liquid M-medium is removed with a pipette and 40 mL of Agrobacterium suspension is added to the Petri.TM. dish (500 segments with 40 mL of Agrobacterium solution). The hypocotyl segments are treated for 30 minutes with periodic swirling of the Petri.TM. dish so that the hypocotyl segments remain immersed in the Agrobacterium solution. At the end of the treatment period, the Agrobacterium solution is pipetted into a waste beaker; autoclaved and discarded (the Agrobacterium solution is completely removed to prevent Agrobacterium overgrowth). The treated hypocotyls are transferred with forceps back to the original plates containing MSK1D1 media overlaid with filter paper (care is taken to ensure that the segments did not dry). The transformed hypocotyl segments and non-transformed control hypocotyl segments are returned to the Percival.TM. growth chamber under reduced light intensity (by covering the plates with aluminum foil), and the treated hypocotyl segments are co-cultivated with Agrobacterium for 3 days.

[0346] Callus Induction on Selection Medium:

[0347] After 3 days of co-cultivation, the hypocotyl segments are individually transferred with forceps onto callus induction medium, MSK1D1H1 (MS, 1 mg/L kinetin, 1 mg/L 2,4-D, 0.5 gm/L MES, 5 mg/L AgNO.sub.3, 300 mg/L Timentin.TM., 200 mg/L carbenicillin, 1 mg/L Herbiacem, 3% sucrose, 0.7% phytagar) with growth regime set at 22-26.degree. C. The hypocotyl segments are anchored on the medium but are not deeply embedded into the medium.

[0348] Selection and Shoot Regeneration:

[0349] After 7 days on callus induction medium, the callusing hypocotyl segments are transferred to Shoot Regeneration Medium 1 with selection, MSB3Z1H1 (MS, 3 mg/L BAP, 1 mg/L zeatin, 0.5 gm/L MES, 5 mg/L AgNO.sub.3, 300 mg/L Timentin.TM., 200 mg/L carbenicillin, 1 mg/L Herbiacem, 3% sucrose, 0.7% phytagar). After 14 days, the hypocotyl segments which develop shoots are transferred to Regeneration Medium 2 with increased selection, MSB3Z1H3 (MS, 3 mg/L BAP, 1 mg/L Zeatin, 0.5 gm/L MES, 5 mg/L AgNO.sub.3, 300 mg/l Timentin.TM., 200 mg/L carbenicillin, 3 mg/L Herbiace.TM., 3% sucrose, 0.7% phytagar) with growth regime set at 22-26.degree. C.

[0350] Shoot Elongation:

[0351] After 14 days, the hypocotyl segments that develop shoots are transferred from Regeneration Medium 2 to shoot elongation medium, MSMESH5 (MS, 300 mg/L Timentin.TM., 5 mg/l Herbiace.TM., 2% sucrose, 0.7% TC Agar) with growth regime set at 22-26.degree. C. Shoots that are already elongated were isolated from the hypocotyl segments and transferred to MSMESH5. After 14 days the remaining shoots which have not elongated in the first round of culturing on shoot elongation medium are transferred to fresh shoot elongation medium, MSMESH5. At this stage all remaining hypocotyl segments which do not produce shoots are discarded.

[0352] Root Induction:

[0353] After 14 days of culturing on the shoot elongation medium, the isolated shoots are transferred to MSMEST medium (MS, 0.5 g/L MES, 300 mg/L Timentin.TM., 2% sucrose, 0.7% TC Agar) for root induction at 22-26.degree. C. Any shoots which do not produce roots after incubation in the first transfer to MSMEST medium are transferred for a second or third round of incubation on MSMEST medium until the shoots develop roots.

[0354] PCR Analysis:

[0355] Transformed canola hypocotyl segments which regenerated into shoots comprising roots are further analyzed via a PCR molecular confirmation assay. Leaf tissue is obtained from the green shoots and tested via PCR for the presence of the pat selectable marker gene. Any chlorotic shoots are discarded and not subjected to PCR analysis. Samples that are identified as positive for the presence of the pat selectable marker gene are kept and cultured on MSMEST medium to continue development and elongation of the shoots and roots. The samples that are identified as not containing the pat selectable marker gene negative according to PCR analysis are discarded.

[0356] The transformed canola plants comprising shoots and roots that are PCR-positive for the presence of the pat selectable marker gene are transplanted into soil in a greenhouse. After establishment of the canola plants within soil, the canola plants are further analyzed to quantitate the copy number of the pat gene expression cassette via an Invader.TM. quantitative PCR assay and Southern blotting. Transgenic T.sub.0 canola plants which are confirmed to contain at least one copy of the pat gene expression cassette are advanced for further analysis of the seed. The seeds obtained from theses transgenic T.sub.0 canola plants, i.e., T.sub.1 canola seeds, are analyzed to detect the presences of the target gene.

[0357] While the present disclosure may be susceptible to various modifications and alternative forms, specific embodiments have been described by way of example in detail herein. However, it should be understood that the present disclosure is not intended to be limited to the particular forms disclosed. Rather, the present disclosure is to cover all modifications, equivalents, and alternatives falling within the scope of the present disclosure as defined by the following appended claims and their legal equivalents.

Sequence CWU 1

1

8213745DNADiabrotica virgerifera 1cggactgtca aagtcaaatg tcaaagcgtc aaaactaaaa tttgctagcg tcaaaactaa 60aatcaaaatc ggcaaacatc tgcacgaaaa tagagttgtg cttctatatt tattttgtaa 120ttttgagtac cataatatac taagatgtat gatcaagaag atgatcaatt tgacgatgaa 180gatacagaag aaatcagtgg agaactctgg caggaagcct gctggattgt tattaatgcc 240tactttgatg aaaaaggttt ggtacggcag cagttggata gttttgatga attcattcaa 300atgtctgtac agaggatcgt tgaagattcc ccacagatag atctacaagc agaagcgcag 360catacatctg gggaaatcga aaccccacct cgatatttgc tgaagtttga acagatctat 420ctttcaaaac ctacccattg ggagaaagac ggtgccccat ctcctatgat gcctaatgaa 480gctagattaa gaaatttgac ttattctgct cctctttatg tagatataac aaaaacaatt 540gtgaaagaag gagaggatcc tatagaaact caacatcaga aaacttttat aggtaaaatt 600cccattatgt tgaggtcaac atactgtctg ctcagtggat taacagatcg tgatttaaca 660gaattaaacg agtgtccctt agatcctggc ggatatttca taattaacgg ttctgaaaaa 720gtattaattg ctcaagagaa gatggcaact aacacagtat atgtattttc aatgaaagac 780ggaaaatatg cgtacaaatc tgaaataaga tcttgtcttg agcacagctc tcggccaaca 840tcaactctgt gggtaaatat gatggctcgt ggtggccagg ccatcaaaaa agctgctatt 900ggtcaacgta ttatagctat tcttccatac atcaaacaag agatccctat aatgatagtt 960ttcagagctt tagggtttgt agcagacaga gatattctag aacacattat ttacgatttc 1020gacgatccag aattgatgga aatggtaaaa ccttcgttag atgaagcttt cgtaattcag 1080gaacagaata ttgctttgaa tttcatcgga gcgagaggtg ccaggccggg agtaactaaa 1140gaaaagcgtg tgaaatatgc tagagaaatt ttacaaaagg aaatgttgcc tcatgttggt 1200gtatccgatt tttgtgagac taaaaaagct tattttcttg gatatatggt acatcgactt 1260ttgctggctg cactcggacg tcgagagtta gatgacagag atcactacgg aaataagaga 1320ctcgatttgg ctggaccatt attggctttc ctcttcagag ggcttttcaa gaacctaatg 1380aaagaagttc gtatgtatgc ccagaagttt atcgatagag gcaaagattt caatctggat 1440ctggccatca aaaccaaact aataacggac ggtctgaggt attctctcgc tactggaaac 1500tggggtgacc agaaaaaagc ccatcaagca agagctggcg tgtcccaggt attgaatcgt 1560ctaactttcg catcgacgtt gtcacattta aggcgtgtca attctccaat tggacgagac 1620ggtaaactag ccaagcctcg acagttgcat aatacgttgt ggggaatgat ttgccctgct 1680gaaactccag aaggtgctgc tgtaggactt gtaaaaaatc ttgctctgat ggcttatatt 1740tccgtcggtt cccaaccatc gccaattttg gagttcttgg aggagtggtc catggaaaac 1800ttggaagaaa tagcgccatc tgcaattgct aacgctacca aaatctttgt gaatggttgt 1860tgggtgggaa ttcacagaga ccctgaacaa cttatggcga cactgcgtaa acttcgacgt 1920caaatggaca tcatcgtatc agaagtatcg atgattcgag atattcgtga cagagaaata 1980agaatttaca cagacgccgg aagaatctgt agacctttgt taatcgtcga aaatggccag 2040ttgctattga agaaaagaca tattgatatg ttaaaagaaa gagaatataa taattatggt 2100tggcaggtac tggtcgcgtc tggtgtggtg gagtacatag acaccttaga agaagaaacc 2160gtaatgattg ccatgaaccc cgaagattta cgccaagaca aagaatgcgc ttattgtaca 2220acatacactc attgtgaaat tcatccagcc atgattttag gagtttgcgc ttccatcatt 2280ccgttcccag atcacaacca gagtcccaga aacacctatc aaagtgctat gggtaaacaa 2340gccatgggtg tctatatcac aaacttccac gttagaatgg acacactggc ccacgtcctg 2400tactatccac ataaacctct ggtaacgaca agatctatgg agtatcttag attcagagag 2460ttaccggctg gaatcaatag tatcgttgcg attgcttgtt atacaggata caatcaggaa 2520gattctgtta tcttgaatgc ttctgcagta gaaagaggat ttttcagatc tgtgttttac 2580cggtcttata aagacgccga atccaaacgt ataggagacc aggaagaaca attcgaaaaa 2640ccgacaagac agacgtgcca gggcatgagg aatgcccttt acgataaatt agacgacgac 2700ggactgatat ctccaggtat tcgtgtgtct ggagacgatg tagttatagg aaaaactatg 2760acgctaccag aaacagatga cgagttggat ggaactacaa aacggtactc caagagagac 2820gcatcaacat ttttgcgtaa cagtgaaact ggagttgttg atcaagtgat gttaacgcta 2880aattcagaag gatataagtt ttgtaagata agggtgagat ctgtgaggat accacaaatt 2940ggagacaagt tcgcgtctag gcacggacaa aagggaacgt gcggtataca ataccgtcaa 3000gaggatatga tttttagtgc tgaaggtatt actccagaca ttatcatcaa tcctcacgct 3060atcccctccc gtatgacgat tggtcacttg atcgagtgca tccaaggtaa ggtatcatcc 3120aataaaggag aaatcggtga tgctacacct ttcaacgatg ccgtcaacgt acagaaaatc 3180tccactttgt tacaagaata tggttatcaa ctcagaggca acgaagtaat gtacaacggc 3240cacactggac gtaagataaa tgctcagatt ttcttaggac ctacttacta tcaaagattg 3300aagcacatgg tggacgataa gatccattca agagctagag gaccgttgca gattctcgtc 3360agacagccta tggagggtcg tgcaagagac ggtggtctac gtttcggtga gatggaacga 3420gattgtcaaa tttcacacgg tgctgcacaa ttcttaagag agaggctgtt tgaagtttct 3480gatccttata gaatccatat ttgcaacttc tgtggtttga tagctatcgc caatttgcgt 3540aacaacacct ttgaatgtaa gggttgcaaa aataagacgc agatatcgca agttagactg 3600ccttatgctg cgaaattact gttccaagag ctaatgtcga tgaatatagc gccgagactt 3660atggtactgt agtgttttaa gtaataaaat aaatgtcctt atttaagagt attttatatt 3720gaaataaaca ataaaattat aaaaa 374521175PRTDiabrotica virgerifera 2Met Tyr Asp Gln Glu Asp Asp Gln Phe Asp Asp Glu Asp Thr Glu Glu1 5 10 15Ile Ser Gly Glu Leu Trp Gln Glu Ala Cys Trp Ile Val Ile Asn Ala 20 25 30Tyr Phe Asp Glu Lys Gly Leu Val Arg Gln Gln Leu Asp Ser Phe Asp 35 40 45Glu Phe Ile Gln Met Ser Val Gln Arg Ile Val Glu Asp Ser Pro Gln 50 55 60Ile Asp Leu Gln Ala Glu Ala Gln His Thr Ser Gly Glu Ile Glu Thr65 70 75 80Pro Pro Arg Tyr Leu Leu Lys Phe Glu Gln Ile Tyr Leu Ser Lys Pro 85 90 95Thr His Trp Glu Lys Asp Gly Ala Pro Ser Pro Met Met Pro Asn Glu 100 105 110Ala Arg Leu Arg Asn Leu Thr Tyr Ser Ala Pro Leu Tyr Val Asp Ile 115 120 125Thr Lys Thr Ile Val Lys Glu Gly Glu Asp Pro Ile Glu Thr Gln His 130 135 140Gln Lys Thr Phe Ile Gly Lys Ile Pro Ile Met Leu Arg Ser Thr Tyr145 150 155 160Cys Leu Leu Ser Gly Leu Thr Asp Arg Asp Leu Thr Glu Leu Asn Glu 165 170 175Cys Pro Leu Asp Pro Gly Gly Tyr Phe Ile Ile Asn Gly Ser Glu Lys 180 185 190Val Leu Ile Ala Gln Glu Lys Met Ala Thr Asn Thr Val Tyr Val Phe 195 200 205Ser Met Lys Asp Gly Lys Tyr Ala Tyr Lys Ser Glu Ile Arg Ser Cys 210 215 220Leu Glu His Ser Ser Arg Pro Thr Ser Thr Leu Trp Val Asn Met Met225 230 235 240Ala Arg Gly Gly Gln Ala Ile Lys Lys Ala Ala Ile Gly Gln Arg Ile 245 250 255Ile Ala Ile Leu Pro Tyr Ile Lys Gln Glu Ile Pro Ile Met Ile Val 260 265 270Phe Arg Ala Leu Gly Phe Val Ala Asp Arg Asp Ile Leu Glu His Ile 275 280 285Ile Tyr Asp Phe Asp Asp Pro Glu Leu Met Glu Met Val Lys Pro Ser 290 295 300Leu Asp Glu Ala Phe Val Ile Gln Glu Gln Asn Ile Ala Leu Asn Phe305 310 315 320Ile Gly Ala Arg Gly Ala Arg Pro Gly Val Thr Lys Glu Lys Arg Val 325 330 335Lys Tyr Ala Arg Glu Ile Leu Gln Lys Glu Met Leu Pro His Val Gly 340 345 350Val Ser Asp Phe Cys Glu Thr Lys Lys Ala Tyr Phe Leu Gly Tyr Met 355 360 365Val His Arg Leu Leu Leu Ala Ala Leu Gly Arg Arg Glu Leu Asp Asp 370 375 380Arg Asp His Tyr Gly Asn Lys Arg Leu Asp Leu Ala Gly Pro Leu Leu385 390 395 400Ala Phe Leu Phe Arg Gly Leu Phe Lys Asn Leu Met Lys Glu Val Arg 405 410 415Met Tyr Ala Gln Lys Phe Ile Asp Arg Gly Lys Asp Phe Asn Leu Asp 420 425 430Leu Ala Ile Lys Thr Lys Leu Ile Thr Asp Gly Leu Arg Tyr Ser Leu 435 440 445Ala Thr Gly Asn Trp Gly Asp Gln Lys Lys Ala His Gln Ala Arg Ala 450 455 460Gly Val Ser Gln Val Leu Asn Arg Leu Thr Phe Ala Ser Thr Leu Ser465 470 475 480His Leu Arg Arg Val Asn Ser Pro Ile Gly Arg Asp Gly Lys Leu Ala 485 490 495Lys Pro Arg Gln Leu His Asn Thr Leu Trp Gly Met Ile Cys Pro Ala 500 505 510Glu Thr Pro Glu Gly Ala Ala Val Gly Leu Val Lys Asn Leu Ala Leu 515 520 525Met Ala Tyr Ile Ser Val Gly Ser Gln Pro Ser Pro Ile Leu Glu Phe 530 535 540Leu Glu Glu Trp Ser Met Glu Asn Leu Glu Glu Ile Ala Pro Ser Ala545 550 555 560Ile Ala Asn Ala Thr Lys Ile Phe Val Asn Gly Cys Trp Val Gly Ile 565 570 575His Arg Asp Pro Glu Gln Leu Met Ala Thr Leu Arg Lys Leu Arg Arg 580 585 590Gln Met Asp Ile Ile Val Ser Glu Val Ser Met Ile Arg Asp Ile Arg 595 600 605Asp Arg Glu Ile Arg Ile Tyr Thr Asp Ala Gly Arg Ile Cys Arg Pro 610 615 620Leu Leu Ile Val Glu Asn Gly Gln Leu Leu Leu Lys Lys Arg His Ile625 630 635 640Asp Met Leu Lys Glu Arg Glu Tyr Asn Asn Tyr Gly Trp Gln Val Leu 645 650 655Val Ala Ser Gly Val Val Glu Tyr Ile Asp Thr Leu Glu Glu Glu Thr 660 665 670Val Met Ile Ala Met Asn Pro Glu Asp Leu Arg Gln Asp Lys Glu Cys 675 680 685Ala Tyr Cys Thr Thr Tyr Thr His Cys Glu Ile His Pro Ala Met Ile 690 695 700Leu Gly Val Cys Ala Ser Ile Ile Pro Phe Pro Asp His Asn Gln Ser705 710 715 720Pro Arg Asn Thr Tyr Gln Ser Ala Met Gly Lys Gln Ala Met Gly Val 725 730 735Tyr Ile Thr Asn Phe His Val Arg Met Asp Thr Leu Ala His Val Leu 740 745 750Tyr Tyr Pro His Lys Pro Leu Val Thr Thr Arg Ser Met Glu Tyr Leu 755 760 765Arg Phe Arg Glu Leu Pro Ala Gly Ile Asn Ser Ile Val Ala Ile Ala 770 775 780Cys Tyr Thr Gly Tyr Asn Gln Glu Asp Ser Val Ile Leu Asn Ala Ser785 790 795 800Ala Val Glu Arg Gly Phe Phe Arg Ser Val Phe Tyr Arg Ser Tyr Lys 805 810 815Asp Ala Glu Ser Lys Arg Ile Gly Asp Gln Glu Glu Gln Phe Glu Lys 820 825 830Pro Thr Arg Gln Thr Cys Gln Gly Met Arg Asn Ala Leu Tyr Asp Lys 835 840 845Leu Asp Asp Asp Gly Leu Ile Ser Pro Gly Ile Arg Val Ser Gly Asp 850 855 860Asp Val Val Ile Gly Lys Thr Met Thr Leu Pro Glu Thr Asp Asp Glu865 870 875 880Leu Asp Gly Thr Thr Lys Arg Tyr Ser Lys Arg Asp Ala Ser Thr Phe 885 890 895Leu Arg Asn Ser Glu Thr Gly Val Val Asp Gln Val Met Leu Thr Leu 900 905 910Asn Ser Glu Gly Tyr Lys Phe Cys Lys Ile Arg Val Arg Ser Val Arg 915 920 925Ile Pro Gln Ile Gly Asp Lys Phe Ala Ser Arg His Gly Gln Lys Gly 930 935 940Thr Cys Gly Ile Gln Tyr Arg Gln Glu Asp Met Ile Phe Ser Ala Glu945 950 955 960Gly Ile Thr Pro Asp Ile Ile Ile Asn Pro His Ala Ile Pro Ser Arg 965 970 975Met Thr Ile Gly His Leu Ile Glu Cys Ile Gln Gly Lys Val Ser Ser 980 985 990Asn Lys Gly Glu Ile Gly Asp Ala Thr Pro Phe Asn Asp Ala Val Asn 995 1000 1005Val Gln Lys Ile Ser Thr Leu Leu Gln Glu Tyr Gly Tyr Gln Leu 1010 1015 1020Arg Gly Asn Glu Val Met Tyr Asn Gly His Thr Gly Arg Lys Ile 1025 1030 1035Asn Ala Gln Ile Phe Leu Gly Pro Thr Tyr Tyr Gln Arg Leu Lys 1040 1045 1050His Met Val Asp Asp Lys Ile His Ser Arg Ala Arg Gly Pro Leu 1055 1060 1065Gln Ile Leu Val Arg Gln Pro Met Glu Gly Arg Ala Arg Asp Gly 1070 1075 1080Gly Leu Arg Phe Gly Glu Met Glu Arg Asp Cys Gln Ile Ser His 1085 1090 1095Gly Ala Ala Gln Phe Leu Arg Glu Arg Leu Phe Glu Val Ser Asp 1100 1105 1110Pro Tyr Arg Ile His Ile Cys Asn Phe Cys Gly Leu Ile Ala Ile 1115 1120 1125Ala Asn Leu Arg Asn Asn Thr Phe Glu Cys Lys Gly Cys Lys Asn 1130 1135 1140Lys Thr Gln Ile Ser Gln Val Arg Leu Pro Tyr Ala Ala Lys Leu 1145 1150 1155Leu Phe Gln Glu Leu Met Ser Met Asn Ile Ala Pro Arg Leu Met 1160 1165 1170Val Leu 11753468DNADiabrotica virgerifera 3cctacccatt gggagaaaga cggtgcccca tctcctatga tgcctaatga agctagatta 60agaaatttga cttattctgc tcctctttat gtagatataa caaaaacaat tgtgaaagaa 120ggagaggatc ctatagaaac tcaacatcag aaaactttta taggtaaaat tcccattatg 180ttgaggtcaa catactgtct gctcagtgga ttaacagatc gtgatttaac agaattaaac 240gagtgtccct tagatcctgg cggatatttc ataattaacg gttctgaaaa agtattaatt 300gctcaagaga agatggcaac taacacagta tatgtatttt caatgaaaga cggaaaatat 360gcgtacaaat ctgaaataag atcttgtctt gagcacagct ctcggccaac atcaactctg 420tgggtaaata tgatggctcg tggtggccag gccatcaaaa aagctgct 4684180DNADiabrotica virgerifera 4aaataagaga ctcgatttgg ctggaccatt attggctttc ctcttcagag ggcttttcaa 60gaacctaatg aaagaagttc gtatgtatgc ccagaagttt atcgatagag gcaaagattt 120caatctggat ctggccatca aaaccaaact aataacggac ggtctgaggt attctctcgc 1805161DNADiabrotica virgerifera 5ttctgcagta gaaagaggat ttttcagatc tgtgttttac cggtcttata aagacgccga 60atccaaacgt ataggagacc aggaagaaca attcgaaaaa ccgacaagac agacgtgcca 120gggcatgagg aatgcccttt acgataaatt agacgacgac g 161624DNAArtificial SequenceT7 phage promoter 6ttaatacgac tcactatagg gaga 247503DNAArtificial SequenceYFP coding region segment 7caccatgggc tccagcggcg ccctgctgtt ccacggcaag atcccctacg tggtggagat 60ggagggcaat gtggatggcc acaccttcag catccgcggc aagggctacg gcgatgccag 120cgtgggcaag gtggatgccc agttcatctg caccaccggc gatgtgcccg tgccctggag 180caccctggtg accaccctga cctacggcgc ccagtgcttc gccaagtacg gccccgagct 240gaaggatttc tacaagagct gcatgcccga tggctacgtg caggagcgca ccatcacctt 300cgagggcgat ggcaatttca agacccgcgc cgaggtgacc ttcgagaatg gcagcgtgta 360caatcgcgtg aagctgaatg gccagggctt caagaaggat ggccacgtgc tgggcaagaa 420tctggagttc aatttcaccc cccactgcct gtacatctgg ggcgatcagg ccaatcacgg 480cctgaagagc gccttcaaga tct 503845DNAArtificial SequenceRNAPreg1-F1T7 PCR Primer Oligonucleotide 8ttaatacgac tcactatagg gagacctacc cattgggaga aagac 45943DNAArtificial SequenceRNAPreg1R1T7 PCR Primer Oligonucleotide 9ttaatacgac tcactatagg gagaagcagc ttttttgatg gcc 431047DNAArtificial SequenceRNAPreg 2 F1T7 PCR Primer Oligonucleotide 10ttaatacgac tcactatagg gagaaaataa gagactcgat ttggctg 471144DNAArtificial SequenceRNAPreg2 R1T7 PCR Primer Oligonucleotide 11ttaatacgac tcactatagg gagagcgaga gaatacctca gacc 441249DNAArtificial SequenceRNAPreg 3 -F1T7 PCR Primer Oligonucleotide 12ttaatacgac tcactatagg gagattctgc agtagaaaga ggatttttc 491349DNAArtificial SequenceRNAPreg 3 R1T7 PCR Primer Oligonucleotide 13ttaatacgac tcactatagg gagagtcgtc gtctaattta tcgtaaagg 491447DNAArtificial SequenceYFP-F_T7 PCR Primer Oligonucleotide 14ttaatacgac tcactatagg gagacaccat gggctccagc ggcgccc 471547DNAArtificial SequenceYFP-R_T7 PCR Primer Oligonucleotide 15ttaatacgac tcactatagg gagaagatct tgaaggcgct cttcagg 4716585DNAArtificial SequenceRNAPII-140 hairpin-RNA-forming sequence v1 16aaataagaga ctcgatttgg ctggaccatt attggctttc ctcttcagag ggcttttcaa 60gaacctaatg aaagaagttc gtatgtatgc ccagaagttt atcgatagag gcaaagattt 120caatctggat ctggccatca aaaccaaact aataacggac ggtctgaggt attctctcgc 180gactagtacc ggttgggaaa ggtatgtttc tgcttctacc tttgatatat atataataat 240tatcactaat tagtagtaat atagtatttc aagtattttt ttcaaaataa aagaatgtag 300tatatagcta ttgcttttct gtagtttata agtgtgtata ttttaattta taacttttct 360aatatatgac caaaacatgg tgatgtgcag gttgatccgc ggttagcgag agaatacctc 420agaccgtccg ttattagttt ggttttgatg gccagatcca gattgaaatc tttgcctcta 480tcgataaact tctgggcata catacgaact tctttcatta ggttcttgaa aagccctctg 540aagaggaaag ccaataatgg tccagccaaa tcgagtctct tattt 58517545DNAArtificial SequenceRNAPII-140 hairpin-RNA-forming sequence v2 17ttctgcagta gaaagaggat ttttcagatc tgtgttttac cggtcttata aagacgccga 60atccaaacgt ataggagacc aggaagaaca attcgaaaaa ccgacaagac agacgtgcca 120gggcatgagg aatgcccttt acgataaatt agacgacgac gactagtacc ggttgggaaa 180ggtatgtttc tgcttctacc tttgatatat atataataat tatcactaat tagtagtaat 240atagtatttc aagtattttt ttcaaaataa aagaatgtag tatatagcta ttgcttttct 300gtagtttata agtgtgtata ttttaattta taacttttct aatatatgac caaaacatgg 360tgatgtgcag gttgatccgc ggttagtcgt cgtctaattt atcgtaaagg gcattcctca 420tgccctggca cgtctgtctt gtcggttttt cgaattgttc ttcctggtct cctatacgtt 480tggattcggc gtctttataa gaccggtaaa acacagatct gaaaaatcct ctttctactg 540cagaa 54518471DNAArtificial SequenceYFP hairpin-RNA-forming sequence v2 18atgtcatctg gagcacttct ctttcatggg aagattcctt acgttgtgga gatggaaggg

60aatgttgatg gccacacctt tagcatacgt gggaaaggct acggagatgc ctcagtggga 120aaggactagt accggttggg aaaggtatgt ttctgcttct acctttgata tatatataat 180aattatcact aattagtagt aatatagtat ttcaagtatt tttttcaaaa taaaagaatg 240tagtatatag ctattgcttt tctgtagttt ataagtgtgt atattttaat ttataacttt 300tctaatatat gaccaaaaca tggtgatgtg caggttgatc cgcggttact ttcccactga 360ggcatctccg tagcctttcc cacgtatgct aaaggtgtgg ccatcaacat tcccttccat 420ctccacaacg taaggaatct tcccatgaaa gagaagtgct ccagatgaca t 47119225DNASolanum tuberosum 19gactagtacc ggttgggaaa ggtatgtttc tgcttctacc tttgatatat atataataat 60tatcactaat tagtagtaat atagtatttc aagtattttt ttcaaaataa aagaatgtag 120tatatagcta ttgcttttct gtagtttata agtgtgtata ttttaattta taacttttct 180aatatatgac caaaacatgg tgatgtgcag gttgatccgc ggtta 22520702DNAArtificial SequencePlant-optimized yellow fluorescent protein coding region 20atgtcatctg gagcacttct ctttcatggg aagattcctt acgttgtgga gatggaaggg 60aatgttgatg gccacacctt tagcatacgt gggaaaggct acggagatgc ctcagtggga 120aaggttgatg cacagttcat ctgcacaact ggtgatgttc ctgtgccttg gagcacactt 180gtcaccactc tcacctatgg agcacagtgc tttgccaagt atggtccaga gttgaaggac 240ttctacaagt cctgtatgcc agatggctat gtgcaagagc gcacaatcac ctttgaagga 300gatggcaact tcaagactag ggctgaagtc acctttgaga atgggtctgt ctacaatagg 360gtcaaactca atggtcaagg cttcaagaaa gatggtcatg tgttgggaaa gaacttggag 420ttcaacttca ctccccactg cctctacatc tggggtgacc aagccaacca cggtctcaag 480tcagccttca agatctgtca tgagattact ggcagcaaag gcgacttcat agtggctgac 540cacacccaga tgaacactcc cattggtgga ggtccagttc atgttccaga gtatcatcac 600atgtcttacc atgtgaaact ttccaaagat gtgacagacc acagagacaa catgtccttg 660aaagaaactg tcagagctgt tgactgtcgc aagacctacc tt 70221218DNADiabrotica virgerifera 21tagctctgat gacagagccc atcgagtttc aagccaaaca gttgcataaa gctatcagcg 60gattgggaac tgatgaaagt acaatmgtmg aaattttaag tgtmcacaac aacgatgaga 120ttataagaat ttcccaggcc tatgaaggat tgtaccaacg mtcattggaa tctgatatca 180aaggagatac ctcaggaaca ttaaaaaaga attattag 21822424DNADiabrotica virgeriferamisc_feature(393)..(393)n is a, c, g, or tmisc_feature(394)..(394)n is a, c, g, or tmisc_feature(395)..(395)n is a, c, g, or t 22ttgttacaag ctggagaact tctctttgct ggaaccgaag agtcagtatt taatgctgta 60ttctgtcaaa gaaataaacc acaattgaat ttgatattcg acaaatatga agaaattgtt 120gggcatccca ttgaaaaagc cattgaaaac gagttttcag gaaatgctaa acaagccatg 180ttacacctta tccagagcgt aagagatcaa gttgcatatt tggtaaccag gctgcatgat 240tcaatggcag gcgtcggtac tgacgataga actttaatca gaattgttgt ttcgagatct 300gaaatcgatc tagaggaaat caaacaatgc tatgaagaaa tctacagtaa aaccttggct 360gataggatag cggatgacac atctggcgac tannnaaaag ccttattagc cgttgttggt 420taag 42423397DNADiabrotica virgerifera 23agatgttggc tgcatctaga gaattacaca agttcttcca tgattgcaag gatgtactga 60gcagaatagt ggaaaaacag gtatccatgt ctgatgaatt gggaagggac gcaggagctg 120tcaatgccct tcaacgcaaa caccagaact tcctccaaga cctacaaaca ctccaatcga 180acgtccaaca aatccaagaa gaatcagcta aacttcaagc tagctatgcc ggtgatagag 240ctaaagaaat caccaacagg gagcaggaag tggtagcagc ctgggcagcc ttgcagatcg 300cttgcgatca gagacacgga aaattgagcg atactggtga tctattcaaa ttctttaact 360tggtacgaac gttgatgcag tggatggacg aatggac 39724490DNADiabrotica virgerifera 24gcagatgaac accagcgaga aaccaagaga tgttagtggt gttgaattgt tgatgaacaa 60ccatcagaca ctcaaggctg agatcgaagc cagagaagac aactttacgg cttgtatttc 120tttaggaaag gaattgttga gccgtaatca ctatgctagt gctgatatta aggataaatt 180ggtcgcgttg acgaatcaaa ggaatgctgt actacagagg tgggaagaaa gatgggagaa 240cttgcaactc atcctcgagg tataccaatt cgccagagat gcggccgtcg ccgaagcatg 300gttgatcgca caagaacctt acttgatgag ccaagaacta ggacacacca ttgacgacgt 360tgaaaacttg ataaagaaac acgaagcgtt cgaaaaatcg gcagcggcgc aagaagagag 420attcagtgct ttggagagac tgacgacgtt cgaattgaga gaaataaaga ggaaacaaga 480agctgcccag 49025330DNADiabrotica virgerifera 25agtgaaatgt tagcaaatat aacatccaag tttcgtaatt gtacttgctc agttagaaaa 60tattctgtag tttcactatc ttcaaccgaa aatagaataa atgtagaacc tcgcgaactt 120gcctttcctc caaaatatca agaacctcga caagtttggt tggagagttt agatacgata 180gacgacaaaa aattgggtat tcttgagctg catcctgatg tttttgctac taatccaaga 240atagatatta tacatcaaaa tgttagatgg caaagtttat atagatatgt aagctatgct 300catacaaagt caagatttga agtgagaggt 33026320DNADiabrotica virgerifera 26caaagtcaag atttgaagtg agaggtggag gtcgaaaacc gtggccgcaa aagggattgg 60gacgtgctcg acatggttca attagaagtc cactttggag aggtggagga gttgttcatg 120gaccaaaatc tccaacccct catttttaca tgattccatt ctacacccgt ttgctgggtt 180tgactagcgc actttcagta aaatttgccc aagatgactt gcacgttgtg gatagtctag 240atctgccaac tgacgaacaa agttatatag aagagctggt caaaagccgc ttttgggggt 300ccttcttgtt ttatttgtag 3202746DNAArtificial SequenceAnn-F1_T7 PCR Primer Oligonucleotide 27ttaatacgac tcactatagg gagagctcca acagtggttc cttatc 462829DNAArtificial SequenceAnn-R1 PCR Primer Oligonucleotide 28ctaataattc ttttttaatg ttcctgagg 292922DNAArtificial SequenceAnn-F1 PCR Primer Oligonucleotide 29gctccaacag tggttcctta tc 223053DNAArtificial SequenceAnn-R1_T7 PCR Primer Oligonucleotide 30ttaatacgac tcactatagg gagactaata attctttttt aatgttcctg agg 533148DNAArtificial SequenceAnn-F2_T7 PCR Primer Oligonucleotide 31ttaatacgac tcactatagg gagattgtta caagctggag aacttctc 483224DNAArtificial SequenceAnn-R2 PCR Primer Oligonucleotide 32cttaaccaac aacggctaat aagg 243324DNAArtificial SequenceAnn-F2 PCR Primer Oligonucleotide 33ttgttacaag ctggagaact tctc 243448DNAArtificial SequenceAnn-R2T7 PCR Primer Oligonucleotide 34ttaatacgac tcactatagg gagacttaac caacaacggc taataagg 483547DNAArtificial SequenceBetasp2-F1_T7 PCR Primer Oligonucleotide 35ttaatacgac tcactatagg gagaagatgt tggctgcatc tagagaa 473622DNAArtificial SequenceBetasp2-R1 PCR Primer Oligonucleotide 36gtccattcgt ccatccactg ca 223723DNAArtificial SequenceBetasp2-F1 PCR Primer Oligonucleotide 37agatgttggc tgcatctaga gaa 233846DNAArtificial SequenceBetasp2-R1_T7 PCR Primer Oligonucleotide 38ttaatacgac tcactatagg gagagtccat tcgtccatcc actgca 463946DNAArtificial SequenceBetasp2-F2_T7 PCR Primer Oligonucleotide 39ttaatacgac tcactatagg gagagcagat gaacaccagc gagaaa 464022DNAArtificial SequenceBetasp2-R2 PCR Primer Oligonucleotide 40ctgggcagct tcttgtttcc tc 224122DNAArtificial SequenceBetasp2-F2 PCR Primer Oligonucleotide 41gcagatgaac accagcgaga aa 224246DNAArtificial SequenceBetasp2-R2_T7 PCR Primer Oligonucleotide 42ttaatacgac tcactatagg gagactgggc agcttcttgt ttcctc 464351DNAArtificial SequenceL4-F1_T7 PCR Primer Oligonucleotide 43ttaatacgac tcactatagg gagaagtgaa atgttagcaa atataacatc c 514426DNAArtificial SequenceL4-R1 PCR Primer Oligonucleotide 44acctctcact tcaaatcttg actttg 264527DNAArtificial SequenceL4-F1 PCR Primer Oligonucleotide 45agtgaaatgt tagcaaatat aacatcc 274650DNAArtificial SequenceL4-R1_T7 PCR Primer Oligonucleotide 46ttaatacgac tcactatagg gagaacctct cacttcaaat cttgactttg 504750DNAArtificial SequenceL4-F2_T7 PCR Primer Oligonucleotide 47ttaatacgac tcactatagg gagacaaagt caagatttga agtgagaggt 504825DNAArtificial SequenceL4-R2 PCR Primer Oligonucleotide 48ctacaaataa aacaagaagg acccc 254926DNAArtificial SequenceL4-F2 PCR Primer Oligonucleotide 49caaagtcaag atttgaagtg agaggt 265049DNAArtificial SequenceL4-R2_T7 PCR Primer Oligonucleotide 50ttaatacgac tcactatagg gagactacaa ataaaacaag aaggacccc 49511150DNAZea mays 51caacggggca gcactgcact gcactgcaac tgcgaatttc cgtcagcttg gagcggtcca 60agcgccctgc gaagcaaact acgccgatgg cttcggcggc ggcgtgggag ggtccgacgg 120ccgcggagct gaagacagcg ggggcggagg tgattcccgg cggcgtgcga gtgaaggggt 180gggtcatcca gtcccacaaa ggccctatcc tcaacgccgc ctctctgcaa cgctttgaag 240atgaacttca aacaacacat ttacctgaga tggtttttgg agagagtttc ttgtcacttc 300aacatacaca aactggcatc aaatttcatt ttaatgcgct tgatgcactc aaggcatgga 360agaaagaggc actgccacct gttgaggttc ctgctgcagc aaaatggaag ttcagaagta 420agccttctga ccaggttata cttgactacg actatacatt tacgacacca tattgtggga 480gtgatgctgt ggttgtgaac tctggcactc cacaaacaag tttagatgga tgcggcactt 540tgtgttggga ggatactaat gatcggattg acattgttgc cctttcagca aaagaaccca 600ttcttttcta cgacgaggtt atcttgtatg aagatgagtt agctgacaat ggtatctcat 660ttcttactgt gcgagtgagg gtaatgccaa ctggttggtt tctgcttttg cgtttttggc 720ttagagttga tggtgtactg atgaggttga gagacactcg gttacattgc ctgtttggaa 780acggcgacgg agccaagcca gtggtacttc gtgagtgctg ctggagggaa gcaacatttg 840ctactttgtc tgcgaaagga tatccttcgg actctgcagc gtacgcggac ccgaacctta 900ttgcccataa gcttcctatt gtgacgcaga agacccaaaa gctgaaaaat cctacctgac 960tgacacaaag gcgccctacc gcgtgtacat catgactgtc ctgtcctatc gttgcctttt 1020gtgtttgcca catgttgtgg atgtacgttt ctatgacgaa acaccatagt ccatttcgcc 1080tgggccgaac agagatagct gattgtcatg tcacgtttga attagaccat tccttagccc 1140tttttccccc 11505222DNAArtificial SequenceT20NV PCR Primer Oligonucleotidemisc_feature(22)..(22)n is a, c, g, or t 52tttttttttt tttttttttt vn 225320DNAArtificial SequenceP5U76S (F) PCR Primer Oligonucleotide 53ttgtgatgtt ggtggcgtat 205424DNAArtificial SequenceP5U76A (R) PCR Primer Oligonucleotide 54tgttaaataa aaccccaaag atcg 245521DNAArtificial SequenceTIPmxF PCR Primer Oligonucleotide 55tgagggtaat gccaactggt t 215624DNAArtificial SequenceTIPmxR PCR Primer Oligonucleotide 56gcaatgtaac cgagtgtctc tcaa 245732DNAArtificial SequenceHXTIP Probe Oligonucleotide 57tttttggctt agagttgatg gtgtactgat ga 3258151DNAArtificial SequencePortion of SpecR coding region 58gaccgtaagg cttgatgaaa caacgcggcg agctttgatc aacgaccttt tggaaacttc 60ggcttcccct ggagagagcg agattctccg cgctgtagaa gtcaccattg ttgtgcacga 120cgacatcatt ccgtggcgtt atccagctaa g 1515969DNAArtificial SequencePortion of AAD1 coding region 59tgttcggttc cctctaccaa gcacagaacc gtcgcttcag caacacctca gtcaaggtga 60tggatgttg 69604233DNAZea mays 60agcctggtgt ttccggagga gacagacatg atccctgccg ttgctgatcc gacgacgctg 60gacggcgggg gcgcgcgcag gccgttgctc ccggagacgg accctcgggg gcgtgctgcc 120gccggcgccg agcagaagcg gccgccggct acgccgaccg ttctcaccgc cgtcgtctcc 180gccgtgctcc tgctcgtcct cgtggcggtc acagtcctcg cgtcgcagca cgtcgacggg 240caggctgggg gcgttcccgc gggcgaagat gccgtcgtcg tcgaggtggc cgcctcccgt 300ggcgtggctg agggcgtgtc ggagaagtcc acggccccgc tcctcggctc cggcgcgctc 360caggacttct cctggaccaa cgcgatgctg gcgtggcagc gcacggcgtt ccacttccag 420ccccccaaga actggatgaa cggttagttg gacccgtcgc catcggtgac gacgcgcgga 480tcgttttttt cttttttcct ctcgttctgg ctctaacttg gttccgcgtt tctgtcacgg 540acgcctcgtg cacatggcga tacccgatcc gccggccgcg tatatctatc tacctcgacc 600ggcttctcca gatccgaacg gtaagttgtt ggctccgata cgatcgatca catgtgagct 660cggcatgctg cttttctgcg cgtgcatgcg gctcctagca ttccacgtcc acgggtcgtg 720acatcaatgc acgatataat cgtatcggta cagagatatt gtcccatcag ctgctagctt 780tcgcgtattg atgtcgtgac attttgcacg caggtccgct gtatcacaag ggctggtacc 840acctcttcta ccagtggaac ccggactccg cggtatgggg caacatcacc tggggccacg 900ccgtctcgcg cgacctcctc cactggctgc acctaccgct ggccatggtg cccgatcacc 960cgtacgacgc caacggcgtc tggtccgggt cggcgacgcg cctgcccgac ggccggatcg 1020tcatgctcta cacgggctcc acggcggagt cgtcggcgca ggtgcagaac ctcgcggagc 1080cggccgacgc gtccgacccg ctgctgcggg agtgggtcaa gtcggacgcc aacccggtgc 1140tggtgccgcc gccgggcatc gggccgacgg acttccgcga cccgacgacg gcgtgtcgga 1200cgccggccgg caacgacacg gcgtggcggg tcgccatcgg gtccaaggac cgggaccacg 1260cggggctggc gctggtgtac cggacggagg acttcgtgcg gtacgacccg gcgccggcgc 1320tgatgcacgc cgtgccgggc accggcatgt gggagtgcgt ggacttctac ccggtggccg 1380cgggatcagg cgccgcggcg ggcagcgggg acgggctgga gacgtccgcg gcgccgggac 1440ccggggtgaa gcacgtgctc aaggctagcc tcgacgacga caagcacgac tactacgcga 1500tcggcaccta cgacccggcg acggacacct ggacccccga cagcgcggag gacgacgtcg 1560ggatcggcct ccggtacgac tatggcaagt actacgcgtc gaagaccttc tacgaccccg 1620tccttcgccg gcgggtgctc tgggggtggg tcggcgagac cgacagcgag cgcgcggaca 1680tcctcaaggg ctgggcatcc gtgcaggtac gtctcagggt ttgaggctag catggcttca 1740atcttgctgg catcgaatca ttaatgggca gatattataa cttgataatc tgggttggtt 1800gtgtgtggtg gggatggtga cacacgcgcg gtaataatgt agctaagctg gttaaggatg 1860agtaatgggg ttgcgtataa acgacagctc tgctaccatt acttctgaca cccgattgaa 1920ggagacaaca gtaggggtag ccggtagggt tcgtcgactt gccttttctt ttttcctttg 1980ttttgttgtg gatcgtccaa cacaaggaaa ataggatcat ccaacaaaca tggaagtaat 2040cccgtaaaac atttctcaag gaaccatcta gctagacgag cgtggcatga tccatgcatg 2100cacaaacact agataggtct ctgcagctgt gatgttcctt tacatatacc accgtccaaa 2160ctgaatccgg tctgaaaatt gttcaagcag agaggccccg atcctcacac ctgtacacgt 2220ccctgtacgc gccgtcgtgg tctcccgtga tcctgccccg tcccctccac gcggccacgc 2280ctgctgcagc gctctgtaca agcgtgcacc acgtgagaat ttccgtctac tcgagcctag 2340tagttagacg ggaaaacgag aggaagcgca cggtccaagc acaacacttt gcgcgggccc 2400gtgacttgtc tccggttggc tgagggcgcg cgacagagat gtatggcgcc gcggcgtgtc 2460ttgtgtcttg tcttgcctat acaccgtagt cagagactgt gtcaaagccg tccaacgaca 2520atgagctagg aaacgggttg gagagctggg ttcttgcctt gcctcctgtg atgtctttgc 2580cttgcatagg gggcgcagta tgtagctttg cgttttactt cacgccaaag gatactgctg 2640atcgtgaatt attattatta tatatatatc gaatatcgat ttcgtcgctc tcgtggggtt 2700ttattttcca gactcaaact tttcaaaagg cctgtgtttt agttcttttc ttccaattga 2760gtaggcaagg cgtgtgagtg tgaccaacgc atgcatggat atcgtggtag actggtagag 2820ctgtcgttac cagcgcgatg cttgtatatg tttgcagtat tttcaaatga atgtctcagc 2880tagcgtacag ttgaccaagt cgacgtggag ggcgcacaac agacctctga cattattcac 2940ttttttttta ccatgccgtg cacgtgcagt caatccccag gacggtcctc ctggacacga 3000agacgggcag caacctgctc cagtggccgg tggtggaggt ggagaacctc cggatgagcg 3060gcaagagctt cgacggcgtc gcgctggacc gcggatccgt cgtgcccctc gacgtcggca 3120aggcgacgca ggtgacgccg cacgcagcct gctgcagcga acgaactcgc gcgttgccgg 3180cccgcggcca gctgacttag tttctctggc tgatcgaccg tgtgcctgcg tgcgtgcagt 3240tggacatcga ggctgtgttc gaggtggacg cgtcggacgc ggcgggcgtc acggaggccg 3300acgtgacgtt caactgcagc accagcgcag gcgcggcggg ccggggcctg ctcggcccgt 3360tcggccttct cgtgctggcg gacgacgact tgtccgagca gaccgccgtg tacttctacc 3420tgctcaaggg cacggacggc agcctccaaa ctttcttctg ccaagacgag ctcaggtatg 3480tatgttatga cttatgacca tgcatgcatg cgcatttctt agctaggctg tgaagcttct 3540tgttgagttg tttcacagat gcttaccgtc tgctttgttt cgtatttcga ctaggcatcc 3600aaggcgaacg atctggttaa gagagtatac gggagcttgg tccctgtgct agatggggag 3660aatctctcgg tcagaatact ggtaagtttt tacagcgcca gccatgcatg tgttggccag 3720ccagctgctg gtactttgga cactcgttct tctcgcactg ctcattattg cttctgatct 3780ggatgcacta caaattgaag gttgaccact ccatcgtgga gagctttgct caaggcggga 3840ggacgtgcat cacgtcgcga gtgtacccca cacgagccat ctacgactcc gcccgcgtct 3900tcctcttcaa caacgccaca catgctcacg tcaaagcaaa atccgtcaag atctggcagc 3960tcaactccgc ctacatccgg ccatatccgg caacgacgac ttctctatga ctaaattaag 4020tgacggacag ataggcgata ttgcatactt gcatcatgaa ctcatttgta caacagtgat 4080tgtttaattt atttgctgcc ttccttatcc ttcttgtgaa actatatggt acacacatgt 4140atcattaggt ctagtagtgt tgttgcaaag acacttagac accagaggtt ccaggagtat 4200cagagataag gtataagagg gagcagggag cag 42336125DNAArtificial SequenceST-LS1- F PCR Primer Oligonucleotide 61gtatgtttct gcttctacct ttgat 256229DNAArtificial SequenceST-LS1- R PCR Primer Oligonucleotide 62ccatgttttg gtcatatatt agaaaagtt 296334DNAArtificial SequenceST-LS1-P Probe Oligonucleotide 63agtaatatag tatttcaagt atttttttca aaat 346420DNAArtificial SequenceGAAD1-F PCR Primer Oligonucleotide 64tgttcggttc cctctaccaa 206522DNAArtificial SequenceGAAD1-R PCR Primer Oligonucleotide 65caacatccat caccttgact ga 226624DNAArtificial SequenceGAAD1-P Probe Oligonucleotide 66cacagaaccg tcgcttcagc aaca 246718DNAArtificial SequenceIVR1-F PCR Primer Oligonucleotide 67tggcggacga cgacttgt 186819DNAArtificial SequenceIVR1-R PCR Primer Oligonucleotide 68aaagtttgga ggctgccgt 196926DNAArtificial SequenceIVR1-P Probe Oligonucleotide 69cgagcagacc gccgtgtact tctacc 267019DNAArtificial SequenceSPC1A PCR Primer Oligonucleotide 70cttagctgga taacgccac 197119DNAArtificial SequenceSPC1S PCR Primer Oligonucleotide 71gaccgtaagg cttgatgaa

197221DNAArtificial SequenceTQSPEC Probe Oligonucleotide 72cgagattctc cgcgctgtag a 21733093DNAMeligethes aeneus 73gagacccaac accagaagac tttcataggg aaaatcccga ttatgttgag gtctacgtac 60tgccttctca gcggcttaac agatcgtgat ttgacggagt taaacgagtg tcctttggat 120cccgggggtt atttcatcat aaacgggtcg gagaaggttt taattgccca ggaaaaaatg 180gctacgaaca cagtgtatgt gttttcgatg aaggacggga aatacgcgtt taaatccgag 240attaggtcgt gtttggagca ttcttcgcgc cccacctcca ctttgtgggt gaatatgatg 300gctcgtggcg ggcaagctgt gaaaaaggca gccatcgggc aaagaatcat cgctatttta 360ccatatatca agcaagaaat acccattatg atcgtattca gagcgctagg ttttgtggcc 420gacagagaca tcctcgaaca catcatctat gactttgacg accctgaaat gatggagatg 480gtgaaaccgt ccctagacga ggcttttgta atccaagagc agggtgtggc cttgaatttt 540attggtgcta gaggggccag gcccggcgta acgagggaaa agcgtgttaa atacgccagg 600gaaattttgc agaaggaaat gctgccgcat gtaggagttt ccgatttctg cgaaaccaaa 660aaagcgtatt tcttggggta catggtgcac aggctgcttc tggcctcttt ggggcgcaga 720gagttagacg acagggatca ttacggcaac aaaaggttgg atttggctgg gccgttgctg 780gctttcttgt tcagaggtct tttcaaaaac ttaatgaagg aagtgcgcat gtacgcccaa 840aaattcatcg acagaggaaa agatttcaac ttggatttgg caatcaaaac caaactcatc 900accgacggtt tgcgttactc tcttgccacc ggtaactggg gcgaccagaa aaaggcccat 960caagccagag ccggagtgtc tcaggtactg aacagactga cttacgcctc gactttatct 1020catttgaggc gcgtaaactc gcccatcggt cgcgacggta aactagccaa accccgtcag 1080ttgcacaaca ccctgtgggg catgatttgc ccggcggaaa cgccagaggg cgctgcggtg 1140ggtttggtaa aaaatctcgc ccttatggct tacatttccg tcggttcgca accctctccg 1200atcttggagt tcttggagga gtggtcgatg gagaatttgg aggaaatagc gccgtctgct 1260atcgctaacg ccactaagat ttttgtcaat gggtgttggg tcggtattca cagggatccg 1320gagcaattga cggcgacttt gaggaagcta cgtcgccaga tggatattat cgtatccgag 1380gtatccatga tccgtgatat ccgcgatcgc gaaatccgta tctacacgga tgctggtcgt 1440atttgcagac ctttattgat tgctaaaaat ggcagcctgt tactgaaaaa agaacacatc 1500gacatgttga aagagagaga atacaacaac tatggctggc aagtgttggt agcctcaggt 1560gttgtcgaat acattgacac cctagaagaa gaaactgtga tgattgccat gtctcctgac 1620gatttgagac aagacaagga gtgcgcctac tgtacgactt acactcactg cgaaattcat 1680cccgccatga ttttgggagt ctgcgcgtca attatcccgt tccccgatca caaccaaagt 1740cccaggaaca cctatcaaag cgccatggga aaacaagcca tgggcgtgta cataacaaac 1800ttccacgtgc ggatggacac gctcgcgcac gtgctctact acccccacaa accgctggta 1860accaccagat ccatggagta cctgcggttc agagagcttc ccgccggcat caacagcatc 1920gtggccatcg cctgctacac cggctacaac caggaggatt cggttatttt aaacgcttcg 1980gccgtcgaaa gaggcttctt ccgatcggtg ttttatcgtt cgtacaagga cgccgagtcc 2040aagcgcattg gggatcagga ggagcagttc gagaagccga ccaggcagac ctgccagggc 2100atgcgcaacg cgctgtacga caaactcgac gacgacggta tcatttcgcc cggtattcgt 2160gtctccgggg acgacgtcgt catcggcaaa accatgacac tcccggaaaa cgacgatgag 2220ctggacggta acacgaagaa gttcaccaag agggacgcca gtactttctt gcgtaacagc 2280gagactggcg tggtggatca ggtgatgttg accttgaact ccgagggtta caagttctgt 2340aagattcgcg tgaggtccgt gaggattccg cagataggcg acaaattcgc ctcgcgtcac 2400gggcagaagg gtacttgcgg catacagtac cggcaagaag atatgatttt ctcgtgcgag 2460ggtttgaccc cggacatcat catcaacccg cacgccatcc catctcgtat gacgattggg 2520catttgatcg agtgcatcca aggtaaggta tcggcgaata agggggagat cggggacgcg 2580accccgttta acgacgcggt aaacgtgcag aaaatttcca ctctcctgca agagtacggg 2640taccaactga gagggaacga ggtgatgtac aacgggcaca cggggcgcaa aatgaacgcg 2700cagattttcc tgggccccac ctactaccag cgcctcaagc acatggtgga cgataagatc 2760cactcgaggg ccagaggccc ggtgcagatc ctcgtcaggc agcccatgga gggtcgagcc 2820agggacgggg gcctgcgttt cggggagatg gagcgcgatt gccagatttc gcacggcgcg 2880gcgcagtttc tgcgcgagcg cttgttcgag gtgtccgatc cctacaggat ccacgtgtgc 2940aacttctgcg ggctgatcgc catcgctaac ttgcggaaca acacgttcga gtgcaagggg 3000tgcaagaata agacgcagat ttcgcagaca tggatcctgt agggatcgga cacctcgaac 3060aagcgctcgc gcagaaactg cgccgcgccg tgc 3093741013PRTMeligethes aeneus 74Glu Thr Gln His Gln Lys Thr Phe Ile Gly Lys Ile Pro Ile Met Leu1 5 10 15Arg Ser Thr Tyr Cys Leu Leu Ser Gly Leu Thr Asp Arg Asp Leu Thr 20 25 30Glu Leu Asn Glu Cys Pro Leu Asp Pro Gly Gly Tyr Phe Ile Ile Asn 35 40 45Gly Ser Glu Lys Val Leu Ile Ala Gln Glu Lys Met Ala Thr Asn Thr 50 55 60Val Tyr Val Phe Ser Met Lys Asp Gly Lys Tyr Ala Phe Lys Ser Glu65 70 75 80Ile Arg Ser Cys Leu Glu His Ser Ser Arg Pro Thr Ser Thr Leu Trp 85 90 95Val Asn Met Met Ala Arg Gly Gly Gln Ala Val Lys Lys Ala Ala Ile 100 105 110Gly Gln Arg Ile Ile Ala Ile Leu Pro Tyr Ile Lys Gln Glu Ile Pro 115 120 125Ile Met Ile Val Phe Arg Ala Leu Gly Phe Val Ala Asp Arg Asp Ile 130 135 140Leu Glu His Ile Ile Tyr Asp Phe Asp Asp Pro Glu Met Met Glu Met145 150 155 160Val Lys Pro Ser Leu Asp Glu Ala Phe Val Ile Gln Glu Gln Gly Val 165 170 175Ala Leu Asn Phe Ile Gly Ala Arg Gly Ala Arg Pro Gly Val Thr Arg 180 185 190Glu Lys Arg Val Lys Tyr Ala Arg Glu Ile Leu Gln Lys Glu Met Leu 195 200 205Pro His Val Gly Val Ser Asp Phe Cys Glu Thr Lys Lys Ala Tyr Phe 210 215 220Leu Gly Tyr Met Val His Arg Leu Leu Leu Ala Ser Leu Gly Arg Arg225 230 235 240Glu Leu Asp Asp Arg Asp His Tyr Gly Asn Lys Arg Leu Asp Leu Ala 245 250 255Gly Pro Leu Leu Ala Phe Leu Phe Arg Gly Leu Phe Lys Asn Leu Met 260 265 270Lys Glu Val Arg Met Tyr Ala Gln Lys Phe Ile Asp Arg Gly Lys Asp 275 280 285Phe Asn Leu Asp Leu Ala Ile Lys Thr Lys Leu Ile Thr Asp Gly Leu 290 295 300Arg Tyr Ser Leu Ala Thr Gly Asn Trp Gly Asp Gln Lys Lys Ala His305 310 315 320Gln Ala Arg Ala Gly Val Ser Gln Val Leu Asn Arg Leu Thr Tyr Ala 325 330 335Ser Thr Leu Ser His Leu Arg Arg Val Asn Ser Pro Ile Gly Arg Asp 340 345 350Gly Lys Leu Ala Lys Pro Arg Gln Leu His Asn Thr Leu Trp Gly Met 355 360 365Ile Cys Pro Ala Glu Thr Pro Glu Gly Ala Ala Val Gly Leu Val Lys 370 375 380Asn Leu Ala Leu Met Ala Tyr Ile Ser Val Gly Ser Gln Pro Ser Pro385 390 395 400Ile Leu Glu Phe Leu Glu Glu Trp Ser Met Glu Asn Leu Glu Glu Ile 405 410 415Ala Pro Ser Ala Ile Ala Asn Ala Thr Lys Ile Phe Val Asn Gly Cys 420 425 430Trp Val Gly Ile His Arg Asp Pro Glu Gln Leu Thr Ala Thr Leu Arg 435 440 445Lys Leu Arg Arg Gln Met Asp Ile Ile Val Ser Glu Val Ser Met Ile 450 455 460Arg Asp Ile Arg Asp Arg Glu Ile Arg Ile Tyr Thr Asp Ala Gly Arg465 470 475 480Ile Cys Arg Pro Leu Leu Ile Ala Lys Asn Gly Ser Leu Leu Leu Lys 485 490 495Lys Glu His Ile Asp Met Leu Lys Glu Arg Glu Tyr Asn Asn Tyr Gly 500 505 510Trp Gln Val Leu Val Ala Ser Gly Val Val Glu Tyr Ile Asp Thr Leu 515 520 525Glu Glu Glu Thr Val Met Ile Ala Met Ser Pro Asp Asp Leu Arg Gln 530 535 540Asp Lys Glu Cys Ala Tyr Cys Thr Thr Tyr Thr His Cys Glu Ile His545 550 555 560Pro Ala Met Ile Leu Gly Val Cys Ala Ser Ile Ile Pro Phe Pro Asp 565 570 575His Asn Gln Ser Pro Arg Asn Thr Tyr Gln Ser Ala Met Gly Lys Gln 580 585 590Ala Met Gly Val Tyr Ile Thr Asn Phe His Val Arg Met Asp Thr Leu 595 600 605Ala His Val Leu Tyr Tyr Pro His Lys Pro Leu Val Thr Thr Arg Ser 610 615 620Met Glu Tyr Leu Arg Phe Arg Glu Leu Pro Ala Gly Ile Asn Ser Ile625 630 635 640Val Ala Ile Ala Cys Tyr Thr Gly Tyr Asn Gln Glu Asp Ser Val Ile 645 650 655Leu Asn Ala Ser Ala Val Glu Arg Gly Phe Phe Arg Ser Val Phe Tyr 660 665 670Arg Ser Tyr Lys Asp Ala Glu Ser Lys Arg Ile Gly Asp Gln Glu Glu 675 680 685Gln Phe Glu Lys Pro Thr Arg Gln Thr Cys Gln Gly Met Arg Asn Ala 690 695 700Leu Tyr Asp Lys Leu Asp Asp Asp Gly Ile Ile Ser Pro Gly Ile Arg705 710 715 720Val Ser Gly Asp Asp Val Val Ile Gly Lys Thr Met Thr Leu Pro Glu 725 730 735Asn Asp Asp Glu Leu Asp Gly Asn Thr Lys Lys Phe Thr Lys Arg Asp 740 745 750Ala Ser Thr Phe Leu Arg Asn Ser Glu Thr Gly Val Val Asp Gln Val 755 760 765Met Leu Thr Leu Asn Ser Glu Gly Tyr Lys Phe Cys Lys Ile Arg Val 770 775 780Arg Ser Val Arg Ile Pro Gln Ile Gly Asp Lys Phe Ala Ser Arg His785 790 795 800Gly Gln Lys Gly Thr Cys Gly Ile Gln Tyr Arg Gln Glu Asp Met Ile 805 810 815Phe Ser Cys Glu Gly Leu Thr Pro Asp Ile Ile Ile Asn Pro His Ala 820 825 830Ile Pro Ser Arg Met Thr Ile Gly His Leu Ile Glu Cys Ile Gln Gly 835 840 845Lys Val Ser Ala Asn Lys Gly Glu Ile Gly Asp Ala Thr Pro Phe Asn 850 855 860Asp Ala Val Asn Val Gln Lys Ile Ser Thr Leu Leu Gln Glu Tyr Gly865 870 875 880Tyr Gln Leu Arg Gly Asn Glu Val Met Tyr Asn Gly His Thr Gly Arg 885 890 895Lys Met Asn Ala Gln Ile Phe Leu Gly Pro Thr Tyr Tyr Gln Arg Leu 900 905 910Lys His Met Val Asp Asp Lys Ile His Ser Arg Ala Arg Gly Pro Val 915 920 925Gln Ile Leu Val Arg Gln Pro Met Glu Gly Arg Ala Arg Asp Gly Gly 930 935 940Leu Arg Phe Gly Glu Met Glu Arg Asp Cys Gln Ile Ser His Gly Ala945 950 955 960Ala Gln Phe Leu Arg Glu Arg Leu Phe Glu Val Ser Asp Pro Tyr Arg 965 970 975Ile His Val Cys Asn Phe Cys Gly Leu Ile Ala Ile Ala Asn Leu Arg 980 985 990Asn Asn Thr Phe Glu Cys Lys Gly Cys Lys Asn Lys Thr Gln Ile Ser 995 1000 1005Gln Thr Trp Ile Leu 1010752279DNAMeligethes aeneus 75gagacccaac accagaagac tttcataggg aaaatcccga ttatgttgag gtctacgtac 60tgccttctca gcggcttaac agatcgtgat ttgacggagt taaacgagtg tcctttggat 120cccgggggtt atttcatcat aaacgggtcg gagaaggttt taattgccca ggaaaaaatg 180gctacgaaca cagtgtatgt gttttcgatg aaggacggga aatacgcgtt taaatccgag 240attaggtcgt gtttggagca ttcttcgcgc cccacctcca ctttgtgggt gaacatgatg 300gcccgtggtg ggcaggctgt caaaaaggcg gccatcgggc aaagaattat tgccatttta 360ccatatatca agcaagaaat acccattatg atcgtattca gagcgttggg ttttgtggct 420gacagagata tcctggaaca catcatttat gactttgacg accctgaaat gatggagatg 480gtgaaaccgt ccctggacga ggcctttgta attcaagagc agggtgtggc tttgaatttt 540atcggggcta gaggggccag gcccggcgta acgagggaaa agcgtgttaa atacgccagg 600gaaattttgc agaaggaaat gctgccgcat gtaggagttt ccgatttctg cgaaaccaaa 660aaagcgtatt tcttggggta catggtgcac aggctgcttc tggcctcttt ggggcgcaga 720gagttagacg acagggatca ttacggcaac aaaaggttgg atttggctgg gccgttgctg 780gctttcttgt tcagaggtct tttcaaaaac ttaatgaagg aagtgcgcat gtacgcccaa 840aaattcatcg acagaggaaa agatttcaac ttggatttgg caatcaaaac caaactcatc 900accgacggtt tgcgttactc tcttgccacc ggtaactggg gcgaccagaa aaaggcccat 960caagccagag ccggagtgtc tcaggtactg aacagactga cttacgcctc gactttatct 1020catttgaggc gcgtaaactc gcccatcggt cgcgacggta aactagccaa accccgtcag 1080ttgcacaaca ccctgtgggg catgatttgc ccggcggaaa cgccagaggg cgctgcggtg 1140ggtttggtaa aaaatctcgc ccttatggct tacatttccg tcggttcgca accctctccg 1200atcttggagt tcttggagga gtggtcgatg gagaatttgg aggaaatagc gccgtctgct 1260atcgctaacg ccactaagat ttttgtcaat gggtgttggg tcggtattca cagggatccg 1320gagcaattga cggcgacttt gaggaagcta cgtcgccaga tggatattat cgtatccgag 1380gtatccatga tccgtgatat ccgcgatcgc gaaatccgta tctacacgga tgctggtcgt 1440atttgcagac ctttattgat tgctaaaaat ggcagcctgt tactgaaaaa agaacacatc 1500gacatgttga aagagagaga atacaacaac tatggctggc aagtgttggt agcctcaggt 1560gttgtcgaat acattgacac cctagaagaa gaaactgtga tgattgccat gtctcctgac 1620gatttgagac aagacaagga gtgcgcctac tgtacgactt acactcactg cgaaattcat 1680cccgccatga ttttgggagt ctgcgcgtca attatcccgt tccccgatca caaccaaagt 1740cccaggaaca cctatcaaag cgccatggga aaacaagcca tgggcgtgta cataacaaac 1800ttccacgtgc ggatggacac gctcgcgcac gtgctctact acccccacaa accgctggta 1860accaccagat ccatggagta cctgcggttc agagagctcc ccgccggcat caacagcatc 1920gtggccatcg cctgctacac cggctacaac caggaagatt cggttatatt gaacgcttcg 1980gccgtcgaaa gaggcttctt ccggtcggtg ttctaccgtt cgtacaagga cgccgagtcc 2040aaacggatcg gggatcagga ggagcagttc gagaagccga ccaggcagac ctgccagggc 2100atgcgcaacg cgctgtacga caaattggac gacgacggca taatttcgcc tggcatccgt 2160gtttccgggg acgatgtcgt cataggcaaa accatgacac tcccggagaa cgatgatgag 2220ctggacggta acacgaagaa gttcaccaag agggacgcca gtactttctt gcgtaacag 227976759PRTMeligethes aeneus 76Glu Thr Gln His Gln Lys Thr Phe Ile Gly Lys Ile Pro Ile Met Leu1 5 10 15Arg Ser Thr Tyr Cys Leu Leu Ser Gly Leu Thr Asp Arg Asp Leu Thr 20 25 30Glu Leu Asn Glu Cys Pro Leu Asp Pro Gly Gly Tyr Phe Ile Ile Asn 35 40 45Gly Ser Glu Lys Val Leu Ile Ala Gln Glu Lys Met Ala Thr Asn Thr 50 55 60Val Tyr Val Phe Ser Met Lys Asp Gly Lys Tyr Ala Phe Lys Ser Glu65 70 75 80Ile Arg Ser Cys Leu Glu His Ser Ser Arg Pro Thr Ser Thr Leu Trp 85 90 95Val Asn Met Met Ala Arg Gly Gly Gln Ala Val Lys Lys Ala Ala Ile 100 105 110Gly Gln Arg Ile Ile Ala Ile Leu Pro Tyr Ile Lys Gln Glu Ile Pro 115 120 125Ile Met Ile Val Phe Arg Ala Leu Gly Phe Val Ala Asp Arg Asp Ile 130 135 140Leu Glu His Ile Ile Tyr Asp Phe Asp Asp Pro Glu Met Met Glu Met145 150 155 160Val Lys Pro Ser Leu Asp Glu Ala Phe Val Ile Gln Glu Gln Gly Val 165 170 175Ala Leu Asn Phe Ile Gly Ala Arg Gly Ala Arg Pro Gly Val Thr Arg 180 185 190Glu Lys Arg Val Lys Tyr Ala Arg Glu Ile Leu Gln Lys Glu Met Leu 195 200 205Pro His Val Gly Val Ser Asp Phe Cys Glu Thr Lys Lys Ala Tyr Phe 210 215 220Leu Gly Tyr Met Val His Arg Leu Leu Leu Ala Ser Leu Gly Arg Arg225 230 235 240Glu Leu Asp Asp Arg Asp His Tyr Gly Asn Lys Arg Leu Asp Leu Ala 245 250 255Gly Pro Leu Leu Ala Phe Leu Phe Arg Gly Leu Phe Lys Asn Leu Met 260 265 270Lys Glu Val Arg Met Tyr Ala Gln Lys Phe Ile Asp Arg Gly Lys Asp 275 280 285Phe Asn Leu Asp Leu Ala Ile Lys Thr Lys Leu Ile Thr Asp Gly Leu 290 295 300Arg Tyr Ser Leu Ala Thr Gly Asn Trp Gly Asp Gln Lys Lys Ala His305 310 315 320Gln Ala Arg Ala Gly Val Ser Gln Val Leu Asn Arg Leu Thr Tyr Ala 325 330 335Ser Thr Leu Ser His Leu Arg Arg Val Asn Ser Pro Ile Gly Arg Asp 340 345 350Gly Lys Leu Ala Lys Pro Arg Gln Leu His Asn Thr Leu Trp Gly Met 355 360 365Ile Cys Pro Ala Glu Thr Pro Glu Gly Ala Ala Val Gly Leu Val Lys 370 375 380Asn Leu Ala Leu Met Ala Tyr Ile Ser Val Gly Ser Gln Pro Ser Pro385 390 395 400Ile Leu Glu Phe Leu Glu Glu Trp Ser Met Glu Asn Leu Glu Glu Ile 405 410 415Ala Pro Ser Ala Ile Ala Asn Ala Thr Lys Ile Phe Val Asn Gly Cys 420 425 430Trp Val Gly Ile His Arg Asp Pro Glu Gln Leu Thr Ala Thr Leu Arg 435 440 445Lys Leu Arg Arg Gln Met Asp Ile Ile Val Ser Glu Val Ser Met Ile 450 455 460Arg Asp Ile Arg Asp Arg Glu Ile Arg Ile Tyr Thr Asp Ala Gly Arg465 470 475 480Ile Cys Arg Pro Leu Leu Ile Ala Lys Asn Gly Ser Leu Leu Leu Lys 485 490 495Lys Glu His Ile Asp Met Leu Lys Glu Arg Glu Tyr Asn Asn Tyr Gly 500 505 510Trp Gln Val Leu Val Ala Ser Gly Val Val Glu Tyr Ile Asp Thr Leu 515 520 525Glu Glu Glu Thr Val Met Ile Ala Met Ser Pro Asp Asp Leu Arg Gln 530

535 540Asp Lys Glu Cys Ala Tyr Cys Thr Thr Tyr Thr His Cys Glu Ile His545 550 555 560Pro Ala Met Ile Leu Gly Val Cys Ala Ser Ile Ile Pro Phe Pro Asp 565 570 575His Asn Gln Ser Pro Arg Asn Thr Tyr Gln Ser Ala Met Gly Lys Gln 580 585 590Ala Met Gly Val Tyr Ile Thr Asn Phe His Val Arg Met Asp Thr Leu 595 600 605Ala His Val Leu Tyr Tyr Pro His Lys Pro Leu Val Thr Thr Arg Ser 610 615 620Met Glu Tyr Leu Arg Phe Arg Glu Leu Pro Ala Gly Ile Asn Ser Ile625 630 635 640Val Ala Ile Ala Cys Tyr Thr Gly Tyr Asn Gln Glu Asp Ser Val Ile 645 650 655Leu Asn Ala Ser Ala Val Glu Arg Gly Phe Phe Arg Ser Val Phe Tyr 660 665 670Arg Ser Tyr Lys Asp Ala Glu Ser Lys Arg Ile Gly Asp Gln Glu Glu 675 680 685Gln Phe Glu Lys Pro Thr Arg Gln Thr Cys Gln Gly Met Arg Asn Ala 690 695 700Leu Tyr Asp Lys Leu Asp Asp Asp Gly Ile Ile Ser Pro Gly Ile Arg705 710 715 720Val Ser Gly Asp Asp Val Val Ile Gly Lys Thr Met Thr Leu Pro Glu 725 730 735Asn Asp Asp Glu Leu Asp Gly Asn Thr Lys Lys Phe Thr Lys Arg Asp 740 745 750Ala Ser Thr Phe Leu Arg Asn 75577447DNAMeligethes aeneus 77ccgacggttt gcgttactct cttgccaccg gtaactgggg cgaccagaaa aaggcccatc 60aagccagagc cggagtgtct caggtattga acagactgac ttacgcctcg actttatctc 120atttgaggcg cgtaaactcg cccatcggtc gcgacggtaa attagccaaa ccccgtcagt 180tgcacaacac cctgtggggc atgatttgcc cggcggaaac gccagagggc gctgcggtgg 240gtttggtaaa aaatctcgcc cttatggctt acatttccgt cggttcgcaa ccctctccga 300tcttggagtt cttggaggag tggtcgatgg agaatttgga ggaaatagcg ccgtctgcta 360tcgctaacgc cactaagatt tttgtcaatg ggtgttgggt cggtattcac agggatccgg 420agcaattgac ggcgactttg aggaaac 4477844DNAArtificial Sequenceforward primer to amplify RpII140 78taatacgact cactataggg agagtttcct caaagtcgcc gtca 447944DNAArtificial sequencereverse primer to amplify RpII140 79taatacgact cactataggg agaccgacgg tttgcgttac tctc 4480999PRTMeligethes aeneus 80Met Leu Arg Ser Thr Tyr Cys Leu Leu Ser Gly Leu Thr Asp Arg Asp1 5 10 15Leu Thr Glu Leu Asn Glu Cys Pro Leu Asp Pro Gly Gly Tyr Phe Ile 20 25 30Ile Asn Gly Ser Glu Lys Val Leu Ile Ala Gln Glu Lys Met Ala Thr 35 40 45Asn Thr Val Tyr Val Phe Ser Met Lys Asp Gly Lys Tyr Ala Phe Lys 50 55 60Ser Glu Ile Arg Ser Cys Leu Glu His Ser Ser Arg Pro Thr Ser Thr65 70 75 80Leu Trp Val Asn Met Met Ala Arg Gly Gly Gln Ala Val Lys Lys Ala 85 90 95Ala Ile Gly Gln Arg Ile Ile Ala Ile Leu Pro Tyr Ile Lys Gln Glu 100 105 110Ile Pro Ile Met Ile Val Phe Arg Ala Leu Gly Phe Val Ala Asp Arg 115 120 125Asp Ile Leu Glu His Ile Ile Tyr Asp Phe Asp Asp Pro Glu Met Met 130 135 140Glu Met Val Lys Pro Ser Leu Asp Glu Ala Phe Val Ile Gln Glu Gln145 150 155 160Gly Val Ala Leu Asn Phe Ile Gly Ala Arg Gly Ala Arg Pro Gly Val 165 170 175Thr Arg Glu Lys Arg Val Lys Tyr Ala Arg Glu Ile Leu Gln Lys Glu 180 185 190Met Leu Pro His Val Gly Val Ser Asp Phe Cys Glu Thr Lys Lys Ala 195 200 205Tyr Phe Leu Gly Tyr Met Val His Arg Leu Leu Leu Ala Ser Leu Gly 210 215 220Arg Arg Glu Leu Asp Asp Arg Asp His Tyr Gly Asn Lys Arg Leu Asp225 230 235 240Leu Ala Gly Pro Leu Leu Ala Phe Leu Phe Arg Gly Leu Phe Lys Asn 245 250 255Leu Met Lys Glu Val Arg Met Tyr Ala Gln Lys Phe Ile Asp Arg Gly 260 265 270Lys Asp Phe Asn Leu Asp Leu Ala Ile Lys Thr Lys Leu Ile Thr Asp 275 280 285Gly Leu Arg Tyr Ser Leu Ala Thr Gly Asn Trp Gly Asp Gln Lys Lys 290 295 300Ala His Gln Ala Arg Ala Gly Val Ser Gln Val Leu Asn Arg Leu Thr305 310 315 320Tyr Ala Ser Thr Leu Ser His Leu Arg Arg Val Asn Ser Pro Ile Gly 325 330 335Arg Asp Gly Lys Leu Ala Lys Pro Arg Gln Leu His Asn Thr Leu Trp 340 345 350Gly Met Ile Cys Pro Ala Glu Thr Pro Glu Gly Ala Ala Val Gly Leu 355 360 365Val Lys Asn Leu Ala Leu Met Ala Tyr Ile Ser Val Gly Ser Gln Pro 370 375 380Ser Pro Ile Leu Glu Phe Leu Glu Glu Trp Ser Met Glu Asn Leu Glu385 390 395 400Glu Ile Ala Pro Ser Ala Ile Ala Asn Ala Thr Lys Ile Phe Val Asn 405 410 415Gly Cys Trp Val Gly Ile His Arg Asp Pro Glu Gln Leu Thr Ala Thr 420 425 430Leu Arg Lys Leu Arg Arg Gln Met Asp Ile Ile Val Ser Glu Val Ser 435 440 445Met Ile Arg Asp Ile Arg Asp Arg Glu Ile Arg Ile Tyr Thr Asp Ala 450 455 460Gly Arg Ile Cys Arg Pro Leu Leu Ile Ala Lys Asn Gly Ser Leu Leu465 470 475 480Leu Lys Lys Glu His Ile Asp Met Leu Lys Glu Arg Glu Tyr Asn Asn 485 490 495Tyr Gly Trp Gln Val Leu Val Ala Ser Gly Val Val Glu Tyr Ile Asp 500 505 510Thr Leu Glu Glu Glu Thr Val Met Ile Ala Met Ser Pro Asp Asp Leu 515 520 525Arg Gln Asp Lys Glu Cys Ala Tyr Cys Thr Thr Tyr Thr His Cys Glu 530 535 540Ile His Pro Ala Met Ile Leu Gly Val Cys Ala Ser Ile Ile Pro Phe545 550 555 560Pro Asp His Asn Gln Ser Pro Arg Asn Thr Tyr Gln Ser Ala Met Gly 565 570 575Lys Gln Ala Met Gly Val Tyr Ile Thr Asn Phe His Val Arg Met Asp 580 585 590Thr Leu Ala His Val Leu Tyr Tyr Pro His Lys Pro Leu Val Thr Thr 595 600 605Arg Ser Met Glu Tyr Leu Arg Phe Arg Glu Leu Pro Ala Gly Ile Asn 610 615 620Ser Ile Val Ala Ile Ala Cys Tyr Thr Gly Tyr Asn Gln Glu Asp Ser625 630 635 640Val Ile Leu Asn Ala Ser Ala Val Glu Arg Gly Phe Phe Arg Ser Val 645 650 655Phe Tyr Arg Ser Tyr Lys Asp Ala Glu Ser Lys Arg Ile Gly Asp Gln 660 665 670Glu Glu Gln Phe Glu Lys Pro Thr Arg Gln Thr Cys Gln Gly Met Arg 675 680 685Asn Ala Leu Tyr Asp Lys Leu Asp Asp Asp Gly Ile Ile Ser Pro Gly 690 695 700Ile Arg Val Ser Gly Asp Asp Val Val Ile Gly Lys Thr Met Thr Leu705 710 715 720Pro Glu Asn Asp Asp Glu Leu Asp Gly Asn Thr Lys Lys Phe Thr Lys 725 730 735Arg Asp Ala Ser Thr Phe Leu Arg Asn Ser Glu Thr Gly Val Val Asp 740 745 750Gln Val Met Leu Thr Leu Asn Ser Glu Gly Tyr Lys Phe Cys Lys Ile 755 760 765Arg Val Arg Ser Val Arg Ile Pro Gln Ile Gly Asp Lys Phe Ala Ser 770 775 780Arg His Gly Gln Lys Gly Thr Cys Gly Ile Gln Tyr Arg Gln Glu Asp785 790 795 800Met Ile Phe Ser Cys Glu Gly Leu Thr Pro Asp Ile Ile Ile Asn Pro 805 810 815His Ala Ile Pro Ser Arg Met Thr Ile Gly His Leu Ile Glu Cys Ile 820 825 830Gln Gly Lys Val Ser Ala Asn Lys Gly Glu Ile Gly Asp Ala Thr Pro 835 840 845Phe Asn Asp Ala Val Asn Val Gln Lys Ile Ser Thr Leu Leu Gln Glu 850 855 860Tyr Gly Tyr Gln Leu Arg Gly Asn Glu Val Met Tyr Asn Gly His Thr865 870 875 880Gly Arg Lys Met Asn Ala Gln Ile Phe Leu Gly Pro Thr Tyr Tyr Gln 885 890 895Arg Leu Lys His Met Val Asp Asp Lys Ile His Ser Arg Ala Arg Gly 900 905 910Pro Val Gln Ile Leu Val Arg Gln Pro Met Glu Gly Arg Ala Arg Asp 915 920 925Gly Gly Leu Arg Phe Gly Glu Met Glu Arg Asp Cys Gln Ile Ser His 930 935 940Gly Ala Ala Gln Phe Leu Arg Glu Arg Leu Phe Glu Val Ser Asp Pro945 950 955 960Tyr Arg Ile His Val Cys Asn Phe Cys Gly Leu Ile Ala Ile Ala Asn 965 970 975Leu Arg Asn Asn Thr Phe Glu Cys Lys Gly Cys Lys Asn Lys Thr Gln 980 985 990Ile Ser Gln Thr Trp Ile Leu 995813673DNAMeligethes aeneus 81cagattaaat cgcttttcgg cggttgtgct tgtgttttta tttttgtgac tttaaagatg 60tatgatcaag atgaagagca atatgaggag gaagacgcgg aagaaattag ttccgaattg 120tggcaggaag cctgttggat cgttataaac gcgtatttcg acgagaaagg cctggtacgg 180caacaattgg acagtttcga tgagttcatt cagatgtctg tgcagagaat cgtggaggat 240tccccgcaaa tcgatttggt ggcagaggcg cagcacacgt cgggagaagt ggaaaacccc 300ccgcgatatt tgctgaaatt cgagcagatt tacctttcga agcccacgca ttgggagaaa 360gacggggccc cgtcccctat gatgcccaac gaggccagac tgagaaattt gacgtactct 420gcacctcttt acgtggacat aacgaagact atcgttaagg agggcgaaga tcctgtcgag 480acccaacacc agaagacttt catagggaaa atcccgatta tgttgaggtc tacgtactgc 540cttctcagcg gcttaacaga tcgtgatttg acggagttaa acgagtgtcc tttggatccc 600gggggttatt tcatcataaa cgggtcggag aaggttttaa ttgcccagga aaaaatggct 660acgaacacag tgtatgtgtt ttcgatgaag gacgggaaat acgcgtttaa atccgagatt 720aggtcgtgtt tggagcattc ttcgcgcccc acctccactt tgtgggtgaa tatgatggct 780cgtggcgggc aagctgtgaa aaaggcagcc atcgggcaaa gaatcatcgc tattttacca 840tatatcaagc aagaaatacc cattatgatc gtattcagag cgctaggttt tgtggccgac 900agagacatcc tcgaacacat catctatgac tttgacgacc ctgaaatgat ggagatggtg 960aaaccgtccc tagacgaggc ttttgtaatc caagagcagg gtgtggcctt gaattttatt 1020ggtgctagag gggccaggcc cggcgtaacg agggaaaagc gtgttaaata cgccagggaa 1080attttgcaga aggaaatgct gccgcatgta ggagtttccg atttctgtga aaccaaaaaa 1140gcgtatttct tggggtacat ggtgcacagg ctgcttctgg cctctttggg gcgcagagag 1200ttagacgaca gggatcatta cggcaacaaa aggttggatt tggctgggcc gttgctggct 1260ttcttgttca gaggtctttt caaaaaccta atgaaggaag tgcgaatgta cgcccaaaaa 1320ttcatcgaca gaggaaaaga tttcaacttg gatttggcaa tcaaaaccaa actcatcacc 1380gacggtttgc gttactctct tgccaccggt aactggggcg accagaaaaa ggcccatcaa 1440gccagagccg gagtgtctca ggtattgaac agactgactt acgcctcgac tttatctcat 1500ttgaggcgcg taaactcgcc catcggtcgc gacggtaaat tagccaaacc ccgtcagttg 1560cacaacaccc tgtggggcat gatttgcccg gcggaaacgc cagagggcgc tgcggtgggt 1620ttggtaaaaa atctcgccct tatggcttac atttccgtcg gttcgcaacc ttctccgatc 1680ttggagttct tggaggagtg gtcgatggag aatttggagg aaatagcgcc gtctgctatc 1740gctaacgcca ctaagatttt tgtcaatggg tgttgggtcg gtattcacag ggatccggag 1800caattgacgg cgactttgag gaaactacgt cgccagatgg atattatcgt atccgaggta 1860tccatgatcc gtgatatccg cgatcgcgaa atccgtatct acacggatgc tggtcgcatt 1920tgcagacctt tattgatcgc caaaaatggc agcctgttac ttaaaaaaga acacatcgac 1980atgttaaaag agagagaata caacaactat ggctggcaag tgttggtagc ctcaggtgtt 2040gtcgaataca ttgacaccct agaggaagaa actgtgatga ttgccatgtc tcctgacgat 2100ttgagacaag acaaggagtg cgcctactgt acgacttaca ctcactgcga aattcatccc 2160gccatgattt tgggagtctg cgcgtcaatt atcccgttcc ccgatcacaa ccaaagtccc 2220aggaacacct atcaaagcgc catgggaaaa caagccatgg gcgtgtacat aacaaacttc 2280cacgtgcgga tggacacgct cgcgcacgtg ctctactacc ctcacaaacc gctggtaacc 2340accagatcca tggagtacct ccggttcaga gagctccccg ccggcatcaa cagcatcgtg 2400gccatcgcct gctacaccgg ctacaaccag gaggattcgg ttattttaaa cgcttcggcc 2460gtcgaaagag gcttcttccg atcggtgttt tatcgttcgt acaaggacgc cgagtccaag 2520cgcattgggg atcaggagga gcagttcgag aagccgacca ggcagacctg ccagggcatg 2580cggaacgcgc tgtacgacaa actcgacgac gacggtatca tttcgcccgg tattcgtgtc 2640tccggtgacg acgtcgtcat cggcaaaacc atgacgctcc cggagaacga tgatgagctg 2700gacggtaaca cgaagaagtt caccaagagg gacgccagta ctttcttgcg taacagcgag 2760actggcgtgg tggatcaggt gatgttgacg ttgaactccg agggttacaa gttctgcaag 2820atccgcgtga ggtccgtgag gattccgcag atcggcgaca agttcgcctc gcgtcacggg 2880cagaagggta cttgcggcat acagtaccgg caagaagata tgattttctc gtgcgagggt 2940ttgaccccgg acatcatcat caacccgcac gccatcccat ctcgtatgac gattgggcat 3000ttgatcgagt gcatccaagg taaggtatcg gcgaataagg gggagatcgg ggacgcgacc 3060ccgtttaacg acgcggtaaa cgtgcagaaa atttccactc tcctgcaaga gtacgggtac 3120caactgagag ggaacgaggt gatgtacaac gggcacacgg ggcgcaaaat gaacgcgcag 3180attttcctgg gccccaccta ctaccagcgc ctcaagcaca tggtggacga caagatccac 3240tcgagggcca gaggcccggt gcagatcctc gtcaggcagc ccatggaggg tcgagccagg 3300gacgggggcc tgcgtttcgg ggagatggag cgcgattgcc agatttcgca cggcgcggcg 3360cagtttctgc gcgagcgctt gttcgaggtg tccgatccct acaggatcca cgtgtgcaac 3420ttctgcgggc tgatcgccat cgccaacttg cggaacaaca cgttcgagtg caaggggtgc 3480aagaataaga cgcagatttc gcaggtcaag ttgccttacg ccgctaagtt gctcttccaa 3540gagctgatgt cgatgaatat cgcccccaga ttgatggtct tataaaaagt ttattttatg 3600tattaggtat tagaatttag ttttgtattg attttatgtg actatgatac cactaaaata 3660aatataaata caa 3673821194PRTMeligethes aeneus 82Gln Ile Lys Ser Leu Phe Gly Gly Cys Ala Cys Val Phe Ile Phe Val1 5 10 15Thr Leu Lys Met Tyr Asp Gln Asp Glu Glu Gln Tyr Glu Glu Glu Asp 20 25 30Ala Glu Glu Ile Ser Ser Glu Leu Trp Gln Glu Ala Cys Trp Ile Val 35 40 45Ile Asn Ala Tyr Phe Asp Glu Lys Gly Leu Val Arg Gln Gln Leu Asp 50 55 60Ser Phe Asp Glu Phe Ile Gln Met Ser Val Gln Arg Ile Val Glu Asp65 70 75 80Ser Pro Gln Ile Asp Leu Val Ala Glu Ala Gln His Thr Ser Gly Glu 85 90 95Val Glu Asn Pro Pro Arg Tyr Leu Leu Lys Phe Glu Gln Ile Tyr Leu 100 105 110Ser Lys Pro Thr His Trp Glu Lys Asp Gly Ala Pro Ser Pro Met Met 115 120 125Pro Asn Glu Ala Arg Leu Arg Asn Leu Thr Tyr Ser Ala Pro Leu Tyr 130 135 140Val Asp Ile Thr Lys Thr Ile Val Lys Glu Gly Glu Asp Pro Val Glu145 150 155 160Thr Gln His Gln Lys Thr Phe Ile Gly Lys Ile Pro Ile Met Leu Arg 165 170 175Ser Thr Tyr Cys Leu Leu Ser Gly Leu Thr Asp Arg Asp Leu Thr Glu 180 185 190Leu Asn Glu Cys Pro Leu Asp Pro Gly Gly Tyr Phe Ile Ile Asn Gly 195 200 205Ser Glu Lys Val Leu Ile Ala Gln Glu Lys Met Ala Thr Asn Thr Val 210 215 220Tyr Val Phe Ser Met Lys Asp Gly Lys Tyr Ala Phe Lys Ser Glu Ile225 230 235 240Arg Ser Cys Leu Glu His Ser Ser Arg Pro Thr Ser Thr Leu Trp Val 245 250 255Asn Met Met Ala Arg Gly Gly Gln Ala Val Lys Lys Ala Ala Ile Gly 260 265 270Gln Arg Ile Ile Ala Ile Leu Pro Tyr Ile Lys Gln Glu Ile Pro Ile 275 280 285Met Ile Val Phe Arg Ala Leu Gly Phe Val Ala Asp Arg Asp Ile Leu 290 295 300Glu His Ile Ile Tyr Asp Phe Asp Asp Pro Glu Met Met Glu Met Val305 310 315 320Lys Pro Ser Leu Asp Glu Ala Phe Val Ile Gln Glu Gln Gly Val Ala 325 330 335Leu Asn Phe Ile Gly Ala Arg Gly Ala Arg Pro Gly Val Thr Arg Glu 340 345 350Lys Arg Val Lys Tyr Ala Arg Glu Ile Leu Gln Lys Glu Met Leu Pro 355 360 365His Val Gly Val Ser Asp Phe Cys Glu Thr Lys Lys Ala Tyr Phe Leu 370 375 380Gly Tyr Met Val His Arg Leu Leu Leu Ala Ser Leu Gly Arg Arg Glu385 390 395 400Leu Asp Asp Arg Asp His Tyr Gly Asn Lys Arg Leu Asp Leu Ala Gly 405 410 415Pro Leu Leu Ala Phe Leu Phe Arg Gly Leu Phe Lys Asn Leu Met Lys 420 425 430Glu Val Arg Met Tyr Ala Gln Lys Phe Ile Asp Arg Gly Lys Asp Phe 435 440 445Asn Leu Asp Leu Ala Ile Lys Thr Lys Leu Ile Thr Asp Gly Leu Arg 450 455 460Tyr Ser Leu Ala Thr Gly Asn Trp Gly Asp Gln Lys Lys Ala His Gln465 470 475 480Ala Arg Ala Gly Val Ser Gln Val Leu Asn Arg Leu Thr Tyr Ala Ser 485 490 495Thr Leu Ser His Leu Arg Arg Val Asn Ser Pro Ile Gly Arg Asp Gly 500

505 510Lys Leu Ala Lys Pro Arg Gln Leu His Asn Thr Leu Trp Gly Met Ile 515 520 525Cys Pro Ala Glu Thr Pro Glu Gly Ala Ala Val Gly Leu Val Lys Asn 530 535 540Leu Ala Leu Met Ala Tyr Ile Ser Val Gly Ser Gln Pro Ser Pro Ile545 550 555 560Leu Glu Phe Leu Glu Glu Trp Ser Met Glu Asn Leu Glu Glu Ile Ala 565 570 575Pro Ser Ala Ile Ala Asn Ala Thr Lys Ile Phe Val Asn Gly Cys Trp 580 585 590Val Gly Ile His Arg Asp Pro Glu Gln Leu Thr Ala Thr Leu Arg Lys 595 600 605Leu Arg Arg Gln Met Asp Ile Ile Val Ser Glu Val Ser Met Ile Arg 610 615 620Asp Ile Arg Asp Arg Glu Ile Arg Ile Tyr Thr Asp Ala Gly Arg Ile625 630 635 640Cys Arg Pro Leu Leu Ile Ala Lys Asn Gly Ser Leu Leu Leu Lys Lys 645 650 655Glu His Ile Asp Met Leu Lys Glu Arg Glu Tyr Asn Asn Tyr Gly Trp 660 665 670Gln Val Leu Val Ala Ser Gly Val Val Glu Tyr Ile Asp Thr Leu Glu 675 680 685Glu Glu Thr Val Met Ile Ala Met Ser Pro Asp Asp Leu Arg Gln Asp 690 695 700Lys Glu Cys Ala Tyr Cys Thr Thr Tyr Thr His Cys Glu Ile His Pro705 710 715 720Ala Met Ile Leu Gly Val Cys Ala Ser Ile Ile Pro Phe Pro Asp His 725 730 735Asn Gln Ser Pro Arg Asn Thr Tyr Gln Ser Ala Met Gly Lys Gln Ala 740 745 750Met Gly Val Tyr Ile Thr Asn Phe His Val Arg Met Asp Thr Leu Ala 755 760 765His Val Leu Tyr Tyr Pro His Lys Pro Leu Val Thr Thr Arg Ser Met 770 775 780Glu Tyr Leu Arg Phe Arg Glu Leu Pro Ala Gly Ile Asn Ser Ile Val785 790 795 800Ala Ile Ala Cys Tyr Thr Gly Tyr Asn Gln Glu Asp Ser Val Ile Leu 805 810 815Asn Ala Ser Ala Val Glu Arg Gly Phe Phe Arg Ser Val Phe Tyr Arg 820 825 830Ser Tyr Lys Asp Ala Glu Ser Lys Arg Ile Gly Asp Gln Glu Glu Gln 835 840 845Phe Glu Lys Pro Thr Arg Gln Thr Cys Gln Gly Met Arg Asn Ala Leu 850 855 860Tyr Asp Lys Leu Asp Asp Asp Gly Ile Ile Ser Pro Gly Ile Arg Val865 870 875 880Ser Gly Asp Asp Val Val Ile Gly Lys Thr Met Thr Leu Pro Glu Asn 885 890 895Asp Asp Glu Leu Asp Gly Asn Thr Lys Lys Phe Thr Lys Arg Asp Ala 900 905 910Ser Thr Phe Leu Arg Asn Ser Glu Thr Gly Val Val Asp Gln Val Met 915 920 925Leu Thr Leu Asn Ser Glu Gly Tyr Lys Phe Cys Lys Ile Arg Val Arg 930 935 940Ser Val Arg Ile Pro Gln Ile Gly Asp Lys Phe Ala Ser Arg His Gly945 950 955 960Gln Lys Gly Thr Cys Gly Ile Gln Tyr Arg Gln Glu Asp Met Ile Phe 965 970 975Ser Cys Glu Gly Leu Thr Pro Asp Ile Ile Ile Asn Pro His Ala Ile 980 985 990Pro Ser Arg Met Thr Ile Gly His Leu Ile Glu Cys Ile Gln Gly Lys 995 1000 1005Val Ser Ala Asn Lys Gly Glu Ile Gly Asp Ala Thr Pro Phe Asn 1010 1015 1020Asp Ala Val Asn Val Gln Lys Ile Ser Thr Leu Leu Gln Glu Tyr 1025 1030 1035Gly Tyr Gln Leu Arg Gly Asn Glu Val Met Tyr Asn Gly His Thr 1040 1045 1050Gly Arg Lys Met Asn Ala Gln Ile Phe Leu Gly Pro Thr Tyr Tyr 1055 1060 1065Gln Arg Leu Lys His Met Val Asp Asp Lys Ile His Ser Arg Ala 1070 1075 1080Arg Gly Pro Val Gln Ile Leu Val Arg Gln Pro Met Glu Gly Arg 1085 1090 1095Ala Arg Asp Gly Gly Leu Arg Phe Gly Glu Met Glu Arg Asp Cys 1100 1105 1110Gln Ile Ser His Gly Ala Ala Gln Phe Leu Arg Glu Arg Leu Phe 1115 1120 1125Glu Val Ser Asp Pro Tyr Arg Ile His Val Cys Asn Phe Cys Gly 1130 1135 1140Leu Ile Ala Ile Ala Asn Leu Arg Asn Asn Thr Phe Glu Cys Lys 1145 1150 1155Gly Cys Lys Asn Lys Thr Gln Ile Ser Gln Val Lys Leu Pro Tyr 1160 1165 1170Ala Ala Lys Leu Leu Phe Gln Glu Leu Met Ser Met Asn Ile Ala 1175 1180 1185Pro Arg Leu Met Val Leu 1190

Claims

1. A double-stranded ribonucleic acid (dsRNA) molecule containing a duplex region comprising: a first polyribonucleotide comprising at least 21 contiguous nucleotides of a first nucleotide sequence selected from the group consisting of SEQ ID NO:89, SEQ ID NO:90, SEQ ID NO:92, and the complements and reverse complements thereof; and a second polyribonucleotide hybridized to the first polyribonucleotide.

2. The dsRNA molecule of claim 1, wherein the first polyribonucleotide comprises at least 21 contiguous nucleotides of SEQ ID NO:91.

3. The dsRNA molecule of claim 1, wherein the second polyribonucleotide comprises a second nucleotide sequence that is the complement or the reverse complement of the first nucleotide sequence.

4. The dsRNA molecule of claim 1, wherein the molecule is a hairpin RNA (hpRNA) molecule further containing a loop region comprising a spacer polyribonucleotide, wherein the spacer polyribonucleotide is located between the first and second polyribonucleotides in the molecule.

5. A nucleic acid molecule comprising a polynucleotide operably linked to a heterologous promoter, wherein the polynucleotide encodes a hairpin ribonucleic acid (hpRNA) molecule, the polynucleotide comprising: a first nucleotide sequence comprising at least 21 contiguous nucleotides of a nucleotide sequence selected from the group consisting of SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:81, and the reverse complements thereof; a second nucleotide sequence; and a third nucleotide sequence that is at least 90% complementary to the reverse complement of the first nucleotide sequence, wherein the second nucleotide sequence is located between the first and third nucleotide sequences in the polynucleotide.

6. The nucleic acid molecule of claim 5, wherein the first nucleotide sequence comprises at least 21 contiguous nucleotides of SEQ ID NO:77 or the reverse complement thereof.

7. The nucleic acid molecule of claim 5, wherein the heterologous promoter is functional in a plant cell.

8. A plant material comprising the dsRNA molecule of claim 4.

9. The plant material of claim 8, wherein the plant material is a transgenic plant material that expresses the dsRNA molecule.

10. The transgenic plant material of claim 9, wherein the plant material is a plant cell.

11. The transgenic plant material of claim 9, wherein the plant material is canola.

12. A transgenic plant or seed thereof comprising the nucleic acid molecule of claim 7, wherein the heterologous promoter is functional in the plant.

13. The transgenic plant or seed thereof of claim 12, wherein the plant is canola.

14. A transgenic plant commodity product comprising the dsRNA molecule of claim 1.

15. A sprayable formulation or artificial pollen beetle diet comprising the dsRNA molecule of claim 1.

16. A method for controlling a pollen beetle insect population, the method comprising feeding insects of the population with an agent comprising the dsRNA molecule of claim 1.

17. The method according to claim 16, wherein the agent is a sprayable formulation or artificial diet.

18. A method for controlling a pollen beetle insect population, the method comprising feeding insects of the population with an agent comprising the dsRNA molecule of claim 4.

19. The method according to claim 18, wherein the agent is a sprayable formulation or artificial diet.

20. The method according to claim 18, wherein the agent is a transgenic plant material expressing the dsRNA molecule.

21. A method for improving the yield of a plant crop, the method comprising: cultivating in the crop the transgenic plant or seed of claim 12, such that the dsRNA molecule is expressed.

22. The method according to claim 21, wherein the crop is canola.

23. The method according to claim 21, wherein the transgenic plant or seed is canola.

24. The method according to claim 22, wherein the transgenic plant or seed is canola.

25. A method for producing a transgenic plant cell, the method comprising: transforming a plant cell with the nucleic acid molecule of claim 7; culturing the transformed plant cell under conditions sufficient to allow for development of a plant cell culture; and selecting a transgenic plant cell that has integrated the polynucleotide in its genome and expresses the dsRNA molecule.

26. A method for producing a pollen beetle-resistant transgenic plant, the method comprising regenerating a transgenic plant from the transgenic plant cell of claim 10.